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Abstract 
 
 
 
 
Cardiovascular diseases are the leading causes of death globally. One contributing factor that can 
lead to heart failure is a myocardial infarction. When an infarct occurs, an occlusion in the tissue 
vasculature prevents blood flow beyond this site. It results in scar tissue formation. The scar is 
non-contractile and reduces the working efficiency of the heart. To compensate, left ventricular 
remodeling will ensue resulting in enlarging of the left ventricle. This progression of events 
ultimately culminates in heart failure. One approach to assist patients who have suffered a heart 
attack is to implant a cardiac patch. Current patches are acellular and aim to retain the geometry 
of the left ventricle, limiting any ventricular remodeling from occurring. While these patches 
provide a passive support, it is hypothesized that incorporation of cells into the patches could result 
in functional support that could help to restore baseline function. To be effective, a cell-populated 
cardiac patch would need to integrate with the host tissue functionally and mechanically. In this 
thesis, we developed a fibrin microthread-based composite scaffold with material properties 
comparable to left ventricular myocardium that promotes regional cardiomyocyte alignment and 
physiologically relevant contractile strains. We hypothesized that a composite material could be 
developed where constituents of the material would complement one another to yield a 
mechanically reinforced scaffold that promotes cardiomyocyte function. Through manipulation of 
the volume fraction of the components, we manipulated the modulus of the layer without 
compromising contractile strain or contractile frequency of incorporated cells. Additionally, 
through strategic restraint of the scaffolds, we utilized cell-mediated compaction to induce a 
tension pattern that increased alignment of incorporated cells. This corresponded to an increase in 
contractile strain magnitudes, and an anisotropic contractile wave propagation through the 
engineered tissue. Finally, we laminated composite layers into a patch mimicking the architecture 
of ventricular myocardium and found that material properties of the patch were similar to 
properties of the target tissue. In summary, we designed a biomimetic composite patch with 
material properties similar to ventricular myocardium that supports cardiomyocyte alignment and 
contractility to promote functional and mechanical integration upon implantation.   
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Chapter 1: Overview 
 
 
 
 
1.1 INTRODUCTION 
Every year approximately 500,000 new cases of heart failure are diagnosed in the United 
States alone,1 making it the leading cause of death in our society. Heart transplantation remains 
the only treatment that can restore function for end stage heart failure. However, donors are limited 
and only ~2,500 cardiac transplantation surgeries occur annually in the United States1 leaving a 
majority of affected patients with compromised cardiac function. Other treatments for end stage 
heart failure include pharmacologic agents and ventricular assist devices, palliative treatments that 
do not regenerate damaged tissue.2 A major cause of heart failure is a myocardial infarction (MI), 
where blood flow through a coronary artery is blocked, resulting in ischemia of downstream cardiac 
muscle. Ischemia causes cardiomyocyte (CM) death and a severe inflammatory response that 
ultimately results in scar tissue formation.3 Because CMs have low proliferation rates,4 the heart 
has a limited capacity to regenerate the myocardium and restore the mechanical function lost after 
an MI. As such, research over the past decade has focused on delivering cells to the infarct site, 
and has progressed to clinical trials.5 Current cell delivery strategies have demonstrated enhanced 
cardiac function,5-7 but are associated with poor cell retention.2, 4 There is a need for an effective 
regenerative solution to heart failure. 
A cardiac patch is a precisely engineered scaffold that may increase cell retention within 
the site and promote cell function.2, 8-9 Despite significant advances in the design of cardiac 
patches, there remains a need to develop an implantable scaffold that promotes substantial 
functional improvements to damaged myocardium. This requires the scaffold to integrate 
mechanically and functionally with host tissue.2, 10 Current cardiac patch strategies to promote 
regeneration of damaged myocardium use natural materials,10-16 synthetic materials,17-19 or 
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decellularized tissues.20-21 Decellularized tissues retain the extracellular matrix architecture, but 
are associated with harsh sterilization methods and difficulty re-populating the scaffolds with 
cells.22 Synthetic polyesters, such as polyglycolic acid (PGA), enable the engineering of 
mechanical and degradation profiles.23  However, synthetic materials lack native cellular niches 
and require protein coatings for cellular interaction. In contrast, natural biopolymers, such as fibrin, 
provide physiologic cell attachment sites and degrade into bioactive peptides.11 While various 
studies have shown that engineered scaffolds are capable of supporting contractile cells10, 15, 20, 24 
and providing moderate increase in heart function,15, 25-26 there remains a significant need to 
develop an engineered cardiac patch with physiologically relevant contractility that easily 
integrates with the surrounding tissue to promote the regeneration of myocardial tissue.2, 10 
Integration of a cardiac patch will ultimately require aligned synchronous contractions of the patch 
that can incorporate with native myocardium in order to generate forces for pumping blood,4 and 
mechanical properties similar to native tissue to avoid mechanical mismatch.8 
Biopolymer threads are fibrous scaffolding materials comprised of repeating subunits of 
naturally derived molecules including proteins such as silk,27-28 collagen,29-33 and chitosan.34-35 
These biodegradable materials exhibit a broad range of mechanical and biochemical properties 
that can be modulated to meet specific applications including cell-mediated regeneration of 
cartilage, tendon, ligament, and skin.27-29 Additionally, thread-based scaffold morphology directs 
alignment of cells,36 ultimately leading to aligned matrix deposition and tissue regeneration.37-38 
Our laboratory has developed novel fibrin microthread scaffolds.39-47 Because fibrin-based 
matrices are seminal during the early phase of wound healing,48 we hypothesize that these fibrin-
based microthreads will serve as a facile tool for myocardium regeneration. Additionally, the 
components of fibrin can be isolated from blood suggesting fibrin scaffolds have the potential to 
be tailored for personalized healthcare strategies.24 Fibrin has cell adhesive properties, can induce 
neovascularization and can reduce infarct expansion.11   
Fibrin has been used in various conformations such as hydrogels,10, 15-16 electrospun 
scaffolds,49 and microthread structures.39, 41-43, 50 Hydrogels are compactible and have supported 
some of the highest contractile forces to date.51  However, hydrogels are typically mechanically 
weak52-53 and ultimately may fail in the dynamic loading environment of the heart.8, 52 Electrospun 
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scaffolds have been shown to influence cellular orientation through the topography of fibrils,4 but 
they are typically dense. Cells have difficulty penetrating the structure and producing high force 
cell-mediated contractions.2 However, by combining hydrogels with a fibrous scaffold, a more 
robust material may be realized that supports cell function.   
 
1.2 OVERALL GOAL and HYPOTHESIS 
Composites are multiphasic materials that exhibit properties of the constituent phases such 
that a better combination of properties is realized.54  We propose to combine fibrin microthreads 
with a fibrin hydrogel to leverage the benefits of the structural cues and mechanical integrity of 
threads with the pliable hydrogel environment that is conducive to cell-mediated contractility. 
With the composite material, we anticipate that functional and mechanical requirements for a 
cardiac patch to integrate with host tissue will be realized. 
We hypothesize that composite myocardial layers of fibrin microthreads within a fibrin gel 
can be combined to form a cardiac patch with customizable stiffness and enhanced cellular 
orientation that promotes aligned contractions with physiologically relevant cellular contractile 
strains.   
To systematically test this hypothesis, three specific aims were defined. We evaluated the 
impact of microthread volume fraction manipulation on cell function and the modulus of the 
resultant composite layers in Specific Aim 1. In Specific Aim 2, we developed a culturing method 
for increasing alignment of incorporated cells and evaluated the impact on cell function and 
phenotype. Additionally, because the method relied on cell-mediated gel compaction to induce 
alignment, we evaluated how compaction altered the volume fraction of composite constituents 
and the resultant modulus of the material. Finally, in Specific Aim 3, we determined the lamination 
angle of composite layers required to yield a patch with material properties comparable to 
ventricular myocardium. The anticipated outcomes of this thesis were to identify the culturing 
conditions and configuration of composite layers needed to yield a patch with functional and 
mechanical properties comparable to ventricular myocardium for integration post-implantation.  
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1.3 SPECIFIC AIM 1: DEVELOP A FIBRIN COMPOSITE LAYER THAT ENABLES 
CUSTOMIZABLE MODULUS VALUES WHILE SUSTAINING CARDIOMYOCYTE 
CONTRACTILITY  
The ability to modulate the mechanical properties and cell alignment within a cardiac patch 
without attenuating cell functionality will have significant impact on developing therapies for 
treating myocardial infarctions. We developed fibrin-based composite layers comprised of aligned 
microthreads distributed uniformly throughout a hydrogel. Increasing the microthread volume 
fraction (~5%, 11% and 22%) significantly increased the moduli of the scaffolds (20.6± 8.1, 46.4± 
23.0, 97.5± 49.3 kPa, respectively), p<0.05.  Analyses of cell-mediated contractile strains and 
frequencies showed no significant differences among composite layers and fibrin hydrogel 
controls, suggesting that microthread-based composite layers exhibit similar active functional 
properties. Nuclear alignment of cells within 100 µm of fibrin microthreads suggests that 
microthreads influence alignment in adjacent areas. In this study, we developed composite layers 
with tunable, mechanical patch properties that improve cell alignment and support cell 
functionality. Chrobak, M. O.; Hansen, K. J.; Gershlak, J. R.; Vratsanos, M.; Kanellias, M.; 
Gaudette, G. R.; Pins, G. D., Design of a fibrin microthread-based composite layer for use in a 
cardiac patch. ACS Biomaterials Science & Engineering 2017; 3 (7): 1394-1403. Copyright 2016 
American Chemical Society. 
 
1.4 SPECIFIC AIM 2: DEVELOP AN ALIGNED COMPOSITE LAYER TO ENHANCE 
CONTRACTILE FUNCTION  
 Cell-populated cardiac patches have the potential to provide functional support to damaged 
myocardium following a myocardial infarction. To do so, a patch must functionally integrate into 
the adjacent host tissue, requiring alignment, similar contractile behavior, and signal propagation. 
Fibrin-based composite layers have been shown to support contractile phenotypes of incorporated 
cardiomyocytes, but alignment was lacking. Here, we describe a culturing method that increased 
alignment of incorporated cells with trends in nuclear alignment similar to native human heart 
control tissue. Additionally, samples with increased alignment had significantly greater maximum 
contractile strains after 10 days in culture relative to unaligned composite layers and gelatin-coated 
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coverslip controls (18.4% ± 7.9, 7.1% ± 2.1 and 4.7% ± 0.7, respectively, p<0.001). A similar 
trend was observed after 14 days in culture, as well as for average contractile strains at days 10 
and 14. Contractile areas were significantly higher for aligned composite layers relative to 
unaligned controls at day 10 (90.5% ±6.0 and 81.8% ±4.1, respectively, p=0.037) with a similar 
trend observed at day 14. Contractile wave propagation was anisotropic for aligned composites 
with the fastest average velocity in the direction parallel to the fibrin microthreads (parallel 
velocity: 11.1 ± 1.5 mm/sec, perpendicular velocity: 4.5 ± 2.0 mm/sec). When evaluating the 
impact of cell-mediated gel compaction on the modulus for the composite layers, a significant 
increase was observed for cultured 5-thread composite layers relative to 5-thread layers without 
cells (p<0.05). This suggests that compaction of the hydrogel increased the volume fraction of the 
microthreads resulting in an increased modulus. In this study, we improve cellular alignment in 
composite layers resulting in greater contractile strains, contractile areas and faster signal 
propagation through the layer.   
Chrobak MO, Kanellias M, Hansen KJ, Gershlak JR, Gaudette GR, Pins GD. Alignment of 
Cardiomyocytes Through Static Tension Increases Contractile Strains in Composite Layers. In 
preparation 2017.   
 
1.5 SPECIFIC AIM 3: PRODUCE A BIO-INSPIRED PATCH WITH MATERIAL 
PROPERTIES COMPARABLE TO NATIVE MYOCARDIUM 
 For a cell-populated cardiac patch to act as a functional therapeutic, it is critical that the patch 
integrate mechanically with the adjacent host tissue. We recently developed fibrin-based 
composite layers that support aligned contractions of cardiomyocytes and are mechanically 
tunable. Because ventricular myocardium is comprised of layers that rotate relative to one another, 
we hypothesized that lamination of composite layers at strategic offsets would result in a patch 
that mimics the material properties of ventricular myocardium. We defined material properties for 
an effective cardiac patch in terms of modulus, anisotropic ratio of modulus values, stiffness, 
ultimate tensile stress, and strain. We then applied a model based on Hooke’s law to determine the 
anticipated modulus when fibrin microthreads were incorporated at angular offsets from an applied 
load (30o increments, 30-120o.) Using the results of the model, we laminated 10-thread and 20-
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thread layers together using fibrin glue at a 90o offset. The glue did not increase patch thickness 
or patch stiffness (p>0.05). The patch was evaluated through tensile testing with loads applied in 
the 20-thread direction or 10-thread direction. We compared the measured patch values to our self-
defined requirements, meant to serve as first evaluations. Our requirements did not look at 
important factors such as suturability or response to cyclic loading, but were metrics to conduct an 
initial evaluation. The resultant material properties of the patch matched the requirements, with 
the exception of stiffness. It is likely that this is because the geometry of the patch did not match 
the pre-defined geometry of the defect region. In this study, we develop a cardiac patch with 
material properties that mimic ventricular myocardium for mechanical integration upon 
implantation. Chrobak MO, Kanellias M, Pins GD. Fibrin Composite Layers can be Strategically 
Laminated to Mimic the Mechanical Properties of Ventricular Myocardium. In preparation 2017.  
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Chapter 2: Background 
 
 
2.1. BIOMIMETICS AND BIO-INSPIRED SOLUTIONS 
The field of biomimetics evaluates nature and natural phenomena to understand underlying 
mechanisms, and to apply those principles to innovate solutions to engineering design problems.1 
The term ‘biomimetics’ was first coined in 1957 by Schmitt2 and is still recognized as a promising 
method to develop the technology of the future. Throughout history, there have been extraordinary 
achievements through biomimetics and bio-inspired solutions. As an example, the Wright brothers 
developed an airplane after finding inspiration through eagles’ wings.3-4 The idea of looking to the 
sky for inspiration continues today as commercial airplanes are inspired by birds.1 Velcro® was 
developed by George de Mastral after observing that burrs often got stuck in his dog’s fur. The 
hook and loop structure mimicked what had been observed from the burrs interlocking with his 
pet’s hair, and is today used in a wide variety of applications requiring strong adhesion.1  
Biomimetic approaches are applicable across a wide variety of fields, including tissue 
engineering. Tissue engineering is traditionally considered the combination of scaffold materials 
with cells and growth factors to generate tissue-like materials for the regeneration of diseased or 
damaged tissues.5 While progress has been made in this area, currently the most progress has been 
seen in barrier tissues, like skin. Some of the greatest success stories for tissue engineering are 
engineered skin scaffolds, with several products reaching the market including Apligraf ® and 
Epicel™.6 For more complex connective tissues and hierarchically structured tissues, far less 
progress has been made. Clinical evaluations are ongoing for bone, cartilage, and muscle. 
However, complicated multifunctional organ systems like the liver, heart and kidney are 
significantly challenging. Rather than trying to engineer a spatially controlled organ with multiple 
tissue types and/or layers with adequate vascularization, work currently focuses on replacing 
specific functions of these organs.6 One of the biggest challenges associated with this approach is 
the functional assembly of an engineered material into complex tissues or organ systems.7 
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2.1.1. GENERAL TISSUE STRUCTURE 
To promote assembly of engineered scaffolds into tissues and organs, it is critical to  
understand what comprises tissues and how this informs its function. Through strategic 
biomimicry, there is the potential to understand essential characteristics required in scaffold design 
and, furthermore, to avoid over-engineering a solution.7 Requirements will vary by tissue type, but 
in general, many tissues within the body are made from similar building blocks. The extracellular 
matrix (ECM) is comprised of material secreted by the cells within a tissue. The composition, 
structural organization and corresponding mechanical properties of ECM are tissue dependent. 
The hierachical structure and function of the ECM is critical in physiological processes that range 
from growth and proliferation to cell death.8  
The ECM is composed of two main components; proteoglycans and insoluble protein 
fibers.8 In native tissue, the fibrillar elements are arranged into hierarchically ordered constructs.  
These fibrillar elements are composed of protein-based building blocks that form structures 20-
200 nanometers in diameter and contain matrix proteins, such as type I collagen and fibrin. The 
structural arrangement of these fibrils varies from tissue to tissue, in a manner that optimizes their 
functional mechanical properties. As an example, tendons have cable-like bundles of type I 
collagen fibers with a crimp pattern that repeats every 45-60 µm. This structure enables uniaxial 
load transfer from muscle to bone.9 The distinct architectures and biochemical compositions of the 
native tissues also serve a critical function in directing cell-mediated tissue regeneration following 
injury or trauma.10 For example, crosslinked fibrin microthreads loaded with hepatocyte growth 
factor (HGF) were used to promote functional regeneration in a skeletal muscle defect model. The 
structure of the scaffolds combined with the biochemical signaling of the HGF resulted in a 
scaffold that promoted ingrowth of myofibers into the wound site and increased differentiation of 
myoblasts.11  
 
2.1.2. RATIONALE FOR BIOMIMETIC TISSUE ENGINEERED SCAFFOLDS 
 Tissue engineered scaffolds provide a three-dimensional (3D) structure that can be tailored 
to support cell types and promote desired tissue formation.10 For regeneration of tissues that require 
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mechanical support for the reparative process to occur, scaffold implantation is considered more 
advantageous than a cell therapy strategy.12 For a scaffold to be effective at promoting regenerative 
processes, it is essential for it to integrate with adjacent tissues. To ensure integration of a scaffold 
and to promote tissue functionality, it is advantageous to recapitulate the structure and composition 
of distinct tissue regions.7 The ECM structure is essential for directing cell functions like survival, 
differentiation, proliferation, metabolism and integrative function.13 These cell behaviors are also 
influenced by the physiological milieu, levels of nutrients and oxygen, and physical regulatory 
signals of their environment.14 Because of this, biomimetic efforts in tissue engineering focus on 
mimicking these specific areas. This requires an understanding of how structures (from nano to 
hierarchical) correspond to cellular responses and, ultimately, tissue functions.1   
The strategic design of scaffolds enables the incorporation of biophysical and biochemical 
cues. The chemical environment of soluble bioactive molecules (i.e. growth factors) and cell-
binding peptides (i.e. ECM proteins) is another aspect of the cell environment that can be beneficial 
to mimic in order to drive specific cell responses.15 This chemical environment can help drive 
interactions with surrounding tissues through biomolecular recognition, ultimately aiding with 
integration. Within their natural environment, cells additionally experience physical cues that 
influence their behavior. Functional cues like mechanical stretch, electrical stimulation and shear 
forces are some examples of physical signals that cells encounter in native tissues and organs.14 
By incorporating similar cues into the development of biomimetic scaffolds, the resultant material 
may more closely mimic the natural tissue to enable facile integration with adjacent tissues.   
 
2.2. COMPOSITES FOR TISSUE ENGINEERING: THEORY AND APPLICATIONS  
To achieve a scaffold capable of integrating with host tissue and providing an environment 
that promotes the proper function, a biomimetic approach is needed. While scaffolds like hydrogels 
are widely explored for their ability to yield an even distribution of cells and to compact ensuring 
high cell densities,16-17 these scaffolds have insufficiencies including reduced mechanical 
integrity.18-20 Hydrogels typically experience failure under low stress conditions due to the lack of 
energy dissipation mechanisms within the material.21 However, when fibrous networks are 
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incorporated within a brittle hydrogel, the strength of the resultant composite material is increased 
through enhanced energy absorption and transfer.22 Composites are materials that combine 
multiple constituents resulting in a unique combination of, or new properties for the final 
material.23 These materials afford an opportunity to generate biomimetic tissues that can better 
mimic the architecture and mechanical properties of native tissues (Figure 2.1).24-25  
 
Figure 2.1. Composite scaffolds can be strategically combined to mimic the structures of target tissues.  
 
Additionally, incorporation of biomolecules or therapeutic agents, like growth factors to 
direct tissue-specific cell functions, can further enhance the biomimetic nature of composite 
scaffolds.26 An understanding of the theory of composites can inform the strategic design of 
scaffolding materials. Focus for this work is placed on fiber-reinforced composite samples made 
of natural biopolymers, summarized in Table 2.1. 
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Table 2.1. Summary of natural biopolymer, fiber-reinforced composites designed for tissue engineering applications. 
Classification Materials Application Key Results Reference 
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Alginate + collagen fibers Soft tissues -Stiffness and strength values tuned through fiber volume fraction modification  27 
Alginate + gelatin nanofibers Cornea -Reinforcement with fibers enhanced mechanical properties  28 
Collagen-chondroitin-6-sulfate + 
collagen fibers Soft tissues -Mechanical properties modulated by fiber incorporation and crosslinking.  
29 
Pullulan-dextran polysaccharide + 
chitosan and alginate IPC fibers Soft tissues 
-Demonstrated improvement of cell adhesion, sustained release of drugs, and 
proliferation with IPC fibers incorporated into hydrogels  
26 
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 Fibrin + fibrin fibers Cardiac 
-Fiber reinforcement enhanced the mechanical properties of the scaffold, increased 
cellular alignment and did not hinder cell function of incorporated cardiomyocytes.  
30 
LysB10 matrix + collagen fibers Soft tissues - Fiber concentration, orientation and layout critical for design of composites for mechanical properties 
25 
Silk /sodium dodecyl sulfate + 
silk fibers Meniscus 
-Laminating angles impacted mechanical responses with improved properties 
observed at 30o and 60o offsets 
31 
R
an
do
m
ly
 o
ri
en
te
d 
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s 
Agarose + cellulose nanowhiskers  Biomedical applications -Significant mechanical reinforcement by nanowhiskers; volume fraction dependent 
32 
Collagen + collagen fibers Tissue engineering 
-Fiber addition limited the contraction of the collagen hydrogel with no detrimental 
effects on cellular response 
33-35 
Nano-HA/ Chitosan scaffold + 
collagen fibers Bone 
- Increased osteoblast differentiation on composites36 that mimic the hierarchical 
structure of bone24 
36 
24 
Silk + chitin whiskers Connective tissues 
-Improved dimensional stability and compression strength with increased volume 
fractions of whiskers. Whiskers also promoted cell spreading  
37 
Silk + silk fibers Connective tissues, Bone 
-Volume fraction impacted compressive properties38-39 and pore size of composites.39 
Composite use impacted cell adhesion, cell proliferation, and the degradation rate of 
the matrix38 
38-39 
Silk + silk fibers Cartilage 
- Critical length of fibers needed for sufficient energy transfer for reinforcement 
identified. Integration of fibers with matrix critical for improved mechanical 
properties 
22 
Silk + silk fibers Bone 
-Fiber length impacted surface roughness, porosity, and compressive strength. 
Strong integration of fibers and matrix improved compressive properties. Enhanced 
differentiation of hMSCs was achieved through changes in surface roughness and 
matrix stiffness 
40 
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2.2.1. PRINCIPLE OF COMBINED ACTION 
Fiber-reinforced composites are multiphasic materials comprised of a dispersed, 
reinforcing phase surrounded by a matrix phase. This composite type is typically designed to 
achieve high strength or stiffness on a weight basis.23 By strategically incorporating different 
materials into a composite, the principle of combined action states that new or better properties, or 
a better combination of properties, can be achieved.23 These properties will be influenced by the 
relative amounts of each phase (typically noted as the volume fractions). Additionally, the 
concentration, size, shape, distribution and orientation of the dispersed phase will impact the 
resultant composite properties.23 There have been several recent examples in the literature where 
composites were designed to incorporate greater cytocompatibility,22, 26, 36 to adjust the material 
degradation rate,38 and to better mimic the structure of native ECM of target tissues.24-25, 30 By 
tactically combining constituents, better scaffold materials for tissue engineering applications were 
realized in these literature examples.  
 
2.2.2. RULE OF MIXTURES 
The rule of mixtures enables the estimation of the properties of the composite through 
weighted averages.41 This rule uses the volume fractions of each constituent multiplied by a 
property to estimate what the resultant property of the composite will be.23 As an example, for an 
aligned, continuous fiber-reinforced composite, the elastic modulus in the direction of alignment 
assuming an isostrain state is shown in Equation 2.123 
𝐸𝐸𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 = 𝐸𝐸𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑉𝑉𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚𝑐𝑐𝑚𝑚 + 𝐸𝐸𝐹𝐹𝑐𝑐𝐹𝐹𝑐𝑐𝑚𝑚𝑉𝑉𝐹𝐹𝑐𝑐𝐹𝐹𝑐𝑐𝑚𝑚      2.1. 
where E is representative of the elastic modulus and V is representative of the volume fractions 
for each component.  
Equation 2.1 demonstrates that the resultant modulus of the composite will be intermediate 
of the moduli values for the matrix and fiber components. By manipulating the volume fraction of 
each component, engineered tissues can be tailored to have different mechanical properties 
depending on the desired application. It has been demonstrated that manipulation of the fiber 
reinforcing component in tissue engineered composites has led to a range of mechanical 
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properties,27, 30, 37, 39 and better maintenance of scaffold shape.33-35, 37 Additionally, the utilization 
of fibers to enhance mechanical properties has been shown to retain the cytocompatibility of the 
scaffold. In contrast to methods that increase protein concentration and decrease the pore size of 
the constructs39, fiber incorporation can enhance cell spreading and alignment.30, 37 The 
manipulation of the composition of the composite scaffolds enables the targeting of different 
tissues,27 suggesting composite scaffolds are a platform technology. However, it should be noted 
that just increasing volume fraction is not sufficient to manipulate the mechanical properties. It 
was demonstrated that incorporation of an increasing volume fraction of cellulose nanowhiskers 
in an agarose hydrogel did not result in mechanical reinforcement. This is likely due to the fact 
that that there were significant disruptions to the matrix with an increased volume fraction.32 This 
demonstrates that integration of components is a critical factor that must be carefully considered 
in composite design.  
 
2.2.3. CRITICAL FIBER LENGTH AND INTEGRATION OF COMPONENTS 
Mechanical characteristics of composite materials are dependent on the degree to which 
applied loads are transmitted to reinforcing fibers.23 The magnitude of the interfacial bond between 
the fiber and matrix phase is critical. To achieve an isostrain state where deformation of the matrix 
and dispersed phases are equivalent requires a strong interfacial bond.41 An isostrain state is an 
assumption required for the rule of mixtures to apply. For incorporated fibers, there is no load 
transmittance that occurs at the end of each fiber. As such, there is a minimum length that is 
required for load transmittance to occur along the fiber resulting in effective strengthening and 
stiffening of the composite material. This “critical length” is dependent on the fiber diameter (d), 
the tensile strength of the fiber (σ*f), and the fiber-matrix bond strength (or shear yield strength of 
matrix- whichever is smaller)(τc). With these values, the critical length required for a composite 
material can be determined through Equation 2.2.23  
𝒍𝒍𝒄𝒄 =  𝝈𝝈∗𝒇𝒇𝒅𝒅𝟐𝟐𝝉𝝉𝒄𝒄        2.2. 
The fiber lengths used for the dispersed phase within a composite will impact the degree of 
reinforcement. Consider a stress applied to the composite material that is equal to the tensile fiber 
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strength. When the fibers are equivalent to the critical length, the maximum fiber load is only 
achieved in the axial center of the fiber. Lengths greater than the critical length result in fiber 
reinforcement becoming more effective; the maximum fiber load can be achieved over a greater 
length of the fiber. For any fiber length that is much greater than the critical length (typically 15 
times the length of the critical length), the fiber is considered a continuous fiber that provides 
significant improvement in the strength of the composite. However, with a fiber length smaller 
than the critical length, the maximum fiber load cannot be achieved. For any fiber length that is 
much smaller than the critical length, virtually no stress transference will occur, resulting in very 
little reinforcement (typical of a particulate type of composite).23  
 Tissue engineering examples have shown that fiber length is a critical design component 
for generating fiber reinforced materials.22, 40 It was further demonstrated that the integration of 
the reinforcing fibers with the surrounding matrix influenced the resultant properties.29 When using 
silk fibers in a silk hydrogel, it was shown that a significant reinforcing effect occurred that was 
fiber length dependent. However, when using silk fibers in an agarose hydrogel, the reinforcing 
effect was reduced, and was not fiber length dependent. This was likely due to weaker interfacial 
bonding between the silk fibers and agarose hydrogel, leading to poor stress transfer to fibers 
during loading.22  
 
2.2.4. ALIGNMENT OF FIBERS 
Alignment of reinforcing fibers within a composite is another critical design 
consideration.41 Fibers may be aligned or have a random orientation throughout the matrix phase. 
Alignment of fibers results in anisotropic mechanical properties, while random orientation 
typically results in isotropic properties.23 Therefore, when evaluating mechanical properties, the 
direction of the applied load will influence what is measured. For fibrous materials, applying a 
load in the direction of fiber orientation will yield greater mechanical properties than when 
evaluating the properties with an applied orthogonal load, as has been shown in the literature.27-28, 
31 Distribution of the fibers throughout the composite is also key with better composite properties 
realized when the fibers are uniformly distributed throughout the matrix phase.41  
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When designing composite materials, it may be desirable to laminate layers at an offset. 
As an example, the ventricular myocardium is composed of layers of myocardium that rotate 
relative to one another from +60 to -60o.42 Using a biomimetic approach to mimic the architecture 
and material properties of the tissue may require fiber-reinforced composite layers to be laminated 
at similar offsets. Strategic lamination can be achieved through understanding how the angular 
offsets will impact the resultant modulus values of the laminated composite material. Hooke’s law 
states that stress and strain are proportional to one another (Equation 2.3)23 
𝜎𝜎 = 𝐸𝐸𝐸𝐸      2.3. 
where σ represents stress, E represents the modulus of elasticity and ϵ represents strain.  
 A dimensionless analysis based on Hooke’s law enables the estimation of the elastic 
modulus of fibrous composites with various off-axis loadings.43 The results of this analysis 
estimate the axial and transverse modulus values (Ex and Ey, respectively) as is shown in 
Equations 2.4 and 2.5 
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where  
𝐺𝐺12 = 𝐺𝐺𝑓𝑓 ∗ 𝐺𝐺𝑐𝑐𝐺𝐺𝑓𝑓 ∗ 𝑉𝑉𝑐𝑐 + 𝐺𝐺𝑐𝑐 ∗ 𝑉𝑉𝑓𝑓 
𝐺𝐺𝑓𝑓 = 𝐸𝐸𝑓𝑓2(1 + 𝜐𝜐𝑓𝑓) 
𝐺𝐺𝑐𝑐 = 𝐸𝐸𝑐𝑐2(1 + 𝜐𝜐𝑐𝑐) 
𝜐𝜐12 = 𝜐𝜐𝑓𝑓 ∗ 𝑉𝑉𝑓𝑓 + 𝜐𝜐𝑐𝑐 ∗ 𝑉𝑉𝑐𝑐 
𝐸𝐸1 = 𝐸𝐸𝑓𝑓 ∗ 𝑉𝑉𝑓𝑓 + 𝐸𝐸𝑐𝑐 ∗ 𝑉𝑉𝑐𝑐 
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𝐸𝐸2 = 𝐸𝐸𝑓𝑓 ∗ 𝐸𝐸𝑐𝑐𝐸𝐸𝑓𝑓 ∗ 𝑉𝑉𝑐𝑐 + 𝐸𝐸𝑐𝑐 ∗ 𝑉𝑉𝑓𝑓 
𝐸𝐸𝑓𝑓 = Elastic modulus of the fibrous component 
𝐸𝐸𝑐𝑐= Elastic modulus of the matrix phase 
𝐺𝐺𝑓𝑓= Shear modulus for the fibrous component 
𝐺𝐺𝑐𝑐= Shear modulus for the matrix phase 
𝜐𝜐𝑓𝑓= Poisson’s ratio for the fibrous component 
𝜐𝜐𝑐𝑐= Poisson’s ratio for the matrix phase 
𝑉𝑉𝑓𝑓= Volume fraction of the fibrous component 
𝑉𝑉𝑐𝑐= Volume fraction of the matrix phase 
 
The analysis is simplified by assuming plane stress conditions where all displacements 
are occurring within one plane. When using this analysis to evaluate a composite with fibers 
aligned with the loading direction, these equations simplify to the Rule of Mixtures (Equation 
2.1). With this tool, an informed design of composite materials can be achieved for specific 
applications. 
 
2.3. CARDIOVASCULAR DISEASE  
Cardiovascular diseases are currently the leading causes of death in the US.  Heart failure 
is a major contributor with 500,000 new cases diagnosed annually in the United States alone.44 
The only treatment that can restore function for end stage heart failure is a heart transplant. 
However, donors are limited. Only ~2,500 cardiac transplantation surgeries occur annually in the 
United States44 leaving the majority of affected patients with compromised cardiac function. Other 
treatments for end stage heart failure include pharmacologic agents and ventricular assist devices, 
palliative treatments that do not regenerate damaged tissue.45  
A major cause of heart failure is a myocardial infarction (MI) where blood flow through a 
coronary artery is blocked resulting in ischemia of downstream cardiac muscle (Figure 2.2). 
Ischemia causes cardiomyocyte (CM) death and a severe inflammatory response that ultimately 
results in scar tissue formation.46 Because CMs have low proliferation rates,47 and due to the 
scarcity of cardiac stem cells in mature cardiac tissue,48 the heart has a limited capacity to 
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regenerate the myocardium and restore the mechanical function lost after an MI. Instead, highly 
proliferative cardiac fibroblasts replace the lost cells and become activated, resulting in secretion 
of type I collagen and formation of a non-functional, mechanically aberrant, fibrous scar that is 
not conducive to the electrochemical or biomechanical properties of healthy, functional 
myocardium. 49-51 Additionally, healthy CMs in the proximity of the infarct site may also die, 
leading to an increased necrotic tissue region. This process often affects the left ventricle and can 
lead to left ventricular remodeling, during which the left ventricle wall becomes thinner and 
structural changes occur50 (Figure 2.2). To compensate for the reduced functionality, the ventricle 
becomes larger to try to achieve needed blood flow. This structural change makes the heart more 
susceptible to dysfunction and eventually leads to heart failure.49  
 
 
Figure 2.2. Progression of cardiac disease following an MI. Healthy myocardium (A, B) becomes damaged during 
an MI when an occlusion in the vasculature leads to necrotic tissue beyond the occlusion site (C, D). An acute 
inflammatory reaction will lead to scar tissue formation (E, F) and ultimately, ventricular remodeling (G, H). Black 
arrows show healthy myocardium (E,G). Gray arrows show degrading extracellular matrix with macrophages (purple 
cells) and fibroblasts (blue cells) (E,G). The blue arrow shows the scar tissue region (G). B, D, F and H are displaying 
cross-sections of the ventricles.   
 
To mitigate this series of events, the CMs lost during a heart attack (on the order of a billion 
cells)13 must be replaced. As such, research over the past decade has focused on delivering cells 
to the infarct site, and treatments using this method have progressed to clinical trials.52 Current cell 
delivery strategies have demonstrated enhanced cardiac function 52-54 but are associated with poor 
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cell retention and survival.45, 47 The optimal cell source, dose and method for delivery has yet to 
be defined.55. An alternative approach to the regeneration of damaged myocardium is to design a 
scaffold that can provide mechanical support 13 and a protective environment against the acute 
inflammatory environment of an infarct site.55 The use of scaffolds provides advantages over cell 
injection approaches. Namely, the scaffold provides a transitional support, enables control over 
graft dimensions and mechanical properties, and provides an environment for the survival of 
incorporated CMs.13, 56 While progress has been made in the development of a cardiac patch for 
myocardial regeneration, there has yet to be a patch able to restore baseline functionality to an 
infarcted heart. There is a significant need for a regenerative solution for MI patients.45  
 
2.4. HEART ANATOMY AND VENTRICULAR MYOCARDIUM 
The heart is comprised of 4 chambers: the left atrium, left ventricle, right atrium and right 
ventricle (Figure 2.3). The atrioventricular valves separate the atria from the ventricles. The 
tricuspid valve separates the right atria from the right ventricle, while the bicuspid valve separates 
the left atria and left ventricle.8 There are two functional phases involved in the heart circulating 
blood: systole (contraction) and diastole (filling). In late diastole, the ventricles passively fill with 
blood. During atrial systole, atrial contraction forces a small volume of blood into the ventricles. 
An isovolumetric ventricular contraction forces the AV valves closed. As pressure builds within 
the ventricles and eventually exceeds the pressure in the arteries, the semilunar valves (which 
separate the ventricles from the pathways away from the heart) are forced open and blood is 
ejected. If leaving from the right ventricle, the blood will pass into the pulmonary arteries, leading 
to re-oxygenatin of the blood via capillary beds in the lungs. If leaving the left ventricle, the blood 
will pass into the aorta, through which the blood is supplied to the rest of the organs of the body. 
Action potentials in the heart originate at the SA node in the right atrium. The signal then travels 
to the atrioventricular node, to the bundle of his and on to purkinje fibers. This pathway ensures 
that atria first contract, then the ventricles from the bottom up.  
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Figure 2.3.  The anatomy of the heart. 
The anterior myocardium is ~1.5 cm thick and composed of highly aligned CMs and ECM 
fibrils, predominantly containing collagen.42, 57 Ventricular myocardium is arranged in 
anisotropically aligned sheets of fibrils that are stacked and rotate from +60o (endocardium) to -
60o (epicardium) (Figure 2.4).42 Within each layer, the fibril size can range from 30-120 nm with 
fibril orientations ranging from +/- 13o relative to one another.58-59 Myocytes closely follow this 
structure, resulting in highly oriented cells and aligned contraction of cells. This alignment results 
in high torsional squeezing enabling efficient pumping of blood.60 Ventricular myocardium has a 
modulus ranging from 20 kPa – 500 kPa as it moves from diastole to systole.45 To promote 
functional tissue regeneration, recapitulating the properties of the native tissue may be 
advantageous.45, 61 
Excerpt from: O’Brien, Megan P., et al. "Designing Biopolymer Microthreads for Tissue 
Engineering and Regenerative Medicine." Current Stem Cell Reports 2.2 (2016): 147-157. 
Figures original. 
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Figure 2.4.  Composition of ventricular myocardium. Myocardium is a 3-4 cell layer thick structure. Cells are 
aligned within each layer, and layers rotate relative to one another from +60 to -60 degrees. Solid colored lines 
represent ECM fibrils within each layer.  
 
2.5. CARDIAC PATCHES: IMPLANTATION STRATEGIES  
A cardiac patch is a precisely engineered scaffold that may help to reverse or prevent 
further damage to the myocardium following an MI.45, 61-62 Following an infarct, a cardiac patch 
can be used to augment or replace the damaged ventricular myocardium. Augmentation 
incorporation would involve laying the cardiac patch over the damaged tissue site in an effort to 
circumvent the scar tissue. Augmentation of the scar region with a cardiac patch may benefit the 
scarred ventricular wall by increasing tissue thickness and providing structural reinforcement. The 
Law of Laplace states that the pressure inside a construct is proportional to the thickness and 
tension of the construct’s wall, and inversely proportional to the radius of the construct.63 Equation 
2.6 shows the one common representation of the Law of Laplace. 64 
   < 𝜎𝜎 > =  𝑃𝑃𝑖𝑖𝑚𝑚𝑖𝑖2
𝑚𝑚𝑜𝑜2−𝑚𝑚𝑖𝑖2
     2.6. 
In 2.6, <σ> is the average stress, Pi is the internal pressure, ri is the internal radius and ro is 
the outter radius. This simplified analysis as a first approximation assumes a hollow spherical 
geometry with uniform wall thickness and isotropic, homogenous material properties. These 
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assumptions are not consistent with left ventricular mechanics, but provide a method for 
simplifying those relationships as a first estimation of how the parameters are related for this 
application.65 By this common representation of the Law of Laplace, an increase in the ventricular 
wall thickness through the augmentation of the scar region with a cardiac patch will reduce the 
average wall stress.66 On its own, this effect could help limit ventricular remodeling67-68 improving 
patient quality of life. Additionally, this approach would be less invasive than replacement therapy. 
However, a major challenge associated with it is the lack of vascularization in the scar tissue 
region. This results in the patch having limited contact with the host vasculature.45 Maintaining 
viability of cell populated patches without a well-defined vasculature system may not be feasible. 
Additionally, this approach does not remove the stiff damaged tissue and does not ultimately heal 
the myocardium.Replacement of ventricular scar tissue involves excision of the damaged tissue 
and replacement of that portion of the ventricular wall with a cardiac patch. One technique that 
can be used for this is a Dor (or modified Dor) procedure. This procedure involves excising the 
damaged tissue, placing a patch to cover the opening, and then closing the myocardium over the 
patch.  This results in the myocardium that was on either side of the scar being joined and is a 
typical approach for acellular patches with the goal of preventing remodeling. The operation 
improves the size and geometry of the left ventricular, reduces wall tension and can enhance the 
overall systolic function of the heart. Patients typically selected for this type of surgery have large 
akinetic ventricles, meaning the patients lack either an inward or outward movement of the 
ventricular region during systole. Patients also typically present with symptoms of angina and /or 
congestive heart failure.69   
For cell-populated scaffolds, an incorporation option is to implant the patch in parallel with 
adjacent tissues so that the patch joins with the tissue that was on either side of the scar region.70-
71 This would require vasculature of the patch to anastomose with the host vasculature, and 
alignment of the patch with the orientation of the cardiomyocytes in the adjacent tissues for 
effective signal propagation and synchronous contractility. We hypothesize that these techniques 
will result in the removal of the damaged tissue and promote the regeneration of functional  
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myocardium. However, this type of approach is challenging; with large, diffuse MI regions it can 
be difficult to successfully implant a patch and not have lethal excess bleeding.71 
Replacement of an infarct with a vascularized patch may help restore lost cardiac function. 
However, it should be noted that infarcts do not have specific geometries and do not always 
transverse the entire width of the ventricular wall.72 As such, it is possible that partial removal of 
the ventricular wall may result in removal of the infarct site while leaving a vascularized region of 
myocardium. A cardiac patch could then be implanted to fill the defect. While there are many 
strategies for implanting a cardiac patch, currently there is no consensus on the best approach. For 
the purposes of this thesis, we have designed a cardiac patch material that can ultimately  be 
implanted in parallel with the myocardium following full-thickness excision of the infarct. 
With a patch replacing a portion of the ventricular wall and acting as a functional support, 
the ideal mechanical properties of the cardiac patch would be comparable to ventricular 
myocardium. This would result in the patch exhibiting similar behaviors to the native tissue in 
response to the forces that result from cyclic loading of the ventricles. In ventricular myocardium 
there are active and passive mechanical aspects that should be considered. When considering 
passive mechanical properties, it has been shown that cardiomyocytes have the greatest contractile 
forces on materials with a modulus similar to that of native myocardium.73 Additionally, in order 
to ensure that a patch was able to withstand and not fail in the demanding mechanical environment 
of the heart, it is critical that any material considered for a cardiac patch have an ultimate tensile 
stress that well exceeds the stresses experienced by the ventricular wall.74 Another important 
consideration is suture retention strength. It is vital that the patch be able to be implanted.61 
When considering active mechanical properties, it is important to consider the function of 
the myocardium. In one heart beat, following depolarization, the ventricles will undergo 
isovolumeic ventricular contractions (as discussed in section 2.4). During these contractions, the 
volume of the ventricles does not change, but there is an increase in ventricular pressure, closing 
the atrioventricular valves. As that pressure rises, the semilunar valves will open and the ventricles 
will contract, decreasing in volume and ejecting the contained blood.8 For a cardiac patch to 
provide a functional support, the patch itself will need to propagate an electrical signal with a 
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similar velocity as the adjacent heart tissue.47 Should it fail to do so, depolarizations will not occur 
at the same rate resulting in delayed contractions of the cells incorporated in the cardiac patch. 
With a delayed contraction, as the pressure builds in the ventricle, the cardiac patch may become 
a weak point as formed myosin cross-bridges within contracting cardiomyocytes can contribute to 
the overall stiffness of the material.75 With a weak spot, there is the potential for bulging of the 
ventricle. Perturbated blood may result that can ultimately culminate in the formation of a clot and 
aneurysm. Therefore, for a cardiac patch to successfully function as a wall replacement, cell 
function and material properties of the cardiac patch will need to be similar to ventricular 
myocardium.  
Current cardiac patch strategies to promote regeneration of damaged myocardium use 
natural materials,62, 76-81 synthetic materials,82-84 cell sheets,85-87 or decellularized tissues.88-89 
Decellularized tissues retain the extracellular matrix architecture, but are associated with harsh 
sterilization methods and with difficulty re-populating the scaffolds with cells.90 Cell sheets have 
shown potential as sheets can be stacked and beat synchronously. However, there is no clinically 
translatable technique for inducing vasculature with these scaffolds, thus limiting their utility 91 
and preventing them from reaching a clinically relevant thickness of 1 cm.45 Synthetic polyesters, 
such as polyglycolic acid (PGA), enable the engineering of mechanical and degradation profiles.92  
However, synthetic materials lack native cellular niches and require protein coatings for cellular 
interaction. In contrast, natural biopolymers, such as fibrin, provide physiologic cell attachment 
sites and degrade into bioactive peptides.76 However, the weak mechanical nature of natural 
biopolymers presents a challenge for their use as cardiac patch scaffolding materials.93  
 
2.6. ACELLULAR CARDIAC PATCHES 
Acellular patches have been developed from synthetic and natural materials. Dacron and 
Gore-Tex (W. L. Gore & Associates, Flagstaff, AZ USA) are commercially available synthetic 
materials that can help prevent remodeling from occurring, but ultimately may result in a foreign 
body response because of their synthetic nature. This response can lead to increased fibrosis and 
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may alter the mechanical properties of the tissue in contact with the patch. This can cause 
functionality to be impaired and may hinder the restorative functionality achieved.94  
Negative reactions to a synthetic patch were demonstrated in a porcine MI model where a 
polytetrafluoroethylene patch (same material as Gore-Tex®) was shown to promote inflammation, 
calcification and cellular necrosis. This tissue response demonstrated a stark contrast to a natural, 
urinary bladder ECM patch placed in the left ventricle, which supported cell infiltration, 
production of ECM and pockets of myocyte-like cells.95 These results closely mirror what was 
reported when comparing the synthetic material, Dacron to an ECM-derived cardiac patch.94 When 
using these materials in a canine model for a full thickness right ventricular defect, it was 
demonstrated that the ECM patch outperformed Dacron through regional systolic and diastolic 
function evaluations. These findings were likely due to the CMs observed in the ECM implant 
region, which was not seen with the Dacron® group.  
Cormatrix® is a clinically approved, decellularized porcine small intestine submucosa 
(SIS) matrix that has been used for myocardium repair. In a recent study, patients who had 
complications resulting from MIs received either a Dor procedure, linear left ventricular aneurysm 
repair or ventricular septal defect repair with Cormatrix.96 Patients had transthoracic 
echocardiographies prior to discharge and were later evaluated at follow-up appointments. The 
echocardiographies demonstrated repair integrity and no ventricular thrombus formation. 
Additionally, no complications such as readmission for any cardiac cause or death occurred. With 
these results, surgeons felt that the lack of CorMatrix ECM repair failures supported further 
investigation into the efficacy and regenerative potential of this material.  
It is important to note that the benefits of an acelluar scaffold may be temporary. As the 
scaffold degrades the reduced wall stress resulting from an increased wall thickness may be lost. 
This was demonstrated in a study where a polyethylene glycol hydrogel was injected in to an 
infarcted rat heart. There was a decrease in end-diastolic volume 4 weeks after MI, but the benefits 
were gone after 3 months.97 Another concern with acellular scaffolds is that patients must rely on 
cells from adjacent regions repopulating the patch, which may not be restricted to CMs. Reports 
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have shown patches ultimately supporting a mixture of cell and tissue types including connective 
tissues, cartilage, and myocardial tissues.94, 98  
A cellular approach may have greater regenerative potential than an acellular approach. 
Studies demonsrate that when small intestine submucosa ECM was combined with mesenchymal 
stem cells, a greater reparative effect was observed in a chronic MI scar in a rabbit model relative 
to SIS ECM alone.99 It was further demonstrated that these incorporated cells were able to migrate 
into the infarct site and differentiate into CMs.  
 
2.7. CELL-POPULATED CARDIAC PATCHES 
A cell-populated cardiac patch has the potential to restore lost function post-MI. Despite 
significant advances in the design of cardiac patches, there remains a need to develop an 
implantable scaffold that promotes substantial functional improvements to damaged myocardium. 
While various studies have shown that engineered scaffolds are capable of supporting contractile 
cells 62, 80, 88, 100 and providing moderate increase in heart function,80, 101-102 there remains a 
significant need to develop an engineered cardiac patch with physiologically relevant contractility 
that easily integrates with the surrounding tissue to promote the regeneration of myocardial 
tissue.45, 62 Integration of a cardiac patch will require the alignment of incorporated cardiomyocytes 
to aid in electrical coupling of the patch to native myocardium in order to promote synchronous 
contractility 47 and stiffness values similar to native tissue in order to avoid mechanical mismatch.61  
 
2.7.1. DECELLULARIZED TISSUES FOR CARDIAC PATCH DEVELOPMENT 
Decellularized heart tissue has been investigated for use as a cardiac patch. This highly 
biomimetic approach enables the retention of tissue architecture, vasculature,90, 103 and proteins 
within the structure such as collagen, elastin and fibronectin.104 Among other scaffold options, this 
type provides the best cell recognition,105-106 supports cell growth and tissue organization, and 
provides cues for adhesion, proliferation, migration, differentiation and function.107 The removal 
of cell components and antigens reduces the potential for a foreign body reaction.108 However, 
decellularization is difficult to completely accomplish. Residual DNA and other materials can 
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elicit an immune response and while harsher decellularization methods may result in more 
complete removal of host cells, they may also compromise tissue architecture. 109  
The decellularization process involves physical, chemical, biological or combination 
treatments of the native tissue.88 Once decellularized, the scaffolds can be re-cellularized with 
selected cell populations. It has been demonstrated that decellularized mouse hearts can be 
repopulated with human iPS cell-derived multipotent cardiovascular progenitor cells. These 
scaffolds demonstrated spontaneous contractions and a normal response to drugs.110 Additionally, 
it has been demonstrated that decellularization of an entire heart can be achieved. Donor hearts not 
used for transplantation were decellularized and seeded with iPS-derived cardiomyocytes. The 
authors demonstrated force generation of incorporated myocytes, showed electrical conductivity, 
pressure development in the left ventricle and metabolic function.111   
While progress in this area has been made, currently decellularized heart tissues are insufficient 
to circulate blood by mechanical force and electrical conduction through the scaffold is slower 
than a healthy heart.87 Although there has been progress, the major challenges of decellularization 
without disruption to the structural and mechanical integrity of the scaffold, recellularization with 
homogenous distribution of cells, in vitro preservation, anticoagulation and endothelialization 
need to be overcome in order to generate a scaffold capable of in vivo functionality.104, 111   
 
2.7.2. CELL SHEETS AS CARDIAC PATCHES   
 More than a billion cells die following an infarct.13 When trying to replace this magnitude 
of cells, one limitation to scaffold-based patches is that the space occupied by the construct will 
be ECM, limiting the density of cells that can fill the defect. An alternative method for producing 
densely cell populated cardiac patches is to use cells alone. While cell suspensions are difficult to 
deliver and retain in the desired area, confluent cell sheets have been shown to be an alternative 
strategy. In this approach, confluent cells are harvested as intact sheets by culturing the cells on 
temperature-responsive polymers, such as poly-(N-isopropylacrylamide) (PIPAAm).112 With this 
method, cells can adhere and proliferate on the polymer at 37oC, but when the temperature is 
lowered to below 32oC, the surface becomes hydrophilic and non-adhesive for the cells. This 
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results in the cells detaching from the polymer, but remaining attached to one another through cell 
adhesion proteins and deposited ECM.113 This technique has been used to derive cell sheets from 
neonatal rat ventricular myocytes and, when two sheets were stacked, synchronous and 
spontaneous contractions were observed.114-115 Additionally, evidence for electrical 
communication between cells in adjoining layers arising from gap junctions was observed within 
1 hour.116 Cell sheets have been transplanted into tissues of rats. When this was done, 
microvasculature rapidly organized within the sheet, and beating of the transplanted construct 
continued for up to 1 year.86  Despite these successful findings, there are limitations to the use of 
cell sheets as a cardiac patch. Clinically, stacked, autologous myoblast sheets were implanted in a 
56-year-old man with dilated cardiomyopathy.117 This treatment resulted in the patient having an 
improved prognosis; he had no arrhythmia and was able to discontinue use of a left ventricular 
assist device. However, these cells do not form gap junctions, preventing them from propagating 
an electrical signal. In another clinical trial these cells were shown to induce arrhythmias when 
implanted in cardiac tissue.118 
Another challenge is generating a cardiac patch of clinically relevant size. If we consider 
the perfusion limit of densely populated cell sheets is approximately 50-100 µm, the size of a 
cardiac patch is then limited to 3 cell layers without a vasculature.91 However, a clinically relevant 
cardiac patch needs to be ~1 cm thick,45 which is significantly greater than  3 layers of cell sheets. 
One strategy to overcome this limitation is to create vascularization through the layers, performing 
a multi-step transplantation. By implanting 3 cell sheets into a rat, and allowing the sheets to 
become vascularized, the 3 sheets can function as the base for a subsequent transplantation. If this 
process is repeated 10 times every 24 hours, it will create a vascularized construct that is 3 mm 
thick. However, this technique will not readily transition to the clinic.91 Although cell sheets have 
demonstrated some improvement in cardiac function when implanted in an animal model 85, the 
biggest hindrance to use of this technology is developing a vascularization method in-vitro that 
can transition to the clinical setting so that a thick construct can be fabricated.87  
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2.7.3. SYNTHETIC MATERIAL CARDIAC PATCH SCAFFOLDS 
Synthetic materials are a promising strategy to create cardiac patches because of their 
customizable nature, as the mechanical properties and degradation kinetics can be readily tuned 
and their properties are highly reproducible. Additionally, their use mitigates concern of pathogen 
transmission risks associated with biological materials.119  Among synthetic materials, some of the 
most commonly-investigated for application as a cardiac patch are polyesters and polyurethanes, 
including polyglycolic acid (PGA)120-121, poly(lactic-co-glycolic) acid (PLGA)122-123, 
poly(glycolide-co-caprolactone) PGCL 124, poly(glycerol sebacate) (PGS) 125-126, and poly(lactide-
co-epsilon-caprolactone) (PLCL) 127. 
PGA has been shown to provide a scaffold environment that can support differentiation of 
myocytes into organized layers.120 Additionally, a PGA patch seeded with embryonic stem cells 
(ESCs) was implanted onto infarcted mice hearts. At 8 weeks, it was observed that engrafted cells 
survived, suggesting that the scaffold efficiently served as a cell delivery device.121  
PLGA is the base material of an epicardial patch composed of vicryl® mesh seeded with 
human fibroblasts that has been investigated as a device to induce angiogenesis in the damaged 
tissue region following an infarct.122 This material was applied as an epicardial patch to an 
ischemic heart in a Sprague-Dawley rat model.123 The patch provided cytokines, growth factors 
and proteins to the area contributing to observed arteriogenesis and tissue repair. Functionally, the 
ejection fraction for the left ventricle increased with application of this patch. Improved left 
ventricular function was also observed for cellularized patches composed of PLCL that were 
implanted onto infarcted hearts in an adult rat model, relative to non-cellularized patches.127
 When implanted onto the epicardial surface, it was demonstrated that a PGCL scaffold 
populated with bone marrow-derived mononuclear cells attenuated left ventricular remodeling and 
systolic dysfunction.124 Limited remodeling was also observed when PGS films were utilized in 
an MI in a rat model. Although unable to support systolic function, the patches were able to reduce 
hypertrophy and may limit remodeling of the tissue.126  
Research by Lisa Freed’s group showed that PGS and PGS-inspired materials created a 
modular, vascularized cardiac scaffold.128 The scaffold is composed of a microfluidic base, a 
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vascular-parenchymal interface and a heart cell scaffold. By manipulating the degradation rates of 
the components of this scaffold, the authors designed a scaffold with an interface that enables 
perfusion-mediated transport in vitro, while degrading quickly in vivo. The fast degradation of the 
interface quickly brings the heart cell scaffold in contact with the host-derived blood vessels when 
implanted. Using a slowly degrading polymer, poly(ester-amide),1:2 poly(1,3-diamino-2-
hydroxypropane-co-polyol sebacate) (APS), for the heart cell scaffold and microfluidic base 
provides an anisotropic mechanical support upon implantation. The synthetic materials enabled 
this clever design as the degradation rates were tunable.   
In another strategy, a mosaic patch was created that mimics the structure of Velcro®. This 
patch was designed to provide a method to incorporate easily stackable units, that could be 
disassembled on demand while preserving the structure, physical integrity and beating function of 
the individual layers. This scaffold wis made of a honeycomb mesh with hooks comprised of 
poly(octamethylene maleate (anhydride) citrate) (POMaC). Cells were seeded in Matrigel (an 
extract from the basal membrane of a sarcoma cell line rich with ECM proteins and bioactive 
substances). Strong mechanical integration of the layers was observed, as was immediate 
functional integration of the stacked layers as demonstrated through electrical stimulation.129   
While considerable progress has been made using synthetic materials, there are still many 
challenges associated with them. These materials typically have poor interaction with cells because 
of their hydrophobic nature13 and they also have poor interaction with the native biological 
environment, often inducing an aggressive inflammatory response in vivo.130 Additionally, 
synthetic materials tend to crumble rather than slowly degrade, and the degradation products can 
be acidic, impacting the viability of cells.13  
2.7.4. NATURAL BIOPOLYMER CARDIAC PATCH SCAFFOLDS 
Natural biopolymers are highly compatible materials with native signaling cues for cells to 
attach, proliferate and differentiate on in vivo.13 These materials have adhesion-specific sites that 
promote cellular interaction, unlike synthetic materials.92 Additionally, natural biopolymers enable 
a biomimetic scaffold that closely resembles the ECM of the native tissue. As described earlier, 
biomimetic approaches may be beneficial in providing instructive cues for tissue regeneration. 
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Natural hydrogels in particular have proven superior for generating highly functional cardiac 
tissues, as they support macroscopic contractions and uniform cell density.131 Some of the most 
commonly investigated natural biopolymers for use as cardiac patches include collagen, gelatin, 
fibrin and alginate.93  
 Collagens types I and III are major components of the ECM of myocardium and are a 
promising material for a cardiac patch.13 When these materials were combined with Matrigel  and 
cultured with rat neonatal ventricular myocytes, an engineered heart tissue was formed that 
displayed functional and morphological properties similar to differentiated heart muscle. 
Implantation studies using a Fischer 344 rat model demonstrated that these engineered tissues 
survive and integrate in vivo.132 Additionally, the tissues electrically coupled with native tissue 
upon implantation in a rat MI model, and ultimately improved diastolic and systolic function 
relative to sham procedure controls.133  
In the MAGNUM clinical trial, authors investigated the use of autologous mononuclear bone 
marrow cells seeded on a collagen matrix. This scaffold was grafted onto infarcted ventricles of 
patients.134 It was observed that the scaffold resulted in improved efficiency of cellular 
cardiomyoplasty, and that there was an increase in the thickness of the ventricular wall at the 
infarct site. As mentioned earlier, an increase in ventricular wall thickness can normalize wall 
stress limiting remodeling and improving diastolic function.134  
With biomimetic mechanical and electrical stimulations, cells incorporated on collagen 
scaffolds have a more mature phenotype. In one study, rat neonatal ventricular myocytes in 
Matrigel were seeded onto Ultrafoam™ collagen sponges. Applications of electrical stimulations 
that mimicked the native heart resulted in cell alignment, coupling and synchronous 
contractions.135 Additionally, application of mechanical stretch to collagen-based scaffolds has 
been shown to improve the maturity of incorporated cells. When applying cyclic mechanical 
stretch to 120% of the initial scaffold length, it was observed that cells incorporated in a collagen/ 
Matrigel matrix underwent hypertrophy and demonstrated functional improvements.136  
While low-density collagen hydrogels support functionality of incorporated cardiomyocytes, 
the lack of mechanical integrity is a limiting factor. Interestingly, a recently published study 
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showed that a high density collagen scaffold could support cardiomyocyte function when co-
cultured with matrix-remodeling stromal cells.137 This co-culture resulted in a scaffold material 
that supported a microvasculature and cellular function in vitro for two weeks, and appears to be 
a promising approach for the development of cardiac patches of clinically relevant size.  
Silk fibroin is another candidate material for a cardiac patch. Silk fibroin has the highest 
mechanical performance of all known natural materials. For a 10mm diameter scaffold with a 
height of 10mm, 84 kPa of compressive strength was reported. This was much greater than 
collagen or chitosan with reported values of 15 and 45 kPa compressive strength, respectively.13 
Silk is being explored as a cardiac patch material in combination with cardiac tissue-derived 
extracellular matrix (cECM) 138, and will be discussed in the composite patch section (Section 
2.7.5). 
Because fibrin is seminal during the early phase of wound healing,139 it is hypothesized 
that this material will serve as a facile tool for myocardium regeneration. Additionally, the 
components of fibrin can be isolated from blood suggesting fibrin scaffolds have the potential to 
be tailored for personalized healthcare strategies.100 Fibrin has cell adhesive properties, can induce 
neovascularization 140and reduce infarct expansion.76  
Fibrin has been investigated in a hydrogel format and has demonstrated some of the highest 
contractile forces and action potential propagation speeds to date.77, 131, 141 Through patterning of 
the hydrogel space with ellipsoidal pores, it has been demonstrated that incorporated cells align 
through gel compaction over time in culture and mature. More recently, bundles of fibrin hydrogel 
have been cultured on free floating on Nylon frames, and when cultured dynamically with a +/-
30o rotation were shown to achieve conduction velocities and contraction forces approaching 
values of adult myocardium.131 
Fibrin-based patches with different cell populations have also been considered. In a recent 
study, the effects of incorporating cardiomyocyte-enriched, or cardiomyocyte-depleted neonatal 
rat cell hearts in an epicardial patch implanted on the infarct region in a rat model was assessed. 
This study showed that when CMs were incorporated into the patch, there was a significant 
improvement in contractile function, and there was elimination of left ventricular wall thinning. 
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The decreased infarct size and reduced wall thinning were also observed for the patch free of CMs, 
but there was no subsequent improvement in cardiac function.80  
Another study utilized cardiac adipose tissue-derived progenitor cells in a fibrin hydrogel 
patch. Prior to embedding in fibrin, the cells were either electromechanically stimulated and 
stretched to condition the cells, or were left untreated. The patches were implanted over an infarct 
region of a murine heart. The findings showed that rodents that received patches with stimulated 
cells had an increase in cardiac function as evaluated by left ventricular ejection fraction relative 
to nontreated animals. Trained cells also expressed main cardiac markers such as connexin 43, α-
actinin and SERCA2, and migrated into the ischemic tissue of the myocardium.142 This study 
demonstrated that conditioning the cells prior to incorporation may increase the functional impact 
of the patch on the heart.  
Other natural materials have also been considered as scaffolds for cardiac patches. A gelatin 
mesh was combined with rat ventricular fetal or adult cardiomyocytes and used to repair the right 
ventricular outflow tract in adult rats. In a 12 week study, seeded cells survived in the area even 
after the scaffold had degraded, demonstrating the cell delivery capability of this material.143 
Additionally, polysaccharides including alginate 144, cellulose 145, chitosan 146, and hyaluronic acid 
(HA) 147 have been investigated for use as a cardiac patch.  
Natural biopolymers are commonly characterized by poor mechanical properties, limited 
processing parameters and rapid degradation kinetics.92, 148 While crosslinking has been suggested 
as a method for improving mechanical properties, it can induce modification to the structure 
impacting the cellular response to the scaffold.13 Furthermore, clinical considerations may 
complicate the use of some natural materials that lack a defined chemical composition. For 
example, Matrigel™  is a commonly used natural material in the development of cardiac patches,  
with  positive results.  However, it is not clear whether Matrigel will be clinically approved for 
human use.119 Although functionality on natural material scaffolds is some of the highest 
reported,131 these challenges still present a barrier for creating implantable, clinically relevant 
cardiac patches from them.  
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2.7.5. COMPOSITE MATERIALS FOR CARDIAC PATCH SCAFFOLDS 
While progress has been made in the development of cardiac patches using synthetic and 
natural materials, there are considerable limitations to each. While synthetic materials demonstrate 
mechanical integrity and tunable degradation, they also can elicit an immune response and do not 
easily interact with cells or the native tissue environment. Natural materials are highly 
biocompatible and provide cell attachment sites, but are typically mechanically weak with rapid 
degradation profiles. As one potential solution, composite materials combining natural and 
synthetic materials have been investigated for use as cardiac patches. Through the combination of 
natural and synthetic materials, a more desirable material for cardiac patches may be achieved. 
 Synthetic materials have been combined with fibrin 149, collagen 150, alginate and gelatin 
151 for the design of a cardiac patch. The incorporation of natural materials with synthetics 
enhances the cellular response relative to synthetic materials alone. However, synthetic materials 
still have drawbacks.  One potential strategy to create better cardiac patches may be to generate a 
natural material that has the mechanical integrity needed for this application. 
Silk fibroin has been combined with cardiac tissue-derived extracellular matrix (cECM). 
This composite material had tunable architectures, degradation rates, and mechanical properties 
dependent on the concentrations of the components utilized. When implanted subcutaneously in a 
rat model, the addition of cECM to the acellular silk scaffold lead to high endogenous cellular 
infiltration. Additionally, the scaffold promoted vascularization after 4 weeks in vivo. When 
evaluating the constructs in vitro and seeding cells onto the scaffolds, the incorporation of the 
cECM promoted greater myosin heavy chain expression, a part of the contractile complex critical 
to cardiomyocyte function.138 This study demonstrates the feasibility of using natural materials to 
create a mechanically tunable scaffold for a cardiac patch application. Further development of a 
cell-populated scaffold of clinically relevant size is critical for the development of a successful 
cardiac patch.  
2.8. BIOPOLYMER MICROTHREADS FOR TISSUE REGENERATION 
Biopolymer microthreads are discrete, fibrous materials, generated from ECM, 
polysaccharides and naturally derived proteins such as fibrin,152-154 silk,155-156 collagen,157-158 
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chitosan, and alginate.159-161 The morphological and biochemical properties of these microthreads 
are comparable to native fibrous structures, and they can be precisely engineered into 
hierarchically ordered, tissue-specific scaffolds with morphological, mechanical and biochemical 
cues to promote cell-mediated tissue regeneration (Figure 2.5). These microthreads can be 
modified to precisely modulate their material properties including tensile strength and degradation 
rates. These thread modifications enable the fabrication of scaffolds that closely mimic properties 
of native tissues.  
 
Figure 2.5: Biopolymer microthreads for tissue engineering applications. Biopolymer microthreads composed of 
different biomaterials (A) can be hierarchically combined to produce scaffolds (B-D). These scaffolds mimic tissue 
structures (E-G) of targeted diseased or injured tissues (H-J).  
 
To enhance the efficiency of cell delivery to a myocardial infarct, our labs pioneered a cell-
seeded fibrin microthread-based suture system to facilitate targeted, localized cell delivery in the 
heart. Biopolymer threads may mimic the fibril architecture observed in native myocardium and 
may help cells to incorporate into the infarct tissue.  
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In one study evaluating the effective delivery of human mesenchymal stem cells (hMSCs), 
cells were incorporated on a fibrin microthread suture and implanted or delivered via IM injection 
to the left ventricular wall of non-infarcted normal rat hearts. Delivery efficiency was greatly 
improved using the fibrin suture relative to the cell injection alone (63.6 +/- 10.6% and 11.8 +/- 
6.2%, respectively).153 In a more recent study, an acellular suture was compared to an hMSC-
seeded suture to assess the impact in normal functioning rat hearts. To compare regional 
mechanical function, systolic area of contraction (SAC) in the region of biopolymer microthread 
delivery was evaluated. Compared to native myocardium, SAC was decreased for acellular 
scaffold implants, while this decrease was less pronounced in the hMSC-seeded suture group. 
Fibrosis was reduced for the hMSC seeded suture group relative to the acellular suture group,162 
suggesting that hMSCs may release factors limiting the fibrotic response to injury. The 
incorporation of hMSCs improved regional mechanics when compared to an acellular scaffold, 
demonstrating the value of delivering healthy cells incorporated onto the biomaterial scaffold. In 
an in vitro analysis, fibrin microthread sutures were able to support viability, proliferative capacity 
and multipotency in hMSCs, suggesting that the fibrin microthreads may be used as a platform 
technology163 and may be applicable to other applications. 
Excerpt from: O’Brien, Megan P., et al. "Designing Biopolymer Microthreads for Tissue 
Engineering and Regenerative Medicine." Current Stem Cell Reports 2.2 (2016): 147-157. 
 
2.9. FIBRIN MICROTHREAD-BASED COMPOSITE SCAFFOLDS  
While fibrin microthreads have shown the ability to guide cellular orientation,152 the 
microthreads are mechanically stiff relative to myocardium and may limit cell-mediated 
contractility.164 In contrast, hydrogels provide compactible environments and have produced some 
of the highest reported contractile force measurements to date.77 However, hydrogels are typically 
qualitatively characterized as mechanically weak165-166 and may fail in the dynamic environment 
of the heart.61, 166 A composite material composed of a microthread element and a hydrogel phase 
may yield a scaffold combining the benefits of structural cues and mechanical integrity of 
microthreads, with the hydrogel environment that is conducive to cell-mediated contractility. 
These materials could be strategically combined to mimic the mechanical environment of native 
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myocardium promoting high functionality of incorporated cells. The use of fibrin microthreads 
within the composite may enable a contractile tissue analog of myocardial tissue. 
2.10. REFERENCES 
1. Hwang, J.; Jeong, Y.; Park, J. M.; Lee, K. H.; Hong, J. W.; Choi, J., Biomimetics: forecasting the future of 
science, engineering, and medicine. International journal of nanomedicine 2015, 10, 5701-13. 
2. Bhushan, B., Biomimetics. Philos Trans A Math Phys Eng Sci 2009, 367 (1893), 1443-4. 
3. Freedman, R.; Wright, W.; Wright, O., The Wright brothers : how they invented the airplane. 1st ed.; Holiday 
House: New York, 1991; p 129 p. 
4. Jakab, P. L., Visions of a flying machine : the Wright brothers and the process of invention. Smithsonian 
Institution Press: Washington, 1990; p xviii, 263 p. 
5. Langer, R.; Vacanti, J. P., Tissue engineering. Science 1993, 260 (5110), 920-6. 
6. Webber, M. J.; Khan, O. F.; Sydlik, S. A.; Tang, B. C.; Langer, R., A perspective on the clinical translation of 
scaffolds for tissue engineering. Annals of biomedical engineering 2015, 43 (3), 641-56. 
7. Qu, D.; Mosher, C. Z.; Boushell, M. K.; Lu, H. H., Engineering complex orthopaedic tissues via strategic 
biomimicry. Annals of biomedical engineering 2015, 43 (3), 697-717. 
8. Silverthorn, D. U.; Johnson, B. R., Human physiology : an integrated approach. 5th ed.; Pearson/Benjamin 
Cummings: San Francisco, 2010; p xxxiv, 867, 83 p. 
9. O'Brien, M. P.; Carnes, M. E.; Page, R. L.; Gaudette, G. R.; Pins, G. D., Designing biopolymer microthreads for 
tissue engineering and regenerative medicine. Current Stem Cell Reports 2016, 2, 147-57. 
10. Atala, A.; Kasper, F. K.; Mikos, A. G., Engineering complex tissues. Science translational medicine 2012, 4 
(160), 160rv12. 
11. Grasman, J. M.; Do, D. M.; Page, R. L.; Pins, G. D., Rapid release of growth factors regenerates force output 
in volumetric muscle loss injuries. Biomaterials 2015, 72, 49-60. 
12. Leor, J.; Cohen, S., Myocardial tissue engineering: creating a muscle patch for a wounded heart. Annals of 
the New York Academy of Sciences 2004, 1015, 312-9. 
13. Silvestri, A.; Boffito, M.; Sartori, S.; Ciardelli, G., Biomimetic materials and scaffolds for myocardial tissue 
regeneration. Macromolecular bioscience 2013, 13 (8), 984-1019. 
14. Radisic, M.; Park, H.; Gerecht, S.; Cannizzaro, C.; Langer, R.; Vunjak-Novakovic, G., Biomimetic approach to 
cardiac tissue engineering. Philosophical transactions of the Royal Society of London. Series B, Biological 
sciences 2007, 362 (1484), 1357-68. 
15. Shin, H.; Jo, S.; Mikos, A. G., Biomimetic materials for tissue engineering. Biomaterials 2003, 24 (24), 4353-
64. 
16. Nuernberger, S.; Cyran, N.; Albrecht, C.; Redl, H.; Vecsei, V.; Marlovits, S., The influence of scaffold 
architecture on chondrocyte distribution and behavior in matrix-associated chondrocyte transplantation 
grafts. Biomaterials 2011, 32 (4), 1032-40. 
17. Benya, P. D.; Shaffer, J. D., Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype 
when cultured in agarose gels. Cell 1982, 30 (1), 215-24. 
18. Bosworth, L. A.; Turner, L. A.; Cartmell, S. H., State of the art composites comprising electrospun fibres 
coupled with hydrogels: a review. Nanomedicine : nanotechnology, biology, and medicine 2013, 9 (3), 322-
35. 
19. Anseth, K. S.; Bowman, C. N.; Brannon-Peppas, L., Mechanical properties of hydrogels and their 
experimental determination. Biomaterials 1996, 17 (17), 1647-57. 
20. Stammen, J. A.; Williams, S.; Ku, D. N.; Guldberg, R. E., Mechanical properties of a novel PVA hydrogel in 
shear and unconfined compression. Biomaterials 2001, 22 (8), 799-806. 
21. Huang, T.; Xu, H.; Jiao, K.; Zhu, L.; Brown, H. R.; Wang, H., A novel hydrogel with high mechanical strength: a 
macromolecular microsphere composite hydrogel. Advanced materials 2007, 19 (1622). 
 Chapter 2 
Background 40 
 
 
22. Yodmuang, S.; McNamara, S. L.; Nover, A. B.; Mandal, B. B.; Aganwal, M.; Kelly, T. A. N.; Chao, P. H. G.; Hung, 
C.; Kaplan, D. L.; Vunjak-Novakovic, G., Silk microfiber-reinforced silk hydrogel composites for functional 
cartilage tissue repair. Acta biomaterialia 2015, 11, 27-36. 
23. Callister, W. D.; Rethwisch, D. G., Fundamentals of materials science and engineering : an integrated 
approach. 4th ed.; Wiley: Hoboken, N.J., 2012; p xxv, 910 p. 
24. Huang, Z.; Feng, Q.; Yu, B.; Li, S., Biomimetic properties of an injectable chitosan/ nano-hydroxyapatite/ 
collagen composite. Mat Sci Eng C-Mater 2011, 31, 683-687. 
25. Naik, N.; Caves, J.; Chaikof, E. L.; Allen, M. G., Generation of spatially aligned collagen fiber networks 
through microtransfer molding. Adv Healthc Mater 2014, 3 (3), 367-74. 
26. Cutiongco, M. F.; Tan, M. H.; Ng, M. Y.; Le Visage, C.; Yim, E. K., Composite pullulan-dextran polysaccharide 
scaffold with interfacial polyelectrolyte complexation fibers: a platform with enhanced cell interaction and 
spatial distribution. Acta biomaterialia 2014, 10 (10), 4410-8. 
27. Sharabi, M.; Mandelberg, Y.; Benayahu, D.; Benayahu, Y.; Azem, A.; Haj-Ali, R., A new class of bio-composite 
materials of unique collagen fibers. Journal of the mechanical behavior of biomedical materials 2014, 36, 71-
81. 
28. Tonsomboon, K.; Oyen, M. L., Composite electrospun gelatin fiber-alginate gel scaffolds for mechanically 
robust tissue engineered cornea. Journal of the mechanical behavior of biomedical materials 2013, 21, 185-
94. 
29. Shepherd, J. H.; Ghose, S.; Kew, S. J.; Moavenian, A.; Best, S. M.; Cameron, R. E., Effect of fiber crosslinking 
on collagen-fiber reinforced collagen-chondroitin-6-sulfate materials for regenerating load-bearing soft 
tissues. Journal of biomedical materials research. Part A 2013, 101 (1), 176-84. 
30. Chrobak, M. O.; Hansen, K. J.; Gershlak, J. R.; Vratsanos, M.; Kanellias, M.; Gaudette, G. R.; Pins, G. D., 
Design of a fibrin microthread-based composite layer for use in a cardiac patch. ACS Biomaterials Science & 
Engineering 2016. 
31. Li, G.; Liu, J.; Zheng, Z.; Wang, X.; Kaplan, D. L., Structural Mimetic Silk Fiber-Reinforced Composite Scaffolds 
Using Multi-Angle Fibers. Macromolecular bioscience 2015, 15 (8), 1125-33. 
32. Le Goff, K. J.; Gaillard, C.; Helbert, W.; Garnier, C.; Aubry, T., Rheological study of reinforcement of agarose 
hydrogels by cellulose nanowhiskers. Carbohydrate polymers 2015, 116, 117-23. 
33. Gentleman, E.; Nauman, E. A.; Livesay, G. A.; Dee, K. C., Collagen composite biomaterials resist contraction 
while allowing development of adipocytic soft tissue in vitro. Tissue engineering 2006, 12 (6), 1639-49. 
34. Gentleman, E.; Dee, K. C.; Livesay, G. A.; Nauman, E. A., Operating curves to characterize the contraction of 
fibroblast-seeded collagen gel/collagen fiber composite biomaterials: effect of fiber mass. Plast Reconstr 
Surg 2007, 119 (2), 508-16. 
35. Gentleman, E.; Nauman, E. A.; Dee, K. C.; Livesay, G. A., Short collagen fibers provide control of contraction 
and permeability in fibroblast-seeded collagen gels. Tissue engineering 2004, 10 (3-4), 421-7. 
36. Chen, Y.; Huang, Z.; Li, X.; Li, S.; Zhou, Z.; Zhang, Y.; Feng, Q.; Yu, B., In vitro biocompatibility and osteoblast 
differentiation of an injectable chitosan/nano-hydroxyapatite/ collagen scaffold. Journal of Nanomaterials 
2012, 2012. 
37. Wongpanit, P.; Sanchavanakit, N.; Pavasant, P.; Bunaprasert, T.; Tabata, Y.; Rujiravanit, R., Preparation and 
characterization of chitin whisker-reinforced silk fibroin nanocomposite sponges. Macromolecular 
Nanotechnology 2007, 43, 4123-4135. 
38. Mobini, S.; Taghizadeh-Jahed, M.; Khanmohammadi, M.; Moshiri, A.; Naderi, M. M.; Heidari-Vala, H.; Ashrafi 
Helan, J.; Khanjani, S.; Springer, A.; Akhondi, M. M.; Kazemnejad, S., Comparative evaluation of in vivo 
biocompatibility and biodegradability of regenerated silk scaffolds reinforced with/without natural silk 
fibers. Journal of biomaterials applications 2016, 30 (6), 793-809. 
39. Mobini, S.; Hoyer, B.; Solati-Hashjin, M.; Lode, A.; Nosoudi, N.; Samadikuchaksaraei, A.; Gelinsky, M., 
Fabrication and characterization of regenerated silk scaffolds reinforced with natural silk fibers for bone 
tissue engineering. Journal of biomedical materials research. Part A 2013, 101 (8), 2392-404. 
 Chapter 2 
Background 41 
 
 
40. Mandal, B. B.; Grinberg, A.; Gil, E. S.; Panilaitis, B.; Kaplan, D. L., High-strength silk protein scaffolds for bone 
repair. Proceedings of the National Academy of Sciences of the United States of America 2012, 109 (20), 
7699-704. 
41. Park, J. B.; Lakes, R. S., Biomaterials: an introduction. 2nd ed.; Plenum Press: New York, 1992. 
42. Sommer, G.; Haspinger, D. C.; Andra, M.; Sacherer, M.; Viertler, C.; Regitnig, P.; Holzapfel, G. A., 
Quantification of Shear Deformations and Corresponding Stresses in the Biaxially Tested Human 
Myocardium. Annals of biomedical engineering 2015. 
43. Yeh, H. L.; Yeh, H. Y., A dimensionless analysis of young's modulus and stress distribution for orthotropic 
materials. Journal of Aeronautics and Aerospace Engineering 2014, 3 (1). 
44. Mozaffarian, D.; Benjamin, E. J.; Go, A. S.; Arnett, D. K.; Blaha, M. J.; Cushman, M.; de Ferranti, S.; Despres, J. 
P.; Fullerton, H. J.; Howard, V. J.; Huffman, M. D.; Judd, S. E.; Kissela, B. M.; Lackland, D. T.; Lichtman, J. H.; 
Lisabeth, L. D.; Liu, S.; Mackey, R. H.; Matchar, D. B.; McGuire, D. K.; Mohler, E. R., 3rd; Moy, C. S.; Muntner, 
P.; Mussolino, M. E.; Nasir, K.; Neumar, R. W.; Nichol, G.; Palaniappan, L.; Pandey, D. K.; Reeves, M. J.; 
Rodriguez, C. J.; Sorlie, P. D.; Stein, J.; Towfighi, A.; Turan, T. N.; Virani, S. S.; Willey, J. Z.; Woo, D.; Yeh, R. W.; 
Turner, M. B.; American Heart Association Statistics, C.; Stroke Statistics, S., Heart disease and stroke 
statistics--2015 update: a report from the American Heart Association. Circulation 2015, 131 (4), e29-322. 
45. Radisic, M.; Christman, K. L., Materials science and tissue engineering: repairing the heart. Mayo Clinic 
proceedings 2013, 88 (8), 884-98. 
46. Frangogiannis, N. G.; Smith, C. W.; Entman, M. L., The inflammatory response in myocardial infarction. 
Cardiovascular research 2002, 53 (1), 31-47. 
47. Vunjak-Novakovic, G.; Tandon, N.; Godier, A.; Maidhof, R.; Marsano, A.; Martens, T. P.; Radisic, M., 
Challenges in cardiac tissue engineering. Tissue engineering. Part B, Reviews 2010, 16 (2), 169-87. 
48. Beltrami, A. P.; Barlucchi, L.; Torella, D.; Baker, M.; Limana, F.; Chimenti, S.; Kasahara, H.; Rota, M.; Musso, 
E.; Urbanek, K.; Leri, A.; Kajstura, J.; Nadal-Ginard, B.; Anversa, P., Adult cardiac stem cells are multipotent 
and support myocardial regeneration. Cell 2003, 114 (6), 763-76. 
49. Cohen, S.; Leor, J., Rebuilding broken hearts. Biologists and engineers working together in the fledgling field 
of tissue engineering are within reach of one of their greatest goals: constructing a living human heart 
patch. Sci Am 2004, 291 (5), 44-51. 
50. Holmes, J. W.; Borg, T. K.; Covell, J. W., Structure and mechanics of healing myocardial infarcts. Annual 
review of biomedical engineering 2005, 7, 223-53. 
51. Sun, Y.; Weber, K. T., Infarct scar: a dynamic tissue. Cardiovascular research 2000, 46 (2), 250-6. 
52. Menasche, P., Cardiac cell therapy: lessons from clinical trials. Journal of molecular and cellular cardiology 
2011, 50 (2), 258-65. 
53. Jakob, P.; Landmesser, U., Current status of cell-based therapy for heart failure. Current heart failure reports 
2013, 10 (2), 165-76. 
54. Shah, V. K.; Shalia, K. K., Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box. 
Stem cells international 2011, 2011, 536758. 
55. Li, X.; Tamama, K.; Xie, X.; Guan, J., Improving Cell Engraftment in Cardiac Stem Cell Therapy. Stem cells 
international 2016, 2016, 7168797. 
56. Vu, D. T.; Martinez, E. C.; Kofidis, T., Myocardial restoration: is it the cell or the architecture or both? Cardiol 
Res Pract 2012, 2012, 240497. 
57. Black, L. D., 3rd; Meyers, J. D.; Weinbaum, J. S.; Shvelidze, Y. A.; Tranquillo, R. T., Cell-induced alignment 
augments twitch force in fibrin gel-based engineered myocardium via gap junction modification. Tissue 
engineering. Part A 2009, 15 (10), 3099-108. 
58. Kim, D. H.; Lipke, E. A.; Kim, P.; Cheong, R.; Thompson, S.; Delannoy, M.; Suh, K. Y.; Tung, L.; Levchenko, A., 
Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proceedings of 
the National Academy of Sciences of the United States of America 2010, 107 (2), 565-70. 
 Chapter 2 
Background 42 
 
 
59. Lee, W. N.; Pernot, M.; Couade, M.; Messas, E.; Bruneval, P.; Bel, A.; Hagege, A. A.; Fink, M.; Tanter, M., 
Mapping myocardial fiber orientation using echocardiography-based shear wave imaging. IEEE transactions 
on medical imaging 2012, 31 (3), 554-62. 
60. Coulombe, K. L.; Bajpai, V. K.; Andreadis, S. T.; Murry, C. E., Heart Regeneration with Engineered Myocardial 
Tissue. Annual review of biomedical engineering 2014. 
61. Reis, L. A.; Chiu, L. L.; Feric, N.; Fu, L.; Radisic, M., Biomaterials in myocardial tissue engineering. Journal of 
tissue engineering and regenerative medicine 2014, 10 (1), 11-28. 
62. Liau, B.; Christoforou, N.; Leong, K. W.; Bursac, N., Pluripotent stem cell-derived cardiac tissue patch with 
advanced structure and function. Biomaterials 2011, 32 (35), 9180-7. 
63. Basford, J. R., The Law of Laplace and its relevance to contemporary medicine and rehabilitation. Arch Phys 
Med Rehabil 2002, 83 (8), 1165-70. 
64. Fung, Y. C., A first course in continuum mechanics. 2d ed.; Prentice-Hall: Englewood Cliffs, N.J., 1977; p xii, 
340 p. 
65. Moriarty, T. F., The law of Laplace. Its limitations as a relation for diastolic pressure, volume, or wall stress of 
the left ventricle. Circulation research 1980, 46 (3), 321-31. 
66. Segers, V. F.; Lee, R. T., Biomaterials to enhance stem cell function in the heart. Circulation research 2011, 
109 (8), 910-22. 
67. Chen, Q. Z.; Harding, S. E.; Ali, N. N.; Lyon, A. R.; Boccaccini, A. R., Biomaterials in cardiac tissue engineering: 
Ten years of research survey. Materials Science & Engineering R 2008, 59, 1-37. 
68. Ifkovits, J. L.; Tous, E.; Minakawa, M.; Morita, M.; Robb, J. D.; Koomalsingh, K. J.; Gorman, J. H., 3rd; Gorman, 
R. C.; Burdick, J. A., Injectable hydrogel properties influence infarct expansion and extent of postinfarction 
left ventricular remodeling in an ovine model. Proceedings of the National Academy of Sciences of the 
United States of America 2010, 107 (25), 11507-12. 
69. Sartipy, U.; Albage, A.; Lindblom, D., The Dor procedure for left ventricular reconstruction. Ten-year clinical 
experience. Eur J Cardiothorac Surg 2005, 27 (6), 1005-10. 
70. Kelly, D. J.; Rosen, A. B.; Schuldt, A. J.; Kochupura, P. V.; Doronin, S. V.; Potapova, I. A.; Azeloglu, E. U.; 
Badylak, S. F.; Brink, P. R.; Cohen, I. S.; Gaudette, G. R., Increased myocyte content and mechanical function 
within a tissue-engineered myocardial patch following implantation. Tissue engineering. Part A 2009, 15 (8), 
2189-201. 
71. Cui, J.; Li, J.; Mathison, M.; Tondato, F.; Mulkey, S. P.; Micko, C.; Chronos, N. A.; Robinson, K. A., A clinically 
relevant large-animal model for evaluation of tissue-engineered cardiac surgical patch materials. Cardiovasc 
Revasc Med 2005, 6 (3), 113-20. 
72. Ukwatta, E.; Arevalo, H.; Rajchl, M.; White, J.; Pashakhanloo, F.; Prakosa, A.; Herzka, D. A.; McVeigh, E.; 
Lardo, A. C.; Trayanova, N. A.; Vadakkumpadan, F., Image-based reconstruction of three-dimensional 
myocardial infarct geometry for patient-specific modeling of cardiac electrophysiology. Med Phys 2015, 42 
(8), 4579-90. 
73. Tallawi, M.; Rai, R.; Boccaccini, A. R.; Aifantis, K. E., Effect of substrate mechanics on cardiomyocyte 
maturation and growth. Tissue engineering. Part B, Reviews 2015, 21 (1), 157-65. 
74. Pok, S.; Myers, J. D.; Madihally, S. V.; Jacot, J. G., A multilayered scaffold of a chitosan and gelatin hydrogel 
supported by a PCL core for cardiac tissue engineering. Acta biomaterialia 2013, 9 (3), 5630-42. 
75. Campbell, K. S.; Patel, J. R.; Moss, R. L., Cycling cross-bridges increase myocardial stiffness at submaximal 
levels of Ca2+ activation. Biophysical journal 2003, 84 (6), 3807-3815. 
76. Thomson, K. S.; Korte, F. S.; Giachelli, C. M.; Ratner, B. D.; Regnier, M.; Scatena, M., Prevascularized 
microtemplated fibrin scaffolds for cardiac tissue engineering applications. Tissue engineering. Part A 2013, 
19 (7-8), 967-77. 
77. Zhang, D.; Shadrin, I. Y.; Lam, J.; Xian, H. Q.; Snodgrass, H. R.; Bursac, N., Tissue-engineered cardiac patch for 
advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 2013, 34 (23), 5813-
20. 
 Chapter 2 
Background 43 
 
 
78. Miklas, J. W.; Dallabrida, S. M.; Reis, L. A.; Ismail, N.; Rupnick, M.; Radisic, M., QHREDGS enhances tube 
formation, metabolism and survival of endothelial cells in collagen-chitosan hydrogels. PloS one 2013, 8 (8), 
e72956. 
79. Morin, K. T.; Dries-Devlin, J. L.; Tranquillo, R. T., Engineered microvessels with strong alignment and high 
lumen density via cell-induced fibrin gel compaction and interstitial flow. Tissue engineering. Part A 2014, 20 
(3-4), 553-65. 
80. Wendel, J. S.; Ye, L.; Zhang, P.; Tranquillo, R. T.; Zhang, J. J., Functional consequences of a tissue-engineered 
myocardial patch for cardiac repair in a rat infarct model. Tissue engineering. Part A 2014, 20 (7-8), 1325-35. 
81. Xiong, Q.; Hill, K. L.; Li, Q.; Suntharalingam, P.; Mansoor, A.; Wang, X.; Jameel, M. N.; Zhang, P.; Swingen, C.; 
Kaufman, D. S.; Zhang, J., A fibrin patch-based enhanced delivery of human embryonic stem cell-derived 
vascular cell transplantation in a porcine model of postinfarction left ventricular remodeling. Stem cells 
2011, 29 (2), 367-75. 
82. Fleischer, S.; Feiner, R.; Shapira, A.; Ji, J.; Sui, X.; Daniel Wagner, H.; Dvir, T., Spring-like fibers for cardiac 
tissue engineering. Biomaterials 2013, 34 (34), 8599-606. 
83. Jacot, J. G.; McCulloch, A. D.; Omens, J. H., Substrate stiffness affects the functional maturation of neonatal 
rat ventricular myocytes. Biophysical journal 2008, 95 (7), 3479-87. 
84. Ma, Z.; Koo, S.; Finnegan, M. A.; Loskill, P.; Huebsch, N.; Marks, N. C.; Conklin, B. R.; Grigoropoulos, C. P.; 
Healy, K. E., Three-dimensional filamentous human diseased cardiac tissue model. Biomaterials 2014, 35 (5), 
1367-77. 
85. Sekine, H.; Shimizu, T.; Hobo, K.; Sekiya, S.; Yang, J.; Yamato, M.; Kurosawa, H.; Kobayashi, E.; Okano, T., 
Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and 
improves cardiac function of ischemic hearts. Circulation 2008, 118 (14 Suppl), S145-52. 
86. Shimizu, T.; Sekine, H.; Isoi, Y.; Yamato, M.; Kikuchi, A.; Okano, T., Long-term survival and growth of pulsatile 
myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue engineering 2006, 12 
(3), 499-507. 
87. Masuda, S.; Shimizu, T., Three-dimensional cardiac tissue fabrication based on cell sheet technology. Adv 
Drug Deliv Rev 2016, 96, 103-9. 
88. Ott, H. C.; Matthiesen, T. S.; Goh, S. K.; Black, L. D.; Kren, S. M.; Netoff, T. I.; Taylor, D. A., Perfusion-
decellularized matrix: using nature's platform to engineer a bioartificial heart. Nature medicine 2008, 14 (2), 
213-21. 
89. Robertson, M. J.; Dries-Devlin, J. L.; Kren, S. M.; Burchfield, J. S.; Taylor, D. A., Optimizing recellularization of 
whole decellularized heart extracellular matrix. PloS one 2014, 9 (2), e90406. 
90. Song, J. J.; Ott, H. C., Organ engineering based on decellularized matrix scaffolds. Trends in molecular 
medicine 2011, 17 (8), 424-32. 
91. Shimizu, T.; Sekine, H.; Yang, J.; Isoi, Y.; Yamato, M.; Kikuchi, A.; Kobayashi, E.; Okano, T., Polysurgery of cell 
sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J 2006, 20 
(6), 708-10. 
92. Jawad, H.; Lyon, A. R.; Harding, S. E.; Ali, N. N.; Boccaccini, A. R., Myocardial tissue engineering. British 
medical bulletin 2008, 87, 31-47. 
93. Kaiser, N. J.; Coulombe, K. L., Physiologically inspired cardiac scaffolds for tailored in vivo function and heart 
regeneration. Biomedical materials 2015, 10 (3), 034003. 
94. Kochupura, P. V.; Azeloglu, E. U.; Kelly, D. J.; Doronin, S. V.; Badylak, S. F.; Krukenkamp, I. B.; Cohen, I. S.; 
Gaudette, G. R., Tissue-engineered myocardial patch derived from extracellular matrix provides regional 
mechanical function. Circulation 2005, 112 (9 Suppl), I144-9. 
95. Robinson, K. A.; Li, J.; Mathison, M.; Redkar, A.; Cui, J.; Chronos, N. A.; Matheny, R. G.; Badylak, S. F., 
Extracellular matrix scaffold for cardiac repair. Circulation 2005, 112 (9 Suppl), I135-43. 
96. Yanagawa, B.; Rao, V.; Yau, T. M.; Cusimano, R. J., Initial experience with intraventricular repair using 
CorMatrix extracellular matrix. Innovations (Phila) 2013, 8 (5), 348-52. 
 Chapter 2 
Background 44 
 
 
97. Dobner, S.; Bezuidenhout, D.; Govender, P.; Zilla, P.; Davies, N., A synthetic non-degradable polyethylene 
glycol hydrogel retards adverse post-infarct left ventricular remodeling. J Card Fail 2009, 15 (7), 629-36. 
98. Badylak, S.; Obermiller, J.; Geddes, L.; Matheny, R., Extracellular matrix for myocardial repair. Heart Surg 
Forum 2003, 6 (2), E20-6. 
99. Okada, M.; Payne, T. R.; Oshima, H.; Momoi, N.; Tobita, K.; Huard, J., Differential efficacy of gels derived 
from small intestinal submucosa as an injectable biomaterial for myocardial infarct repair. Biomaterials 
2010, 31 (30), 7678-83. 
100. Hogan, M.; Mohamed, M.; Tao, Z. W.; Gutierrez, L.; Birla, R., Establishing the Framework to Support 
Bioartificial Heart Fabrication Using Fibrin-Based Three-Dimensional Artificial Heart Muscle. Artificial organs 
2014, 61 (4), 429-36. 
101. Remlinger, N. T.; Gilbert, T. W.; Yoshida, M.; Guest, B. N.; Hashizume, R.; Weaver, M. L.; Wagner, W. R.; 
Brown, B. N.; Tobita, K.; Wearden, P. D., Urinary bladder matrix promotes site appropriate tissue formation 
following right ventricle outflow tract repair. Organogenesis 2013, 9 (3), 149-60. 
102. Zhang, G.; Hu, Q.; Braunlin, E. A.; Suggs, L. J.; Zhang, J., Enhancing efficacy of stem cell transplantation to the 
heart with a PEGylated fibrin biomatrix. Tissue engineering. Part A 2008, 14 (6), 1025-36. 
103. Moroni, F.; Mirabella, T., Decellularized matrices for cardiovascular tissue engineering. Am J Stem Cells 
2014, 3 (1), 1-20. 
104. Rana, D.; Zreiqat, H.; Benkirane-Jessel, N.; Ramakrishna, S.; Ramalingam, M., Development of decellularized 
scaffolds for stem cell-driven tissue engineering. Journal of tissue engineering and regenerative medicine 
2015. 
105. Lopes, S. A.; Costa, F. D.; Paula, J. B.; Dhomen, P.; Phol, F.; Vilani, R.; Roderjan, J. G.; Vieira, E. D., 
Decellularized heterografts versus cryopreserved homografts: experimental study in sheep model. Rev Bras 
Cir Cardiovasc 2009, 24 (1), 15-22. 
106. Gui, L.; Muto, A.; Chan, S. A.; Breuer, C. K.; Niklason, L. E., Development of decellularized human umbilical 
arteries as small-diameter vascular grafts. Tissue engineering. Part A 2009, 15 (9), 2665-76. 
107. Leor, J.; Amsalem, Y.; Cohen, S., Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol 
Ther 2005, 105 (2), 151-63. 
108. Badylak, S. F.; Tullius, R.; Kokini, K.; Shelbourne, K. D.; Klootwyk, T.; Voytik, S. L.; Kraine, M. R.; Simmons, C., 
The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. 
Journal of biomedical materials research 1995, 29 (8), 977-85. 
109. Crapo, P. M.; Gilbert, T. W.; Badylak, S. F., An overview of tissue and whole organ decellularization 
processes. Biomaterials 2011, 32 (12), 3233-43. 
110. Lu, T. Y.; Lin, B.; Kim, J.; Sullivan, M.; Tobita, K.; Salama, G.; Yang, L., Repopulation of decellularized mouse 
heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells. Nature 
communications 2013, 4, 2307. 
111. Guyette, J. P.; Charest, J. M.; Mills, R. W.; Jank, B. J.; Moser, P. T.; Gilpin, S. E.; Gershlak, J. R.; Okamoto, T.; 
Gonzalez, G.; Milan, D. J.; Gaudette, G. R.; Ott, H. C., Bioengineering Human Myocardium on Native 
Extracellular Matrix. Circulation research 2016, 118 (1), 56-72. 
112. Okano, T.; Yamada, N.; Sakai, H.; Sakurai, Y., A novel recovery system for cultured cells using plasma-treated 
polystyrene dishes grafted with poly(N-isopropylacrylamide). Journal of biomedical materials research 1993, 
27 (10), 1243-51. 
113. Kushida, A.; Yamato, M.; Konno, C.; Kikuchi, A.; Sakurai, Y.; Okano, T., Decrease in culture temperature 
releases monolayer endothelial cell sheets together with deposited fibronectin matrix from temperature-
responsive culture surfaces. Journal of biomedical materials research 1999, 45 (4), 355-62. 
114. Shimizu, T.; Yamato, M.; Akutsu, T.; Shibata, T.; Isoi, Y.; Kikuchi, A.; Umezu, M.; Okano, T., Electrically 
communicating three-dimensional cardiac tissue mimic fabricated by layered cultured cardiomyocyte 
sheets. Journal of biomedical materials research 2002, 60 (1), 110-7. 
 Chapter 2 
Background 45 
 
 
115. Shimizu, T.; Yamato, M.; Isoi, Y.; Akutsu, T.; Setomaru, T.; Abe, K.; Kikuchi, A.; Umezu, M.; Okano, T., 
Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique 
and temperature-responsive cell culture surfaces. Circulation research 2002, 90 (3), e40. 
116. Haraguchi, Y.; Shimizu, T.; Yamato, M.; Kikuchi, A.; Okano, T., Electrical coupling of cardiomyocyte sheets 
occurs rapidly via functional gap junction formation. Biomaterials 2006, 27 (27), 4765-74. 
117. Sawa, Y.; Miyagawa, S.; Sakaguchi, T.; Fujita, T.; Matsuyama, A.; Saito, A.; Shimizu, T.; Okano, T., Tissue 
engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with 
DCM: report of a case. Surgery today 2012, 42 (2), 181-4. 
118. Menasche, P.; Hagege, A. A.; Vilquin, J. T.; Desnos, M.; Abergel, E.; Pouzet, B.; Bel, A.; Sarateanu, S.; Scorsin, 
M.; Schwartz, K.; Bruneval, P.; Benbunan, M.; Marolleau, J. P.; Duboc, D., Autologous skeletal myoblast 
transplantation for severe postinfarction left ventricular dysfunction. Journal of the American College of 
Cardiology 2003, 41 (7), 1078-83. 
119. Akhyari, P.; Kamiya, H.; Haverich, A.; Karck, M.; Lichtenberg, A., Myocardial tissue engineering: the 
extracellular matrix. Eur J Cardiothorac Surg 2008, 34 (2), 229-41. 
120. Bursac, N.; Papadaki, M.; Cohen, R. J.; Schoen, F. J.; Eisenberg, S. R.; Carrier, R.; Vunjak-Novakovic, G.; Freed, 
L. E., Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. The 
American journal of physiology 1999, 277 (2 Pt 2), H433-44. 
121. Ke, Q.; Yang, Y.; Rana, J. S.; Chen, Y.; Morgan, J. P.; Xiao, Y. F., Embryonic stem cells cultured in 
biodegradable scaffold repair infarcted myocardium in mice. Sheng Li Xue Bao 2005, 57 (6), 673-81. 
122. Kellar, R. S.; Landeen, L. K.; Shepherd, B. R.; Naughton, G. K.; Ratcliffe, A.; Williams, S. K., Scaffold-based 
three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in 
infarcted heart tissue. Circulation 2001, 104 (17), 2063-8. 
123. Thai, H. M.; Juneman, E.; Lancaster, J.; Hagerty, T.; Do, R.; Castellano, L.; Kellar, R.; Williams, S.; Sethi, G.; 
Schmelz, M.; Gaballa, M.; Goldman, S., Implantation of a three-dimensional fibroblast matrix improves left 
ventricular function and blood flow after acute myocardial infarction. Cell transplantation 2009, 18 (3), 283-
95. 
124. Piao, H.; Kwon, J. S.; Piao, S.; Sohn, J. H.; Lee, Y. S.; Bae, J. W.; Hwang, K. K.; Kim, D. W.; Jeon, O.; Kim, B. S.; 
Park, Y. B.; Cho, M. C., Effects of cardiac patches engineered with bone marrow-derived mononuclear cells 
and PGCL scaffolds in a rat myocardial infarction model. Biomaterials 2007, 28 (4), 641-9. 
125. Chen, Q. Z.; Bismarck, A.; Hansen, U.; Junaid, S.; Tran, M. Q.; Harding, S. E.; Ali, N. N.; Boccaccini, A. R., 
Characterisation of a soft elastomer poly(glycerol sebacate) designed to match the mechanical properties of 
myocardial tissue. Biomaterials 2008, 29 (1), 47-57. 
126. Stuckey, D. J.; Ishii, H.; Chen, Q. Z.; Boccaccini, A. R.; Hansen, U.; Carr, C. A.; Roether, J. A.; Jawad, H.; Tyler, 
D. J.; Ali, N. N.; Clarke, K.; Harding, S. E., Magnetic resonance imaging evaluation of remodeling by cardiac 
elastomeric tissue scaffold biomaterials in a rat model of myocardial infarction. Tissue engineering. Part A 
2010, 16 (11), 3395-402. 
127. Jin, J.; Jeong, S. I.; Shin, Y. M.; Lim, K. S.; Shin, H.; Lee, Y. M.; Koh, H. C.; Kim, K. S., Transplantation of 
mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in 
a rat myocardial infarction model. Eur J Heart Fail 2009, 11 (2), 147-53. 
128. Ye, X.; Lu, L.; Kolewe, M. E.; Hearon, K.; Fischer, K. M.; Coppeta, J.; Freed, L. E., Scalable units for building 
cardiac tissue. Advanced materials 2014, 26 (42), 7202-8. 
129. Zhang, B.; Montgomery, M.; Davenport-Huyer, L.; Korolj, A.; Radisic, M., Platform technology for scalable 
assembly of instantaneously functional mosaic tissues. Sci Adv 2015, 1 (7), e1500423. 
130. Causa, F.; Netti, P. A.; Ambrosio, L., A multi-functional scaffold for tissue regeneration: the need to engineer 
a tissue analogue. Biomaterials 2007, 28 (34), 5093-9. 
131. Jackman, C. P.; Carlson, A. L.; Bursac, N., Dynamic culture yields engineered myocardium with near-adult 
functional output. Biomaterials 2016, 111, 66-79. 
 Chapter 2 
Background 46 
 
 
132. Zimmermann, W. H.; Melnychenko, I.; Eschenhagen, T., Engineered heart tissue for regeneration of diseased 
hearts. Biomaterials 2004, 25 (9), 1639-47. 
133. Zimmermann, W. H.; Melnychenko, I.; Wasmeier, G.; Didie, M.; Naito, H.; Nixdorff, U.; Hess, A.; Budinsky, L.; 
Brune, K.; Michaelis, B.; Dhein, S.; Schwoerer, A.; Ehmke, H.; Eschenhagen, T., Engineered heart tissue grafts 
improve systolic and diastolic function in infarcted rat hearts. Nature medicine 2006, 12 (4), 452-8. 
134. Chachques, J. C.; Trainini, J. C.; Lago, N.; Cortes-Morichetti, M.; Schussler, O.; Carpentier, A., Myocardial 
Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. 
Ann Thorac Surg 2008, 85 (3), 901-8. 
135. Radisic, M.; Park, H.; Shing, H.; Consi, T.; Schoen, F. J.; Langer, R.; Freed, L. E.; Vunjak-Novakovic, G., 
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on 
scaffolds. Proceedings of the National Academy of Sciences of the United States of America 2004, 101 (52), 
18129-34. 
136. Fink, C.; Ergun, S.; Kralisch, D.; Remmers, U.; Weil, J.; Eschenhagen, T., Chronic stretch of engineered heart 
tissue induces hypertrophy and functional improvement. FASEB J 2000, 14 (5), 669-79. 
137. Roberts, M. A.; Tran, D.; Coulombe, K. L.; Razumova, M.; Regnier, M.; Murry, C. E.; Zheng, Y., Stromal Cells in 
Dense Collagen Promote Cardiomyocyte and Microvascular Patterning in Engineered Human Heart Tissue. 
Tissue engineering. Part A 2016, 22 (7-8), 633-44. 
138. Stoppel, W. L.; Hu, D.; Domian, I. J.; Kaplan, D. L.; Black, L. D., 3rd, Anisotropic silk biomaterials containing 
cardiac extracellular matrix for cardiac tissue engineering. Biomedical materials 2015, 10 (3), 034105. 
139. Thompson, W. D.; Smith, E. B.; Stirk, C. M.; Marshall, F. I.; Stout, A. J.; Kocchar, A., Angiogenic activity of 
fibrin degradation products is located in fibrin fragment E. The Journal of pathology 1992, 168 (1), 47-53. 
140. Ryu, J. H.; Kim, I. K.; Cho, S. W.; Cho, M. C.; Hwang, K. K.; Piao, H.; Piao, S.; Lim, S. H.; Hong, Y. S.; Choi, C. Y.; 
Yoo, K. J.; Kim, B. S., Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances 
neovascularization in infarcted myocardium. Biomaterials 2005, 26 (3), 319-26. 
141. Bian, W.; Badie, N.; Himel, H. D. t.; Bursac, N., Robust T-tubulation and maturation of cardiomyocytes using 
tissue-engineered epicardial mimetics. Biomaterials 2014, 35 (12), 3819-28. 
142. Llucia-Valldeperas, A.; Soler-Botija, C.; Galvez-Monton, C.; Roura, S.; Prat-Vidal, C.; Perea-Gil, I.; Sanchez, B.; 
Bragos, R.; Vunjak-Novakovic, G.; Bayes-Genis, A., Electromechanical Conditioning of Adult Progenitor Cells 
Improves Recovery of Cardiac Function After Myocardial Infarction. Stem cells translational medicine 2016. 
143. Sakai, T.; Li, R. K.; Weisel, R. D.; Mickle, D. A.; Kim, E. T.; Jia, Z. Q.; Yau, T. M., The fate of a tissue-engineered 
cardiac graft in the right ventricular outflow tract of the rat. The Journal of thoracic and cardiovascular 
surgery 2001, 121 (5), 932-42. 
144. Leor, J.; Aboulafia-Etzion, S.; Dar, A.; Shapiro, L.; Barbash, I. M.; Battler, A.; Granot, Y.; Cohen, S., 
Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 2000, 102 
(19 Suppl 3), III56-61. 
145. Entcheva, E.; Bien, H.; Yin, L.; Chung, C. Y.; Farrell, M.; Kostov, Y., Functional cardiac cell constructs on 
cellulose-based scaffolding. Biomaterials 2004, 25 (26), 5753-62. 
146. Blan, N. R.; Birla, R. K., Design and fabrication of heart muscle using scaffold-based tissue engineering. 
Journal of biomedical materials research. Part A 2008, 86 (1), 195-208. 
147. Khademhosseini, A.; Eng, G.; Yeh, J.; Kucharczyk, P. A.; Langer, R.; Vunjak-Novakovic, G.; Radisic, M., 
Microfluidic patterning for fabrication of contractile cardiac organoids. Biomedical microdevices 2007, 9 (2), 
149-57. 
148. Jawad, H.; Ali, N. N.; Lyon, A. R.; Chen, Q. Z.; Harding, S. E.; Boccaccini, A. R., Myocardial tissue engineering: 
a review. Journal of tissue engineering and regenerative medicine 2007, 1 (5), 327-42. 
149. Lisi, A.; Briganti, E.; Ledda, M.; Losi, P.; Grimaldi, S.; Marchese, R.; Soldani, G., A combined synthetic-fibrin 
scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells. PloS one 
2012, 7 (4), e34284. 
 Chapter 2 
Background 47 
 
 
150. Mukherjee, S.; Venugopal, J. R.; Ravichandran, R.; Ramakrishna, S.; Raghunath, M., Evaluation of the 
Biocompatibility of PLACL/Collagen Nanostructured Matrices with Cardiomyocytes as a Model for the 
Regeneration of Infarcted Myocardium. Advanced Functional Materials 2011, 21 (12), 2291-2300. 
151. Boccaccini, A. R.; Harding, S. E., Myocardial tissue engineering. Springer: Heidelberg, 2011; p x, 268 p. 
152. Grasman, J. M.; Pumphrey, L. M.; Dunphy, M.; Perez-Rogers, J.; Pins, G. D., Static axial stretching enhances 
the mechanical properties and cellular responses of fibrin microthreads. Acta biomaterialia 2014, 10 (10), 
4367-76. 
153. Guyette, J. P.; Fakharzadeh, M.; Burford, E. J.; Tao, Z. W.; Pins, G. D.; Rolle, M. W.; Gaudette, G. R., A novel 
suture-based method for efficient transplantation of stem cells. Journal of biomedical materials research. 
Part A 2013, 101 (3), 809-18. 
154. Page, R. L.; Malcuit, C.; Vilner, L.; Vojtic, I.; Shaw, S.; Hedblom, E.; Hu, J.; Pins, G. D.; Rolle, M. W.; Dominko, 
T., Restoration of skeletal muscle defects with adult human cells delivered on fibrin microthreads. Tissue 
engineering. Part A 2011, 17 (21-22), 2629-40. 
155. Altman, G. H.; Diaz, F.; Jakuba, C.; Calabro, T.; Horan, R. L.; Chen, J. S.; Lu, H.; Richmond, J.; Kaplan, D. L., Silk-
based biomaterials. Biomaterials 2003, 24 (3), 401-416. 
156. Altman, G. H.; Horan, R. L.; Lu, H. H.; Moreau, J.; I, M.; Richmond, J. C.; Kaplan, D. L., Silk matrix for tissue 
engineered anterior cruciate ligaments. Biomaterials 2002, 23 (20), 4131-4141. 
157. Cornwell, K. G.; Lei, P.; Andreadis, S. T.; Pins, G. D., Crosslinking of discrete self-assembled collagen threads: 
Effects on mechanical strength and cell-matrix interactions. Journal of Biomedical Materials Research Part A 
2007, 80A (2), 362-371. 
158. Gentleman, E.; Lay, A. N.; Dickerson, D. A.; Nauman, E. A.; Livesay, G. A.; Dee, K. C., Mechanical 
characterization of collagen fibers and scaffolds for tissue engineering. Biomaterials 2003, 24 (21), 3805-
3813. 
159. Funakoshi, T.; Majima, T.; Iwasaki, N.; Suenaga, N.; Sawaguchi, N.; Shimode, K.; Minami, A.; Harada, K.; 
Nishimura, S., Application of tissue engineering techniques for rotator cuff regeneration using a chitosan-
based hyaluronan hybrid fiber scaffold. Am J Sport Med 2005, 33 (8), 1193-1201. 
160. Funakoshi, T.; Majima, T.; Iwasaki, N.; Yamane, S.; Masuko, T.; Minami, A.; Harada, K.; Tamura, H.; Tokura, 
S.; Nishimura, S. I., Novel chitosan-based hyaluronan hybrid polymer fibers as a scaffold in ligament tissue 
engineering. Journal of Biomedical Materials Research Part A 2005, 74A (3), 338-346. 
161. Irie, T.; Majima, T.; Sawaguchi, N.; Funakoshi, T.; Nishimura, S.; Minami, A., Biomechanical and histologic 
evaluation of tissue engineered ligaments using chitosan and hyaluronan hybrid polymer fibers: A rabbit 
medial collateral ligament reconstruction model. Journal of Biomedical Materials Research Part A 2011, 97A 
(2), 111-117. 
162. Tao, Z. W.; Favreau, J. T.; Guyette, J. P.; Hansen, K. J.; Lessard, J.; Burford, E.; Pins, G. D.; Gaudette, G. R., 
Delivering stem cells to the healthy heart on biological sutures: effects on regional mechanical function. 
Journal of tissue engineering and regenerative medicine 2014. 
163. Proulx, M. K.; Carey, S. P.; Ditroia, L. M.; Jones, C. M.; Fakharzadeh, M.; Guyette, J. P.; Clement, A. L.; Orr, R. 
G.; Rolle, M. W.; Pins, G. D.; Gaudette, G. R., Fibrin microthreads support mesenchymal stem cell growth 
while maintaining differentiation potential. Journal of biomedical materials research. Part A 2011, 96 (2), 
301-12. 
164. Bhana, B.; Iyer, R. K.; Chen, W. L.; Zhao, R.; Sider, K. L.; Likhitpanichkul, M.; Simmons, C. A.; Radisic, M., 
Influence of substrate stiffness on the phenotype of heart cells. Biotechnology and bioengineering 2010, 105 
(6), 1148-60. 
165. El-Sherbiny, I. M.; Yacoub, M. H., Hydrogel scaffolds for tissue engineering: Progress and challenges. Global 
cardiology science & practice 2013, 2013 (3), 316-42. 
166. Tandon, V.; Zhang, B.; Radisic, M.; Murthy, S. K., Generation of tissue constructs for cardiovascular 
regenerative medicine: from cell procurement to scaffold design. Biotechnology advances 2013, 31 (5), 722-
35. 
 Chapter 3 
Design of a Fibrin Microthread-Based Composite Layer for Use in a Cardiac Patch 48 
 
 
Chapter 3: Design of a Fibrin Microthread-Based 
Composite Layer for Use in a Cardiac Patch1 
 
Reproduced with permission from Chrobak, M. O.; Hansen, K. J.; Gershlak, J. R.; Vratsanos, M.; Kanellias, M.; 
Gaudette, G. R.; Pins, G. D., Design of a fibrin microthread-based composite layer for use in a cardiac patch. ACS 
Biomaterials Science & Engineering 2017. 3 (7): 1394-1403.  Copyright 2016 American Chemical Society. 
 
3.1 INTRODUCTION 
Cardiovascular diseases are the leading causes of death globally with 500,000 new cases of 
heart failure diagnosed in the United States alone.2 The major condition leading to heart failure is 
myocardial infarction (MI), damage of cardiac tissue resulting from oxygen deprivation ultimately 
reducing functionality. The heart has limited capacity to regenerate damaged myocardium and 
restore mechanical function lost following an MI.3 As such, a therapy that promotes functional 
myocardial regeneration is greatly needed.  
Cardiac patches can be used to replace scar tissue in the heart and are especially useful in 
repairing ventricular aneurysms. However, currently available scaffolds are acellular and only 
provide passive structural support.4-5 Actively contracting cardiac scaffolds may provide better 
options for patients, as they may contribute to the active mechanical function lost after an MI. 
Current strategies to promote active regeneration of damaged myocardium use scaffolds composed 
of natural materials,6-12 synthetic materials,13-15 extracellular matrix,16-17 or decellularized 
tissues.18-19 Sheets of cardiac “progenitor cells,” or engineered tissues that integrate the promising 
functions of biomaterials and stem cell therapies, are being investigated as well. Modular scaffolds 
that integrate myocardial components of the tissue into scalable units20-21 to guide myocardial 
regeneration are also being considered.  While various studies have shown that engineered 
scaffolds are capable of contraction,6-7, 11, 18, 22 and of providing moderate increases in mechanical 
function of the injured heart,11, 16, 23 there is still a need to develop a functional, engineered cardiac 
patch that readily integrates with the surrounding tissue to promote the regeneration of myocardial 
tissue with physiologically relevant contractility.7, 24 
Fibrin-based hydrogels have been extensively researched in the field of cardiac engineering. 
Cell-seeded hydrogels have demonstrated functionality such as high twitch forces comparable to 
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neonatal rat myocardium (8.9 ± 1.1 and 7.8-8.7 mN/mm2, respectively).25 However, hydrogels are 
typically mechanically weak26-27 and ultimately may fail in the dynamic loading environment of 
the heart.26, 28 Thus, it is critical for myocardial regeneration strategies that a cardiac patch be able 
to mechanically29 and functionally integrate with native myocardium.7, 24 To achieve this, a cardiac 
patch should mimic the properties of native myocardium, a highly aligned tissue with modulus 
values ranging from 20 to 500 kPa.24  
In this chapter, we report the development of discrete layers of a microthread-based 
composite scaffold that can be fabricated into engineered myocardial tissue with precisely 
designed structural mechanical properties. Microthreads derived from natural biopolymers, such 
as fibrin, have been investigated for a wide range of tissue engineering applications.30 These 
microthreads exhibit tunable mechanical properties31 and drive cellular orientation.32 Here, we 
hypothesize that fibrin microthreads can be strategically combined with fibrin-based hydrogels to 
create a composite layer that will enable the design of a scaffold that provides mechanical 
properties similar to that of native myocardium, supports cell contractility, and promotes cellular 
orientation. To test this hypothesis, we systematically varied the fibrin microthread volume 
fractions in composite layers and evaluated the moduli of the composite scaffolds. We 
incorporated rat neonatal ventricular myocytes into the composite layers and analyzed the cell-
mediated contractile behavior of the scaffolds by measuring contractile strains and contractile 
frequencies. Finally, we evaluated the effect of the microthreads on cell alignment by measuring 
the nuclear orientation of incorporated cells in the composite scaffolds. Ultimately, we envision 
that these fibrin composite layers will enable the development of an implantable, multilayered 
cardiac patch to facilitate the regeneration of damaged ventricular myocardium.  
 
3.2 MATERIALS and METHODS 
3.2.1 Fabrication of Fibrin Microthread-Based Composite Scaffolds 
To generate biomimetic composite layers, varied densities of fibrin microthreads were 
precisely aligned and integrated into fibrin hydrogels (Figure 3.1).   
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Figure 3.1. Fabrication of a biomimetic composite cardiac patch. Ventricular myocardium is arranged in highly 
aligned layers (A). To fabricate an aligned composite layer, fibrin microthreads are organized (B, C) and embedded 
in a fibrin hydrogel (B).  Ultimately, we anticipate that these individual layers will be stacked to form a multilayered 
scaffold that mimics native myocardium. 
 
3.2.1.1 Microthread Extrusion 
Fibrin microthreads were generated through the co-extrusion of fibrinogen and thrombin 
solutions using techniques described previously.31-34 Briefly, fibrinogen isolated from bovine 
plasma (Sigma, St. Louis, MO) was dissolved in HEPES (N-[2-Hydroxyethyl] piperazine-N’-[2-
ethanesulfonic acid]) buffered saline (HBS, 20 mM HEPES, 0.9% NaCl; pH 7.4) at a concentration 
of 70 mg/mL. The solution was stored at -20oC until use. Thrombin from bovine plasma (Sigma) 
was dissolved in HBS at 40 U/mL and stored at -20oC until use.  
To generate microthreads, fibrinogen and thrombin solutions were thawed to room 
temperature. A 40 mM solution of CaCl2 was mixed with the thrombin solution resulting in a 
working solution of 6 U/mL. Equal volumes of fibrinogen and thrombin/CaCl2 solutions were 
loaded into separate 1 mL syringes. A blending applicator tip (Micromedics Inc., St. Paul, MN) 
was connected to the loaded 1 mL syringes. The solutions were mixed in the applicator tip and 
extruded through polyethylene tubing (BD, Sparks, MD) with an inner diameter of 0.86 mm into 
a buffer bath of 10 mM HEPES (pH 7.4). Microthreads were extruded into a Teflon-coated pan at 
a flow rate of 0.225 mL/min using a dual syringe pump. Following a 10-15 minute polymerization 
time, the scaffolds were carefully removed and stretched to ~150% of their original length to create 
a high strength microthread, and hung to dry under the tension of their own weight.32 
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3.2.1.2 Fibrin Microthread Organization 
A custom fibrin microthread spacer was used to align fibrin microthreads at set distances 
to ensure a uniform layer (Figure 3.2A). The device has evenly spaced ridges with ports and is 
coupled to a house vacuum enabling the placement and maintenance of threads in configurations 
with defined spacing. Layers were organized with either 5, 10, or 20 threads across a 1 cm length 
to vary the volume fraction in the composite (Figure 3.2B). Once organized, threads were mounted 
along the edge, the vacuum was turned off, and aligned microthreads were transferred and secured 
to vellum frames with precut windows using medical grade silicone adhesive.   
 
 
Figure 3.2. Fibrin microthread spacer device. Fibrin microthreads are organized using a custom microthread 
spacer (A) by placing microthreads into grooves (red arrow). Microthreads are secured with frames following 
alignment (white arrow). By incorporating different thread counts into the layer, the volume fraction of fibrin 
microthreads is adjusted (B). Volume fractions were calculated with the assumptions that microthreads have a 
cylindrical shape, and the shape of the scaffolds are rectangular.  
 
To evaluate the consistency of spacing for organized threads, 20 microthreads secured to 
vellum frames were divided into 9 segments (Figure 3.3 A-C), and imaged under 2X 
magnification. For each image, 3 regions (represented as lines in Figure 3.3C) were evaluated. 
For each region, distances between all threads were measured using ImageJ. To ensure results were 
not user-dependent, 4 different users generated samples using the spacing device. A total of 16 
samples were analyzed. A one-way ANOVA was run to determine if statistical differences existed 
in thread spacings between users. Significance level was set to a p value of p<0.05.  
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Figure 3.3. Evaluation of fibrin microthread spacing in composite layers. Twenty-thread fibrin based composite 
layers (A) were evaluated to determine thread spacing consistency. Samples were divided into 9 regions (B) and 
imaged under 2X magnification. For all 9 images, 3 regions were identified (red lines in C). For these regions, 
spacing between all threads was determined.   
 
3.2.2 Mechanical Characterization of Fibrin Composite Layers 
To predict the moduli of fibrin microthread-based composite layers with varying volume 
fractions of components, classical composite theory for aligned, fiber-reinforced composites was 
utilized. This theory enables the estimation of modulus of elasticity (Ecl) of a composite layer in 
the direction of alignment as shown in Equation 3.1,  
𝐸𝐸𝑐𝑐𝑐𝑐 = 𝐸𝐸𝑚𝑚𝑉𝑉𝑚𝑚 +  𝐸𝐸𝑓𝑓𝑉𝑉𝑓𝑓      3.1. 
where Em and Ef are the elastic moduli of the matrix and fibrous components, respectively and 
Vm and Vf are the volume fractions of the matrix and fibrous components, respectively.35 
Mechanical characterization of acellular fibrin composite layers was completed using a 
submerged, uniaxial tensile test. Fibrin composite layers were prepared using modified vellum 
frames that enabled the mechanical characterization of the scaffolds, independent of the frame. A 
hydrogel solution containing 1.6 U/mL thrombin and 3.1 mg/mL fibrinogen was combined and 
mixed on ice, cast over the vellum frames and spread using a pipette tip to provide an even layer. 
For a 144 mm2 area, 150 uL of hydrogel solution was utilized. Following a 30 minute 
polymerization period, a laser displacement technique was used to measure the thickness of the 
composite layer in 3 places per sample.36 These thicknesses were averaged together to obtain a 
representative measurement, and were used with the width of the sample to calculate the cross-
sectional area, assuming a rectangular geometry. Samples were then secured in grips of a uniaxial 
testing machine (ElectroPuls E1000; Instron, Norwood, MA) and a 1 N load cell, with an initial 
gauge length of 13 mm. The sample and grips were submerged in a PBS bath, then uniaxially 
loaded until failure at a strain rate of 10 mm/min.37 Force and displacement values were recorded 
continuously throughout the test at a frequency of 10 Hz. Prior to determining the modulus and 
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phase I and II maximum stress and strain values, all initial load and deformation values were 
zeroed to a baseline value at the onset of each test. Engineering stress was calculated as the amount 
of force recorded divided by the initial cross-sectional area. Strain was calculated as the increased 
extension from the initial length of the composite layer.  
A MATLAB (MathWorks, Natick, MA) script was written to analyze the modulus of the 
layers. With aligned fiber-reinforced composites, there are generally two phases observable on 
stress strain curves.35 For our analysis, we analyzed the slope of the stress strain curves in phase I 
(elastic deformation). This region is typically between 0-30% strain, a physiologically relevant 
strain regime as the average peak shortening in the midwall of the left ventricle is ~23 – 30%.38-39 
Outliers were identified as any modulus value that was 1.5 times greater than the inner quartile 
range (IQR) for each sample set (average modulus ± 1.5*IQR) and were subsequently removed 
from further analysis.32  
 
3.2.3 Cell Culture 
3.2.3.1 Rat Neonatal Ventricular Myocyte (rNVM) Isolation 
All animal experiments were performed under the guidance of and approved by the 
Institutional Animal Care and Use Committee at Worcester Polytechnic Institute.  As previously 
described, cardiomyocytes were isolated from 2 and 3 day old neonatal Sprague Dawley rats 
(Charles River, Wilmington, MA).40 In short, hearts were removed from the neonatal rat, ventricles 
were separated from atria, and then ventricles were minced into ~1mm2 sized pieces.  Ventricle 
pieces were digested at 37°C in type II collagenase (Thermo Fisher Scientific, Waltham, MA) 
serially in 7x7 minute digestions. To enrich the fraction of cardiac myocytes, one 45-minute pre-
plating step was performed.41 Isolated cardiomyocytes were used immediately for experimental 
samples as described below. 
 
3.2.3.2 Composite Layer Fabrication and Tissue Culture 
To ensure that samples remained in the same orientation throughout culture for functional 
evaluations, a purpose-built culture dish and framing system was developed to maintain sample 
orientation throughout the culture period. For hydrogel casting, PDMS sheets were autoclaved and 
coated with sterile 1% Pluronic-F127 in DI water (Sigma, St. Louis, MO) solution for 1 hour. 
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Vellum frames with 5, 10 or 20 aligned threads, or without threads (hydrogel controls), were 
rehydrated in PBS for one hour, then placed on top of the coated PDMS immediately prior to gel 
casting. A hydrogel solution containing 4 x106 cells/mL, 1.6 U/mL thrombin, and 3.1 mg/mL 
fibrinogen was combined and mixed on ice, cast over the vellum frames and spread using a pipette 
tip to provide an even layer. For a 144 mm2 area, 150 uL of hydrogel solution was utilized. Samples 
polymerized in an incubator at 37oC for 30 minutes, then were moved into wells containing DMEM 
(Iscove’s, VWR, Radnor, PA) supplemented with 10% fetal bovine serum (VWR) 2% heat 
inactivated horse serum (Fisher Scientific, Waltham, MA) 1% penicillin streptomycin (Thermo 
Fisher Scientific, Waltham, MA) 1% amphotericin B (Thermo Fisher Scientific), 0.5% gentamicin 
(Thermo Fisher Scientific), 1% glutamax (Thermo Fisher Scientific), 0.0007% B-mercaptoethanol 
(Thermo Fisher Scientific), 50 ug/mL aprotinin, and 1.2 mM CaCl2 and 0.8 mM MgCl2.  
For cell culture controls, glass coverslips (10 x 10mm) (VWR) were coated with 0.7% gelatin 
in DI water (Sigma Aldrich) for 4 hours and secured to the bottom of wells in a 12 well plate using 
autoclaved vacuum grease. Cells were seeded on coverslips with 100 µL of cell suspension (2 x 
106 cells/mL), incubated for 18 hours, rinsed and covered with medium for extended culture. All 
cell culture experiments were maintained for 14 days with medium changes every other day. For 
this work, individual composite layers were evaluated and were identified using the following 
nomenclature scheme: 
5 Thread Composite Layers (5tC), 10 Thread Composite Layers (10tC), 20 Thread Composite 
Layers (20tC), Fibrin Gel Controls (FGC), or Gelatin-coated Coverslips (GCS).  
 
3.2.4 Cardiomyocyte Functional Analysis 
To evaluate cardiomyocyte functionality, spontaneous contractions were recorded at 60 
frames per second with a high speed camera (HiSpec 4, Fastec Imaging Corp, San Diego, CA) 
attached to an inverted microscope (DMIL, Leica Microsystems, Buffalo Grove, IL) at 7, 10, and 
14 days of culture. High density mapping (HDM), an optical technique used to evaluate regional 
mechanical function with high spatial resolution, was applied by selecting a region of interest (size 
dependent on contractile region) and dividing it into 16x16 pixel subwindows to track 
displacements of sequential frames over several images, with an 8 pixel shift and noise threshold 
of 1% strain.42-44 The displacement fields are used to determine maximum contractile strain, 
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average contractile strain, and frequency of contraction. To ensure representative data for each 
sample was obtained, samples were divided into quadrants and one region of interest was identified 
per quadrant per sample, per time point.  Each sample represents the average value from multiple 
regions of interest at each time point. 
 
3.2.5 Phenotypic Analyses 
3.2.5.1 Immunostaining 
To confirm the cardiomyocyte phenotype and evaluate alignment, cell-seeded constructs 
were immunostained to assess the sarcomeric structure of cardiomyocytes and the nuclear 
orientation of all cells incorporated into the layer. At day 14, samples were fixed with 4% 
paraformaldehyde, permeabilized with 0.1% Triton and blocked with 5% BSA in PBS. After 
blocking, tissues were incubated overnight at 4o?? ???? ????? ?????????????????????????-actinin 
primary antibody (Abcam, Cambridge, MA) in a blocking solution. Samples were rinsed in PBS 
and a secondary antibody (Goat anti-mouse Alexa Fluor 546, Life Technologies, Waltham, MA) 
was incubated at room temperature for 30 minutes. A Hoechst counterstain (Thermo Fisher 
Scientific) was incubated with the samples at room temperature for 10 minutes. Tissue samples 
were imaged using a confocal microscope (TCS SP5 Point Scanning Confocal, Leica, Germany). 
For each sample, 3 representative images of the width of the construct were obtained at 200X.  
 
3.2.5.2 Analysis of Nuclear Alignment 
To determine the alignment of cells within the composite layer relative to fibrin 
microthreads, fluorescent images were analyzed using ImageJ (NIH). For each condition, a total 
of 3 samples (9 representative images) were evaluated after 14 days in culture. A binary image 
from the blue channel (representing nuclear staining by Hoechst) was generated, and analyzed 
using the particle analysis function within the ImageJ software to obtain the orientation of the long 
axis of the nucleus with respect to the microthread. Nuclei that were on the edge of the image or 
in contact with other nuclei were excluded from analysis. All values were binned in 15o increments 
and plotted as a histogram to present the distribution of nuclear orientations observed for each 
group.  
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3.2.6 Statistical Analyses 
All statistical analyses were performed using SigmaPlot 12.5 software, with p<0.05 
indicating a significant difference between groups. For contractile strains and frequencies, 
statistical analyses were performed using a two-way analysis of variance (ANOVA). For the 
uniaxial testing data, statistical analyses were performed using a one-way ANOVA. Holm-Sidak 
pairwise multiple comparison tests were performed for all post-hoc analyses with p<0.05 
indicating significant differences between samples. For functional data including maximum 
contractile strain, average contractile strain, and frequency of contraction data are reported as 
means ± standard error. For the reported elastic modulus values, data are presented as means ± 
standard deviation. 
 
3.3 RESULTS 
3.3.1 The Fabrication Method Developed for Composite Layers Enables Reproducible 
Spacing of Aligned Fibrin Microthreads. 
Four users generated 20tC samples using the fibrin microthread spacer. Fibrin microthread spacing 
distances averaged 140 µm for each user, with a standard deviation of 21.74 µm, ~15.5% of the 
average spacing distance.  The average thread separation distances for each user were compared 
with, a one-way ANOVA.  This analysis demonstrated that no significant differences were 
observed, suggesting that the automated thread spacing system creates aligned microthread-based 
scaffolds with reproducible morphological properties.  
 
3.3.2 The Modulus of a Composite Layer Can Be Tuned Through Modulation of the Fibrin 
Microthread Volume Fraction 
The computational model using classic composite theory demonstrated that with an 
increasing volume fraction of fibrin microthreads there should be an increase in modulus of the 
composite layer.  Predicted values ranged from 48 – 190 kPa with microthread volume fractions 
increasing from 2.2% to 8.6%. Assumptions included that the fibrin microthreads had a diameter 
of 130 µm and a stiffness value near 2.2 MPa,32 and that the hydrogel had a stiffness near 0.25 
kPa.45 As the number of fibrin microthreads doubled, the predicted moduli values approximately 
doubled as well. This trend is summarized in Table 3.1.  
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Table 3.1. Predicted moduli for fibrin composite layers with varying volume fractions of fibrin microthreads 
and fibrin hydrogel.  
Number of Threads Volume Fraction of Threads 
Volume Fraction of 
Gel 
Predicted Modulus 
(kPa) 
5 2.2% 97.8% 48 
10 4.3% 95.7% 95 
20 8.6% 91.4% 190 
 
Composite layers were evaluated using uniaxial tensile testing to determine the effect of 
fibrin microthread volume fractions on the moduli of the scaffolds. Aligned fibrous composite 
materials typically have two phases (Figure 3.4A).35 Characteristic stress-strain curves for the 
composite layers showed the anticipated two phases followed by multiple points of failure as 
components of the composite failed (Figure 3.4B). Our analyses characterized the elastic 
deformation of the scaffolds (phase I) for calculating the modulus values of the composites (Figure 
3.4A). Qualitative observations of uniaxial tensile tests suggest that the composite layers remain 
as one cohesive, integrated material upon full failure. As the number of fibrin microthreads was 
doubled, the moduli increased to slightly greater than double values. Significant differences in the 
elastic modulus values were observed between all groups (Figure 3.4 C) (5tC vs 10tC p= 0.048; 
5tC vs 20tC p<0.001; 10tC vs 20tC p<0.001).  
 
 
Figure 3.4. Fibrin microthread volume fraction can be used to mechanically tune a composite layer. Stress strain 
curves for composites generally have two phases (A). All modulus values were taken from phase I of the curves 
(dotted line in A). Characteristic stress strain curves of 5, 10, and 20 thread composite layers are shown in B. * marks 
first point of failure for each sample and arrows show subsequent microthread failure points. Modulus values were 
significantly different between each sample group (denoted with a *) as determined by a one-way ANOVA with Holm-
Sidak post-hoc analysis, p<0.05 (C).   
 
The mechanical data from the tensile testing is further summarized in Table 3.2.  
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Table 3.2. Mechanical data from tensile testing evaluation of fibrin-based composite layers. 
Composite 
Group n 
Tensile Stress 
(Phase I) 
(kPa) 
Tensile Strain 
(Phase I) 
(mm/mm) 
Elastic Modulus (kPa) Tensile 
Stress (Phase 
II) (kPa) 
Tensile Strain 
(Phase II) 
(mm/mm) Predicted Measured 
5tC 15 12.9 ± 5.3
¥ 
(p=0.002) 0.31 ± 0.08 
48 
 
20.6 ± 8.1* 
(10tC: p=0.048) 
(20tC: p<0.001) 
23.2 ± 9.6¥ 
(p<0.001) 1.03 ± 0.25 
10tC 12 13.6 ± 6.0
¥ 
(p=0.005) 0.21 ± 0.06 95 
46.4 ± 23.0* 
(5tC: p=0.048) 
(20tC: p<0.001) 
42.1 ± 25.2¥ 
(p=0.007) 0.99 ± 0.34 
20tC 12 27.7 ± 15.4 0.24 ± 0.09 190 
97.5 ± 49.3* 
(5tC: p<0.001) 
(10tC: p<0.001) 
83.0 ± 45.8 1.07 ± 0.22 
 
¥: Significant difference from the 20tC group 
*: Significant difference from all other groups 
 
3.3.3 Cardiomyocyte Phenotype is Retained in Fibrin-Microthread Composite Layers 
Rat neonatal cardiomyocytes were isolated and incorporated into fibrin-microthread 
composite layers with varied thread densities, fibrin hydrogels, or seeded onto gelatin coated 
coverslips. To ensure that the cells in the scaffolds maintained functional cardiomyocyte 
???????????? ??????????? ?-actinin protein expression was evaluated with putative sarcomeric 
arrangement being considered a hallmark of functional cardiomyocytes.46 For all groups, cells 
exhibited characteristic sarcomeric striations for the duration of the 14 day culture period, 
confirming that the cells in the composite scaffolds maintained phenotypic properties of 
cardiomyocytes (Figure 3.5).   
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Figure 3.5. Striated phenotype of rat neonatal ventricular myocytes cultured in composite fibrin scaffolds. Cells 
were stained with sarcomeric ?-actinin (red) and Hoechst (blue). All controls and test groups exhibited a striated 
????????????????????????????????????????????????????? ??????????????????????-actinin striations.  
 
3.3.4 Functional Properties of Cardiomyocytes are Maintained in Fibrin Microthread-Based 
Composites 
The active functional properties of cardiomyocytes were evaluated by measuring the 
maximum contractile strain, average contractile strain, and contraction frequency using HDM 
applied to high speed videos of contractile regions taken at 7, 10, and 14 days in culture (Figure 
3.6). The maximum and average contractile strain measurements followed similar trends for all 
groups (Figures 3.6A and B). Only the 5tC group had a significant decrease in strain 
measurements between days 10 and 14 (p=0.007 for maximum contractile strain and p=0.048 for 
average contractile strain) (Figure 3.6 A, B). When comparing groups at each time point, all 
groups were significantly greater than the gelatin coated coverslips (GCS) at day 10 for both 
maximum and average contractile strains (for maximum contractile strains p=<0.001 for 5tC, 
p<0.001 for 10tC, p=0.044 for 20tC, p=0.010 for FGC. For average contractile strains, p=0.001 
for 5tC, p=0.006 for 10tC, p=0.002 for 20tC, p=0.023 for FGC) (Figure 3.6 D, E). Significant 
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differences were observed at day 7 for the average contractile strain, with FGC, 5tC, and 10tC 
exhibiting significantly greater (p=0.006 for 5tC, p=0.006 for 10tC, p=0.023 for FGC) average 
strains than GCS (Figure 3.6 E).  
 
 
Figure 3.6. Fibrin composite layers do not hinder the functionality of cardiomyocytes relative to a fibrin 
hydrogel control. Cardiomyocyte functionality is summarized by group (A-C) and by time point (D-F). Maximum 
contractile strain (A,D) values showed that composite layers behaved similarly to fibrin hydrogel controls. Differences 
were evaluated through a Two-Way ANOVA with Holm-Sidak post hoc analysis with p<0.05. A bar denotes a 
significant difference, * denotes significant differences relative to all other groups within cluster, ¥ denotes significant 
difference relative to coverslip controls.  
 
When evaluating contraction frequency, a significant decrease was observed for FGC at 
days 10 and 14 relative to day 7 samples (p <0.001 for day 10, p<0.001 for day 14). The 10tC 
group also exhibited a significant decrease at day 10 relative to day 7 (p=0.006) (Figure 3.6 C). 
All groups had significantly higher frequencies at day 7 relative to GCS (p<0.001 for all groups). 
At day 10, 5tC and 20tC maintained a significantly higher frequency relative to GCS (p=0.035 for 
5tC, p=0.037 for 20tC) (Figure 3.6 F). By day 14, no significant differences were observed for 
any of the functional data among groups.  A critical observation is that at no time point were there 
any significant differences between the FGC and composite groups (5tC, 10tC, 20tC) when 
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comparing any of the functional data (Figure 3.6 D, E, F). Table A.1 in Appendix 1 summarizes 
the functional evaluations with data presented as mean ± standard error.  
 
3.3.5 Fibrin Microthreads Increase Alignment in Adjacent Regions  
 To assess the effect of microthread-based composites on the alignment of cells, confocal images 
of Hoechst-stained samples were analyzed using ImageJ to quantify nuclear orientation. When 
evaluating all cells within the images, nuclear orientation appeared random for FGC and for the 
bulk phase of the composite layers (Figure 3.7 A, B). When analyzing nuclei within 100 µm of 
fibrin microthreads in composite layers, nuclei demonstrated increased orientation with respect to 
the long axes of the microthreads (Figure 3.7 C). The highest percentage of cells for all composite 
groups clustered in the 0-15o orientation bin, with respect to the long axes of the threads: 26%, 
24%, and 23% for 5tC, 10tC and 20tC, respectively. These observations suggest that the highest 
number of cells aligned along the direction of the microthreads when they were cultured adjacent 
to the fibers.  
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Figure 3.7. Nuclear orientation of cells within composite layers. When assessing nuclear alignment in fibrin 
hydrogel controls and composite layers, no trend was observed. However, when assessing regions adjacent to fibrin 
microthreads (within 100 µm), there was a trend suggesting an increase in nuclear orientation as shown by the non-
uniform distribution. All nuclear orientations were taken with respect to the long axes of the fibrin microthreads within 
the composite layer. For fibrin gel controls, the nuclear orientation was taken with respect to the x axis.  
 
3.4 DISCUSSION 
The goal of this study was to develop an aligned fibrin microthread-based composite 
scaffold that enables modulation of the structural properties of the composite material while 
supporting the cell-mediated contractility comparable to that of conventional fibrin hydrogels. To 
achieve this, changes in a composite layer were controlled through the addition of fibrin 
microthreads in varying volume fractions. We demonstrated that through this manipulation, (1) an 
increase in fibrin microthread volume fraction resulted in an increase in modulus for the layer, and 
(2) increasing the fibrin microthread volume fraction supported cell-mediated contractile strains 
and frequency of contractions comparable to hydrogel controls. All composite layers and fibrin 
hydrogel controls significantly increased these parameters relative to a gelatin coated coverslip 
control group (GCS). We also found that (3) fibrin microthreads within the composite layer 
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influence the nuclear orientation of cells immediately adjacent to the fibers (up to a distance of 
100 µm).  
Upon implantation, it is critical that a cardiac patch have similar mechanical properties to 
the host myocardium to avoid mechanical mismatch.24, 29 It has also been found that scaffold 
modulus is an important influence on cardiomyocyte contractile force, phenotype and gene 
expression.14, 24, 46-47 Using composite theory, we predicted that the trend for doubling fibrin 
microthread counts from 5 to 10 and from 10 to 20 microthreads should result in a two-fold 
increase in scaffold moduli (48 kPa to 95 kPa, and 95 kPa to 190 kPa, respectively). We found that 
a comparable trend was observed when scaffolds were subjected to submerged uniaxial tensile 
testing, with moduli increasing two-fold when fibrin microthread counts in the composites were 
increased from 5 to 10 (20.6 kPa to 46.4 kPa), and from 10 to 20 (46.4 kPa to 97.5 kPa).  While 
the trends for predicted and measured moduli values were comparable, the magnitudes of moduli 
values were greater for the computational model than for the experimental measurements. The 
stress-strain curves for the composite layers had two phases which is common for composite 
materials.35The first phase is characteristic of elastic deformation, both of the matrix and fibrous 
components.  The second phase is characteristic of elastic deformation of the fiber phase and 
plastic deformation of the matrix phase. We evaluated the first phase which is more likely to have 
stronger interfacial bonding between components than the second phase. However, composite 
theory for aligned, fiber-reinforced composites assumes an isostrain state.35 It is possible that 
bonding of microthreads and hydrogel within the composite layer was not sufficient to ensure 
equal deformation of components in the first phase, resulting in the observed reduced moduli 
values. Future studies in our laboratory will focus on characterizing the shear strength of the fibrin 
microthread/hydrogel interface to refine the robustness of our predictive model regarding our 
experimental data. Additionally, manipulation of the interfacial bond strength through techniques 
like crosslinking offer a potential method for tuning the resultant modulus of the composite layers.  
The modulus of the patches we developed can be altered through fibrin microthread volume 
fraction. The range of modulus values observed was from 20.6 ± 8.1 – 97.5 ± 49.3 kPa. Rat 
myocardium stiffness can range from 0.1 – 140 kPa24 with neonatal myocardium ranging from 10-
20 kPa.14 To match rat neonatal myocardium, the most appropriate configuration was 5tC (20.6 ± 
8.1 kPa). This may not be the case for other species. If working with a more clinically relevant cell 
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type such as a matured human induced pluripotent stem cell-derived cardiomyocyte, 20tC (97.5 ± 
49.3 kPa) may be more appropriate as human myocardium ranges in stiffness from 20 kPa – 500 
kPa.24  
Composites with a higher fibrin microthread volume fraction are feasible. A distinct 
advantage of our microthread-based composite scaffold is that we anticipate that we could 
fabricate layers with 40 microthreads across a 1 cm width.  Based on the relationship between our 
composite theory model and our experimental findings, we hypothesize that this scaffold would 
exhibit a modulus of 195 kPa. This would result in spacing between threads of approximately 100 
µm, a distance shorter than the diameter of a fibrin microthread (~ 150 µm)32 and a modulus closer 
to the mid-range of stiffness values observed for human myocardium. While a higher thread count 
may increase the modulus to the mid-range, it will reduce the hydrogel volume and therefore the 
volume available to the incorporated cells. There is likely a trade-off in the design for mechanical 
reinforcement and cell function. We hypothesize that crosslinking the fibrin microthreads could 
further enhance the mechanical properties of the layer, allowing for additional control of the 
modulus to ensure the fabrication of composite scaffolds with material properties that match native 
tissue.31 However, it is critical that resultant patch stiffness remains within the physiological range; 
too stiff of a patch could induce a tethering effect, inhibiting contractility of adjacent tissue.29  
 Samples were evaluated over a 14 day culture period as neonatal rat cardiomyocytes 
functionally mature in the first postnatal week14, and it has been reported that fibrin-based 
hydrogels typically reach a steady-state for compaction between days 8-13.41It has also been 
reported that functional assessments of 3-dimensional (3D) scaffolds with rat neonatal 
cardiomyocytes can be assessed for 14 days in culture without significant cell death or scaffold 
breakdown.48 As such, we did not conduct a quantitative analysis of the changes in cell viability 
for this study.  However, we plan to conduct future cell viability studies to confirm these 
observations.  A critical observation from these evaluations was that at no time point did the 
contractile strain or frequency of any composite sample (5tC, 10tC, 20tC) differ significantly from 
FGC. This observation demonstrates that composite layers and fibrin hydrogels exhibit 
comparable active, cell-mediated mechanical properties.  
Fibrin hydrogels have been extensively investigated for use as cardiac patches,6, 25, 49-50 and 
our results show that relative to fibrin hydrogels, our composite improves the modulus and cell 
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alignment without compromising contractile strain or contractile frequency. For the GCS group, a 
beating frequency of ~ 1 Hz was observed, similar to reported literature (61 ± 9 events / min51 and 
40-90 beats/min).52 All hydrogel and composite groups had significantly higher contractile 
frequencies at day 7 with values ~ 2.5 Hz, comparable to reported frequencies for neonatal 
cardiomyocytes in a 3D environment (180 beats/min53 and 2.5-3Hz48 ). The contractile frequency 
decreased significantly for FGC and 10tC after day 7. This is a similar trend to reported literature 
where a decrease in neonatal cardiomyocyte contraction frequency was observed as early as day 
6.48  
When evaluating the maximum and average contractile strains, similar trends were 
observed where all groups remained stable over 14 days with the exception of the 5tC group where 
a significant decrease from day 10 to day 14 was observed. While this decrease was unexpected, 
it is important to note that at both the day 10 and day 14 time points, 5tC was not significantly 
different from any other composite group (10tC, 20tC) or FGC. It is possible that with this cell 
type, a peak in cell function was achieved at day 10. This is further supported by the observation 
that all samples cultured in a 3D environment had significantly higher contractile strains at the day 
10 time point relative to GCS, and that no significant difference was present for contractile strains 
by day 14. Together these findings suggest that cardiomyocytes cultured in our fibrin-microthread 
composite scaffolds exhibit contractile properties comparable to those observed when cells were 
cultured in fibrin hydrogels.  
 Cardiomyocyte alignment may contribute to enhanced functional maturation and 
integration upon implantation with native myocardium.25, 50, 54-55 In healthy myocardium, 
cardiomyocytes in a layer of tissue are aligned within +/- 13o of each other.56 When initially 
evaluating nuclear alignment of cells within the composite layers, no alignment was observed, 
similar to FGC. When we focused the evaluation on nuclear alignment of cells within a 100 µm 
distance from a fibrin microthread, we observed trends in all composite groups towards alignment 
with respect to the long axes of the fibrin microthreads. The greatest percentage of cells were 
oriented between 0-15o of the direction of the microthreads, orientations comparable to native 
tissue. This suggests that fibrin microthreads influence cellular orientation for a limited distance 
in the fibrin hydrogel. This is similar to reports of cellular sensing of rigid bodies not in direct 
cellular contact for a limited distance.57 Cell sensing can influence a range of cell behaviors 
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including cell spreading and migration. When cultured on polyacrylamide gels mimicking soft 
tissues (~1 kPa), it was demonstrated through cell spreading that mesenchymal stem cells were 
able to sense a rigid underlying surface 10-20 µm away, with an average sensing distance of <5 
µm.58 When considering a fibrous biopolymer (specifically, fibrin and collagen hydrogels), 
fibroblasts demonstrated changes in spreading at distances as great as 150 µm from a rigid 
boundary with an average sensing distance of greater than 65 µm.57  It is possible that the rat 
neonatal ventricular myocytes incorporated into our composite layers did not sense fibrin 
microthreads beyond 150 µm and may exhibit random orientation at distances greater than this. 
The gel phase of the composite material will require additional stimuli to ensure alignment of cells 
throughout the layer is comparable to healthy myocardium. Static tension has been shown to 
influence alignment of muscle cells,59 and could potentially further induce alignment in composite 
layers. Other potential options are to increase the number of microthreads, pattern the hydrogel 
phase49 or electrically stimulate the cells. 60  
Ultimately, using a layer-by-layer approach, we anticipate that our composite fibrin layers can 
be strategically combined to create and assess an implantable active composite cardiac patch. In 
the future, we plan to laminate composite layers together with rotating orientation to mimic the 
structure of native myocardium (Figure 3.1). We also aim to couple our composite layers with a 
fibrin-based vascular network to enable the generation of a perfusable, thick, implantable construct 
with cell-mediated contractile properties and signal propagation rates that will ultimately facilitate 
mechanical and electrical coupling to the host tissue and promote the regeneration of functional 
myocardial tissue within an infarcted environment. 
 
3.5 CONCLUSIONS 
In this study, we have shown that increasing the volume fraction of fibrin microthreads in a 
composite layer increases the modulus, enabling the strategic design of the layer composition to 
mimic native tissue. Fibrin microthreads within the layer also increased alignment of cells within 
100 µm of microthreads. Most importantly, these changes occurred without inhibiting contractile 
function. All composite groups demonstrated similar contractile strain behavior relative to a 
hydrogel control, while all composite groups and the hydrogel control showed significantly 
improved contractile function relative to gelatin-coated coverslips. We anticipate that 
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reinforcement of hydrogel materials by microthreads will enable the design of cardiac patches that 
are more suited for implantation. In the future, we plan to assess the effects of static tension on 
aligning cells within the gel space that do not lie in close proximity to a microthread. This will be 
critical to achieve an aligned, highly functional layer.  
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Chapter 4: Alignment of Cardiomyocytes Through 
Static Tension Increases Contractile Strains in 
Composite Layers 
 
 
4.1 INTRODUCTION 
Approximately 1 in 3 deaths in the United States is due to cardiovascular disease (CVD).1 A 
major contributing factor to CVD is a heart attack. When a heart attack occurs, oxygen deficiency 
results in necrotic tissue and ultimately a harsh inflammatory reaction that leaves a scar in place 
of functional ventricular myocardium.2 The scar tissue is non-contractile and reduces the working 
efficiency of the heart. To compensate, ventricular remodeling occurs which can ultimately lead 
to heart failure.3 While treatment options exist, the only treatment that can restore baseline function 
for end stage heart failure is a heart transplant. However, donors are limited restricting use of this 
treatment option.4 There is a need for a regenerative solution for heart attack patients.  
A cardiac patch is a material that is used to augment or replace scar tissue resulting from a 
heart attack.5-6 Clinically available cardiac patches are acellular7 and aim to limit ventricular 
remodeling. While this approach can attenuate the progression towards heart failure, these patches 
do not restore baseline function to the patients. It has been hypothesized that a cell-populated 
cardiac patch could overcome this limitation by providing a functional rather than just passive 
support. Research on the development of cell-populated patches has demonstrated promising 
contractility with contractile forces and action potential propagation speeds approaching adult 
myocardium values,8 however the materials that yield the highest cell function are typically 
hydrogels that lack robust mechanical properties.9-12 In the dynamic environment of the heart, it is 
important that the material exhibit similar mechanical properties to native tissue. Weak materials 
may bulge, resulting in an aneurysm, or rupture during the cyclic loading. Materials that are too 
stiff may result in a tethering effect, limiting the function of the adjacent heart tissue.13  
We recently developed a fibrin-based composite material for use as a cardiac patch.14 This 
material is comprised of a fibrin hydrogel reinforced with fibrin microthreads. We demonstrated 
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that the stiffness of this material can be modulated by manipulating the volume fraction of the 
components. When the volume fraction of the fibrin microthreads increased, we observed a 
corresponding increase in the stiffness values of the material. Additionally, we observed that the 
contractile strains and frequencies of the cardiomyocytes in the scaffold did not vary significantly 
with the increased volume fractions. However, the alignment of incorporated cells was random 
throughout the layer. Only slight improvements in alignment were observed in areas immediately 
adjacent to fibrin microthreads (within 100 µm).  
Native ventricular myocardium is a highly aligned tissue, comprised of anisotropically 
organized layers. Each layer of the myocardium contains fibrils that run +/-13o relative to the mean 
fiber direction.15-16 The orientation of the cardiomyocytes within the tissue closely follows this 
organization. For a cardiac patch to restore baseline function, it is critical that the patch exhibits 
functional properties that are comparable to healthy ventricular myocardium. A critical factor that 
impacts these functional properties is cell alignment, which drives the magnitude and direction of 
the contractility of the patch. 
Previous studies showed that fibrin hydrogels can be compacted by incorporated cells.17 If the 
hydrogel is strategically constrained, the compaction can induce a static tension. Static tension has 
been used in conjunction with hydrogel patterning to induce alignment of incorporated cells.18-20 
To orient the cells in our composite layers, we hypothesize that we can use cell-mediated 
compaction to induce static tension ultimately aligning incorporated cells. To test this hypothesis, 
we created a method for inducing static tension consistently and predominantly in one direction 
within composite layers. In our previous work, we observed no significant alignment for the bulk 
layers.14 Using these layers as an unaligned control, we evaluated a novel experimental culturing 
method that influenced nuclear orientation and cell function of incorporated primary neonatal rat 
ventricular myocytes. To analyze the functional properties of the cells, we evaluated contractile 
principal strains, principal angles, total contractile area, and contractile frequencies. In addition to 
these assessments for the entire recorded region, we also completed a grid assessment breaking the 
recorded region into smaller sub-regions to evaluate regional consistency. Further we evaluated 
whether cell-mediated compaction altered the volume fractions of the composite constituents and 
impacted the stiffness of the scaffolds. To assess the impact on the mechanical properties, we 
modeled the effect volume fraction changes of composite constituents resulting from compaction 
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would have on layer stiffness using composite theory and performed uniaxial tensile testing on 
compacted layers. The results of these analyses will inform the material properties and 
functionality of individual composite layers. Ultimately, we anticipate that composite fibrin layers 
can be strategically laminated to mimic the architecture, function and mechanical properties of 
ventricular myocardium.  
 
4.2 MATERIALS and METHODS 
4.2.1 Fabrication of Fibrin Microthread-Based Composite Scaffolds 
4.2.1.1 Microthread Extrusion 
Fibrin microthreads were generated by co-extruding fibrinogen and thrombin solutions.21-
24 Briefly, a 70 mg/mL solution of fibrinogen (from bovine plasma, Sigma, St. Louis, MO) in 
HEPES (N-[2-Hydroxyethyl] piperazine-N’-[2-ethanesulfonic acid]) buffered saline (HBS, 20 
mM HEPES, 0.9% NaCl; pH 7.4) was made and stored at -20oC until use. A 40 U/mL solution of 
thrombin isolated from bovine plasma (Sigma) in HBS was also made and stored at -20oC. 
Solutions were thawed to room temperature prior to use. The thrombin solution was mixed with a 
40 mM solution of CaCl2 yielding a working solution of 6 U/mL. Equal volumes of fibrinogen and 
thrombin/CaCl2 solutions were loaded into separate 1 mL syringes and connected to a blending 
applicator tip (Micromedics Inc., St. Paul, MN) to mix the solutions. The mixed solution was then 
extruded using a dual syringe pump through polyethylene tubing (BD, Sparks, MD) with an inner 
diameter of 0.86 mm into a 10 mM HEPES buffer bath (pH 7.4) in a Teflon coated pan at a flow 
rate of 0.225 mL/min. After a 10-15-minute polymerization time, the scaffolds were stretched to 
~150% of their original length and hung to dry.24 
 
4.2.1.2 Fibrin Microthread Organization 
Dried fibrin microthreads were organized as previously reported.14 Briefly, a purpose-built 
fibrin microthread spacer was used to align fibrin microthreads at set distances to ensure a uniform 
layer. The device has aligned grooves with pores. This system couples with a house vacuum 
enabling the placement of fibrin microthreads threads at defined spacing. For this work, 
evaluations were completed utilizing composite layers with 5 fibrin microthreads (5tC) or 20 fibrin 
microthreads (20tC) evenly spaced across a 12 mm width. Once organized, threads were secured 
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and were transferred to precut vellum frames. Threads were glued to the vellum frames using 
medical grade silicone adhesive (Factor II, Inc, Lakeside, AZ).  
 
4.2.2 Rat Neonatal Ventricular Myocyte (rNVM) Isolation 
All work involving animals was submitted to and approved by the Institutional Animal 
Care and Use Committee at Worcester Polytechnic Institute. Rat neonatal ventricular myocytes 
were isolated following a previously described protocol.25 Briefly, hearts were excised from 2 and 
3-day old neonatal Sprague Dawley rats (Charles River, Wilmington, MA). The ventricles were 
then separated from the atria and were subsequently minced into ~1mm2 sized pieces. Digestion 
of the ventricle pieces was completed at 37°C using type II collagenase (Thermo Fisher Scientific, 
Waltham, MA) serially in 7x7 minute digestions. One 45-minute pre-plating step was performed 
to enrich the volume of cardiomyocytes in the isolation.19 Cells were used immediately for 
experimentation. 
 
4.2.3 Composite Layer Fabrication and Tissue Culture 
All samples used in cell culture were maintained in medium comprised of DMEM (VWR, 
Radnor, PA) supplemented with 10% defined donor equine serum (Fisher Scientific, Waltham, 
MA), 2% chick embryo extract (United States Biological Corp, Salem, MA), 1% penicillin 
streptomycin (Thermo Fisher Scientific, Waltham, MA), 1% amphotericin B (Thermo Fisher 
Scientific) and 50 ug/mL aprotinin (Sigma Aldrich, St. Louis, MO). All cell culture experiments 
were maintained for 14 days with medium changes every other day.  
The following nomenclature scheme was used for all experimental conditions: unaligned 
controls of 5 thread composite layers (UA5tC), aligned 5 thread composite layers (A5tC), aligned 
20 thread composite layers (A20tC) and gelatin-coated coverslips (GCS). Each experimental 
condition was tested in triplicate. 
 
4.2.3.1 Fabrication of Unaligned Controls (UA5tC) 
 Autoclaved polydimethylsiloxane (PDMS) sheets were coated with sterile 1% Pluronic-F127 
(Sigma, St. Louis, MO) in DI water for 1 hour. Organized fibrin microthreads secured to vellum 
frames were rehydrated in phosphate buffered saline (PBS) (VWR, Radnor, PA) for 1 hour. 
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Immediately prior to gel casting, rehydrated samples were placed on the coated PDMS sheets. A 
hydrogel solution of 4 x106 cells/mL, 4% (v/v) 40 U/mL thrombin, and 28% (v/v) 11 mg/mL 
fibrinogen was mixed on ice, cast over the vellum frames and spread using a pipette tip to provide 
an even layer. For the 144 mm2 area of the sample, 150 uL of hydrogel solution was used. Samples 
were placed in an incubator at 37oC for 30 minutes to polymerize and were then transferred into 
wells. 
 
4.2.3.2 Fabrication of Experimental Composite Samples (A5tC and A20tC)  
Custom hydrogel-casting and culturing devices were generated by casting PDMS into a purpose-
built aluminum mold (Figure 4.1). Casting devices are 19 x 25 mm with 2 mm diameter posts 1 
mm in height, and 1 mm thick walls to restrict the geometry of the cast hydrogel. Culturing devices 
are 19 x 25 mm with 2 mm diameter posts 5 mm in height, and couple with 4 X 1 mm wide, 2 mm 
inner-diameter high-temperature silicone o-rings with a durometer of 70A.  
 
Figure 4.1. The materials and procedure for casting the experimental A5tC and A20tC layers. PDMS is used 
with an aluminum mold to create casting and culturing devices that couple with vellum frames (A). The casting 
device is coated with 1% Pluronics which enables hydrogel incorporation into only 2 of the vellum frame sides. The 
samples are transferred to the culturing device, secured with o-rings and frame side-arms cut for culture (B).  
 
Hydrogel-casting devices were autoclaved and coated with sterile 1% Pluronic-F127 in DI water 
(Sigma, St. Louis, MO) solution for 1 hour. Vellum frames with secured fibrin microthreads (5 or 
20 threads) were rehydrated in PBS for 1 hour. Immediately prior to hydrogel casting, samples 
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were placed on the casting devices. A hydrogel solution of 4 x106 cells/mL, 4% (v/v) 40 U/mL 
thrombin, and 28% (v/v) 11 mg/mL fibrinogen was mixed on ice, cast over the samples and spread 
using a pipette tip to provide an even layer. The casting device prohibited any hydrogel from 
binding to the side arms of the vellum frames. For the sample area of 144 mm2, 150 uL of hydrogel 
solution was utilized. Polymerization occurred in an incubator at 37oC for 30 minutes. Following 
this, samples were moved to culturing devices in wells, and secured to the PDMS posts of the 
device with silicone o-rings (McMaster-Carr, Princeton, NJ). The side arms of the vellum frames 
were then cut, and samples were covered with medium.  
 
4.2.3.3 Seeding of Gelatin-Coated Glass Coverslip Controls (GCS)  
Gelatin coated coverslips (GCS) were used as a control to assess batch-to-batch variation. Glass 
coverslips (VWR) were cut to 10 x 10mm dimensions, autoclaved, and coated with sterile 0.7% 
gelatin (Sigma Aldrich) in DI water for 4 hours. Following coating, coverslips were secured to the 
bottom of wells in a 12 well plate using autoclaved vacuum grease. The plate was stored in an 
incubator at 37oC until use. Following casting of all other samples, 100 µL of cell suspension (2 x 
106 cells/mL) was seeded on each coverslip and incubated at 37oC for 18 hours. Samples were then 
rinsed and covered with medium for extended culture.  
 
4.2.4 Cardiomyocyte Functional Analysis 
4.2.4.1 High Density Mapping (HDM) 
For functional analyses, UA5tC, A5tC and GCS controls were evaluated. Spontaneous 
contractions were recorded at 100X magnification and 60 frames per second with a high-speed 
camera (HiSpec 4, Fastec Imaging Corp, San Diego, CA) attached to an inverted microscope 
(DMIL, Leica Microsystems, Buffalo Grove, IL). Recordings of ~1300 frames were completed at 
7, 10 and 14 days of culture. Because of visible differences in the regional function of A5tC layers, 
two videos per sample per timepoint were collected, one at a region of larger global movements 
(“max”, as identified by thread movement) and one at a region of low global movements (“min”, 
as identified by little if any thread movement). An optical technique, high density mapping (HDM), 
was used to evaluate regional mechanical function with high spatial resolution.26 Two methods 
were utilized to assess the contractile behaviors of incorporated cardiomyocytes; a large region 
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assessment and a grid assessment (Figure 4.2). Regions of interest (ROIs) for each sample were 
selected (large region size: 1200 x 986 pixels, grid size: 20 squares, each 300 x 197 pixels). Each 
ROI was divided into 16 x 16 pixel subwindows, with an 8 pixel shift and 5 averaging windows 
to track displacements of sequential frames over several images, ultimately yielding displacement 
fields.27-28  
 
Figure 4.2. HDM is a method for evaluating regional mechanical function.26 Recordings were taken of 
regions of samples (A). From the recorded images, ROIs were selected. For the large region assessment (B) an ROI 
of ~1200 x 986 pixels was selected. For the grid assessment, 20 regions 197 x 300 pixels in size were selected (C). 
The scale bar is 0.05 mm.    
 
For the large region assessment, the displacement fields were used to determine the 
maximum principal contractile strain for the ROI, the average principal contractile strain across 
the ROI, the frequency of contractions and the percent contractile area. Outliers were identified 
as any strain or frequency value that was 1.5 times greater than the inner quartile range (IQR) for 
each sample set (min: quartile 1 - 1.5*IQR, max: quartile 3 + 1.5*IQR) and were subsequently 
removed from further analysis.24 
Additionally, with the large region assessment the principal angles of 5 contractile strains 
per sample were evaluated. For each sample, a range of principal angles was calculated as a 
measure of how synchronous the sample was contracting. A small range would imply that the 
layer was beating synchronously as the angles were not changing for different contraction cycles. 
A large range however, could result from multiple contractions occurring asynchronously.  
The grid assessment yielded information about the uniformity of the incorporated cells’ 
contractile behavior across the recorded region. For this assessment, the recorded region was 
subdivided into 20 ROIs forming a grid. Each ROI was evaluated individually for maximum 
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principal contractile strain and the associated principal angle value. Additionally, each ROI was 
evaluated for the average principal contractile strain. With this data, 3 evaluations were completed 
(Figure 4.3). To determine the principal angle consistency across the entire recorded region, the 
range of principal angles for the maximum contractile strains of each sample’s 20 ROIs was 
calculated (Figure 4.3 B). This is different from the analysis completed for the large ROI 
assessment. Consistency between contractions for an ROI was not determined; rather, consistency 
across all ROIs in a recorded region was calculated. To evaluate the consistency of the maximum 
and average contractile strain values, a factor we have termed F50 was calculated (Figure 4.3 C). 
This factor is equivalent to the percentage of ROIs within a sample that are equal to or greater than 
50% of the highest maximum contractile strain value calculated for the recorded area. As an 
example, if the highest maximum contractile strain was found to be 10% across the recorded area 
and 5 of the 20 grid blocks had maximum contractile strains >= 5%, the F50 value would be 25%. 
This calculation was also completed for the highest average contractile strain for each sample.  
Additionally, to evaluate the distribution of the maximum contractile strains relative to 
incorporated fibrin microthreads, distances of the highest maximum contractile strains for recorded 
regions from microthreads were determined (Figure 4.3 D). To do so, grid blocks were identified 
where the highest maximum contractile strains were observed. The distance from the center of this 
block to the center of the closest block containing a thread was calculated. If any of the highest 
maximum contractile strains were observed in blocks containing a microthread, the distance was 
evaluated as 0 mm. The same evaluation was completed for the blocks containing the highest 
average contractile strains for the recorded samples.  
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Figure 4.3. Grid evaluations to determine consistency across a recorded region. The recorded region was 
subdivided into a grid of 20 sub-regions (A) and evaluated for contractile strains and principal angles. In B-D, the 
yellow bars indicate the principal angle calculated for the region, and are scaled depending on the calculated maximum 
contractile strain value. Longer bars correspond to greater contractile strains. With this data, the consistency of the 
principal angles (B) and the contractile strains (C) can be evaluated. In C, blue highlighted regions show values greater 
than 50% of the maximum contractile strain. For this example, the F50 factor would be 60%. The distance of the 
highest contractile strains relative to fibrin microthreads was also evaluated (D). Scale bars are 0.05mm.    
 
4.2.4.2 Contractile Wave Propagation Evaluation  
To evaluate contractile wave propagation through the composite layers, cell shortening patterns 
were compared. ROIs (~50 x 150 µm) within the recorded areas were selected that ran parallel and 
perpendicular to the incorporated fibrin microthreads for videos collected at day 14 of culture, 
when areas appeared to be spontaneously, synchronously contracting at a frequency of 
approximately 1.6 Hz (Figure 4.4). For each ROI, contractile strains were plotted against frame 
numbers yielding a strain trace. Traces for regions running parallel to the thread were overlaid. 
Frame differences in contractile peaks were taken and averaged for 5 contractions per sample. This 
value was then multiplied by the framerate used to record the images, 60 fps, to yield a time 
difference. The distance between the two ROIs was measured using ImageJ. The distance was then 
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divided by the time difference to obtain an approximate velocity. This evaluation was repeated for 
regions that ran perpendicular to the incorporated fibrin microthread. To calculate the noise of the 
assessment method, the time that would be required for the signal to travel at the fastest velocity 
found was calculated. This time value was then compared to the rate at which frames were captured 
to determine if the framerate used was sufficient for capturing the propagation. Outliers were 
identified as any velocity value that was 1.5 times greater than the inner quartile range (IQR) for 
each sample set (min: quartile 1 - 1.5*IQR, max: quartile 3 + 1.5*IQR) and were subsequently 
removed from further analysis.24 
 
Figure 4.4. Method for assessing contractile wave propagation. To determine how a signal may be traveling 
through the layer, 4 ROIs that ran parallel (red regions) and perpendicular (green regions) to the incorporated fibrin 
microthreads were analyzed using HDM (A). Traces were then compared to evaluate the time delay between peaks 
(B). Using the time delay and distance between ROIs, propagation velocities were estimated.  
 
4.2.5 Mechanical Characterization of Cultured Composite Layers 
4.2.5.1. Theoretical Model for Predicting Elastic Modulus of Compacted Composite Layers.  
To generate a model for predicting moduli of fibrin microthread-based composite layers following 
compaction in a 14-day culture, classical composite theory for aligned, fiber-reinforced composites 
was utilized. With this theory, the elastic modulus (Ecl) of a composite layer in the direction of 
microthread alignment can be estimated as shown in Equation 4.129  
??? = ???? +  ????      4.1. 
where Em and Ef are the elastic moduli of the matrix and fibrous components, respectively and 
Vm and Vf are the volume fractions of the matrix and fibrous components, respectively.29 
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For this assessment, UA5tC, A5tC and A20tC were analyzed. To evaluate the amount of 
compaction that occurred, the volumes of the compacted layers following 14 days of culture were 
calculated. To do so, a laser displacement technique was used to measure the thickness of the 
composite layer in 3 places per sample.30 A disk with diameter 13 mm, thickness of 1.3mm and 
weight of 1.3 g was placed on the top of the sample prior to measuring. The disk did not deform 
the layers, but enabled a reflective surface for accurate thickness measurements. The widths of the 
constructs were also measured using calipers. For both metrics, 3 measurements were taken and 
averaged. To calculate the volume, a rectangular geometry was assumed. Calculations were also 
completed for acellular (non-compacted) composite layers.  
Unsterilized fibrin microthreads (in acellular layers) were assumed to have a diameter of 
~110 µm while ethanol-sterilized fibrin microthreads (in cultured layers) were assumed to have a 
diameter of ~99 µm.22 Reported modulus values for uncrosslinked fibrin microthreads range from 
2.2 to 22.3 ± 15.1 MPa.22-23, 31 Additionally, fibrin microthreads with human MSCs seeded on the 
surface and cultured with aprotinin supplementation for 3 days have reported modulus values 
of_~0.07 MPa.32 To incorporate the most appropriate parameters into our model, the stiffness 
values of compacted layers following 14 days in culture were compared to stiffness values of 
acellular composite layers with the same microthread configuration (i.e. cultured 5tC layers were 
compared to acellular 5tC layers). The stiffness was determined to be the slope of the load versus 
extension curve. We assumed that the stiffness of the composite layer was predominantly from the 
microthreads. If changes in the mechanical properties of the microthreads occurred over the culture 
period, differences in the stiffness values would be evident. With an understanding of the impact 
of culture on the mechanical nature of the microthreads, we then back-calculated what modulus 
values corresponded to the observed stiffnesses using Equation 4.2, 
? = ? ? ?
?
       4.2. 
 where E is the modulus, K is the stiffness, L is the length of the fibrin microthreads, and A is the 
cross-sectional area of the fibrin microthreads. With the calculated modulus values and volume 
fractions of each component, Equation 4.1 was used to estimate the elastic modulus of the 
compacted layers.  
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4.2.5.2. Mechanical Testing of Compacted Composite Layers.  
 A submerged uniaxial tensile test was used to characterize cell-populated fibrin composite 
layers. To ensure that contractions of incorporated cells did not impact the evaluation of the 
material, scaffolds were cooled to room temperature in PBS and monitored for cessation of 
contractions. Frames of composite layers were glued using medical grade silicone adhesive (Factor 
II, Inc, Lakeside, AZ) to modified vellum frames for securing into the test apparatus. Mechanical 
characterization of the scaffolds was independent of the frame. To assess the cross sectional area 
of the samples, a laser displacement technique was used to measure the thickness of the composite 
layer in 3 places per sample.30  For these measurements, a reflective disk diameter 13 mm, 
thickness of 1.3mm and weight of 1.3 g was used to ensure a highly reflective surface and accurate 
thickness measurements. The width of the samples were measured in 3 places and averaged, and 
used with the thicknesses to calculate the cross-sectional area, assuming a rectangular geometry.  
 Samples were secured in an ElectroPuls E1000 Instron (Norwood, MA) with a 1 N load 
cell and an initial gauge length of 12 mm. The sample and grips were submerged in a PBS bath. 
Uniaxial loading until failure was completed at a strain rate of 10 mm/min. Displacement and force 
values were recorded throughout the test at a frequency of 10 Hz. Engineering stress was calculated 
by dividing the amount of force recorded by the initial cross-sectional area. Strain was calculated 
as the increased extension from the initial length of the samples. The modulus of the layers was 
evaluated with a MATLAB (MathWorks, Natick, MA) script. Composite materials 
characteristically have two phases in the plotted stress strain curves.29 Because in native tissue the 
myocardium is loaded cyclically experiencing strains often exceeding 20% strain,33 we analyzed 
the modulus in the first phase (0-30% strain range). Outliers were identified as any modulus value 
that was 1.5 times greater than the inner quartile range (IQR) for each sample set (min: quartile 1 
- 1.5*IQR, max: quartile 3 + 1.5*IQR) and were subsequently removed from further analysis.24  
 
4.2.6 Phenotypic Analyses 
4.2.6.1 Immunostaining 
To evaluate alignment and the cardiomyocyte phenotype s???????????-actinin, connexin-43 and 
Hoechst were used to visualize the sarcomeric structure of cardiomyocytes, distribution of gap 
junction protein and the orientation of nuclei, respectively. Human myocardium was used for the 
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positive and negative control tissues. The heart tissue was cut into 1-inch cubes prior to fixation. 
Cubes were fixed in 4% paraformaldehyde overnight, then incubated in a 30% sucrose solution 
for 24 hours. The heart tissue was embedded using OCT and cryosectioned at 10 µm thick using a 
Leica CM 3050 cryostat (Leica Microsystems). Composite samples were fixed with 4% 
paraformaldehyde after 14 days in culture. Samples and control tissues were permeabilized with 
0.1% Triton, then blocked using 5% goat serum in PBS (Invitrogen, Carlsbad, CA). Samples and 
positive controls were incubated for 60 minutes with mouse ??????????????????????????-actinin 
primary antibody (Abcam, Cambridge, MA), and rabbit polyclonal to connexin 43 (Abcam) in a 
blocking solution. The negative control was incubated for 60 minutes in PBS and blocking solution 
with no primary antibodies. All samples then were incubated with secondary antibodies (Goat anti-
mouse Alexa Fluor 546, Life Technologies, Waltham, MA and Goat anti-rabbit Alexa Fluor 488, 
Life Technologies) at room temperature for 30 minutes. Hoechst counterstain (Thermo Fisher 
Scientific) was incubated with the samples at room temperature for 10 minutes. Samples and 
control tissues were imaged using a confocal microscope (TCS SP5 Point Scanning Confocal, 
Leica, Germany). For the nuclear orientation evaluation, 3 representative images of the width of 
each construct were obtained at 200X. To visualize connexin-43 distribution and sarcomeric ?-
actinin, an image at 400X was obtained.  
 
4.2.6.2 Analysis of Nuclear Alignment 
 Nuclear alignment was evaluated for the positive control, UA5tC and A5tC constructs.  
The fluorescent images were analyzed using ImageJ (NIH). For each condition, a total of 6 samples 
(18 representative images) were evaluated after 14 days in culture. A binary image was generated 
after isolating the blue channel (representing nuclear staining by Hoechst). The particle analysis 
function within the ImageJ software was used to analyze the particles. The orientation of the long 
axis of the nucleus was taken relative to the incorporated fibrin microthreads. For positive controls, 
the nuclei were analyzed with respect to the predominant direction of alignment within each image. 
Any nuclei on the edge of the image, or in contact with any other nuclei were excluded from 
analysis. Values were plotted as histograms in 15o increments as representative of the distribution 
of the nuclear orientations within each group.  
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4.2.7 Statistical Analyses 
Statistical analyses were run using SigmaPlot 13 (SYSTAT software, Chicago, IL) software. For 
all comparisons, a significance level of p<0.05 was utilized. For contractile strains and frequencies, 
comparisons were made using a Two-way ANOVA on ranked data with a Holm-Sidak post-hoc 
analysis. For signal propagation speed comparisons, a t-test was used to compare speeds parallel 
and perpendicular to the fibrin microthreads. For the uniaxial tensile data, a one-way ANOVA on 
ranks with Dunn’s post-hoc comparison was used to compare 5tC and 10tC cultured and acellular 
layers. A Students t-test was used to compare the 20tC acellular and cultured layers. For all data 
presented, data are reported as means ± standard deviation. 
 
4.3 RESULTS 
4.3.1 Static Tension Induced Through Gel Compaction Improves Nuclear Alignment of 
Incorporated Cells in Composite Layers. 
 Evaluations were completed of the nuclear orientation of cells relative to the fibrin microthread 
for composite layers and relative to the predominant direction of alignment for positive control 
samples of human myocardium. With this analysis method, the positive control has the highest 
alignment of incorporated cells as is shown in Figure 4.5. The majority (46%) of the nuclei were 
within the 0-15o bin with the lowest percentage of cells (~5%) in the 60o<x<75o and 75o<x<90o 
bins. The A5tC layers had a skewed distribution qualitatively similar to the positive controls with 
the majority of the nuclei (28%) falling with the 0-15o bin. The lowest number of nuclei (12%) for 
the A5tC group fell within the 75o<x<90o bin. The UA5tC group had a uniform distribution across 
all bins with 15-20% of nuclei falling within each bin range as would be expected from random 
alignment.  
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Figure 4.5. Nuclear alignment evaluation. Representative images of positive controls (human heart tissue), A5tC 
???? ???????????????????????????????????? ????????????????-actinin, connexin 43 and Hoechst are shown in A. When 
isolating the Hoechst channel, nucleus orientation was evaluated relative to fibrin microthreads (white dotted lines) or 
the predominant direction of alignment for positive controls. Distribution of nuclei orientations is shown in B, with 
human heart demonstrating the greatest alignment. When comparing to the positive control group, A5tC layers more 
closely mimic the control distribution than UA5tC layers.   
 
4.3.2 Immature Connexin-43 Phenotype Observed Across 5tC Layers. 
 Positive control samples (human heart sections), A5tC layers and UA5tC layers were 
stained with sarcomeric ?-actinin, connexin 43 and Hoechst. When evaluating the phenotype of 
????????????? ??????? ???????????????? ????????? ????????????????????? ????????? ??????????? ??-actinin) 
characteristic of a contractile cardiomyocyte phenotype (Figure 4.6). Connexin 43 distribution in 
the positive controls was polarized with clear banding visible at the ends of the cells, a phenotype 
characteristic of mature cardiomyocytes. Connexin 43 distribution in the A5tC and UA5tC groups 
was more circumferential with positive staining visible between cells, but not polarized. This 
staining pattern is characteristic of an immature cardiomyocyte phenotype.34  
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Figure 4.6. Phenotypic comparison of aligned composite layers, unaligned composite layers and human heart 
tissue controls. Positive and negative control tissue was cryosectioned human heart tissue. All samples were stained 
??????????????????????????????-actinin, and Hoechst. Yellow arrows show striations from ?-actinin and white arrows 
show positive connexin 43 staining.  
 
4.3.3 Composite Layers with Increased Alignment Have Higher Contractile Strains and 
Larger Contractile Areas Relative to Unaligned Controls.  
 Macroscopic differences among UA5tC and A5tC groups were visible at day 14. While the 
UA5tC group had contractions occurring all over the layer, they appeared to not have a uniform 
direction. This was in contrast to the A5tC layers which appear to contract in the same direction 
across the layer. For the large ROI assessment, HDM was utilized to assess the functional behavior 
of incorporated rNVMs in composite layers and on gelatin-coated coverslip controls (GCS) 
(Figure 4.7 A). For each sample, the principal angle was determined for 5 contractions. The range 
of the determined angles was then calculated. Ranges were averaged for each group at each 
timepoint and are summarized in (Figure 4.7 B). At day 7, maximum principal contractile strains 
were greatest in the UA5tC group (Figure 4.7 C) (10.4% ± 3.1). By day 10, A5tC min and A5tC 
max regions were greater than UA5tC and GCS (10.3% ± 3.5, 18.4% ± 7.9, 7.1% ± 2.1 and 4.7% 
± 0.7, respectively). A similar trend was observed at day 14. Average principal contractile strains 
followed a similar pattern to the maximum principal strains (Figure 4.7 D). Significant increases 
 Chapter 4 
Alignment Through Static Tension Increases Contractile Strain  87 
 
in strain relative to the GCS controls were evident at day 14 for UA5tC, A5tC min and A5tC max 
groups (1.4% ±0.2, 2.5% ±0.7, 3.2% ±1.9 and 4.6% ±2.4, respectively). Contractile areas were 
similar between all groups at day 7 with a significant increase observed for A5tC regions (min and 
max) by day 10. At day 10, A5tC max areas had significantly greater contractile areas relative to 
the UA5tC group (90.5% ±6.0 and 81.8% ±4.1, respectively). By day 14, all groups had similar 
contractile areas again ranging from 84.1% ± 5.3 (GCS) to 91.5% ± 3.9 (A5tC Max) (Figure 4.7 
E). All groups had similar contractile frequencies across the 14-day culture period with no 
significant differences observed (values ranging from 1.6 to 2.1 Hz) (Figure 4.7 E).  
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 Figure 4.7. Contractile behavior evaluation through HDM with a large ROI. The ROI and distribution of contractile strains across the region are shown in A. The uniformity 
of contractions was evaluated with a principal angle assessment (B). Maximum principal contractile strains (C), average principal contractile strains (D), contractile areas (E), and 
contractile frequencies (F) were calculated for GCS, UA5tC, A5tC- Min and A5tC- Max regions. Statistical differences were evaluated through a two-way ANOVA on ranked data 
with a Holm-Sidak pos-hoc analysis, p<0.05. Differences are shown within timepoints by a bar. Statistical differences within groups across timepoints are shown with *= significantly 
different from day 7 timepoint and # = significantly different from day 10 timepoint. Data are presented at as averages ± standard deviations.  
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4.3.4. The Highest Contractile Strains are Predominantly in Regions Immediately Adjacent to 
Fibrin Microthreads for Aligned Composite Layers.  
To assess variations across a recorded region, a grid assessment was completed with HDM 
in which 20 smaller sub-regions were analyzed to quantify the maximum contractile strain and its 
associated principal angle (Figure 4.8 A). Additionally, the average contractile strain was 
evaluated for each sub-region. With this data, the distance of the region with the highest maximum 
contractile strain, and highest average contractile strain from the nearest incorporated fibrin 
microthread was calculated (Figure 4.8 C-D). For the highest maximum contractile strains, an 
overall trend showed that these regions were typically regions that contained fibrin microthreads 
(a distance of 0 mm). An increasing distance from microthreads corresponded to decreasing 
occurrences of the highest maximum contractile strains. When evaluating this data on a group-by-
group basis, the same distribution was observed for the A5tC layers (max and min regions). The 
UA5tC layers did not have the same trend; the highest maximum contractile strains were observed 
~200 µm from the nearest fibrin microthread. When evaluating the highest average contractile 
strains, a similar overall trend was observed to the highest maximum contractile strains, although 
not as prominent. Again, the A5tC layers had the same trend as with the highest maximum 
contractile strains. The UA5tC layers had the same trend, where the highest average strains were 
observed ~200 µm from the nearest fibrin microthread. 
 
4.3.5. Consistency of Contractile Behavior is Similar for All Composite Layer Groups.  
The grid assessment was used to evaluate the consistency of contractile behavior across the 
entire recorded region. Principal angles for all 20 ROIs within a grid were compared and a range 
of angles calculated for each sample group at timepoints 7, 10 and 14 days in culture (Figure 4.8 
B). When comparing the principal angle ranges through a Two-way ANOVA, no significant 
differences based on group were observed. Significant differences based on timepoint were found 
with day 14 having significantly lower ranges than day 7 and day 10 (day 14 and day 7: p= 0.038, 
day 14 and day 10: p=0.025). This suggests that all groups experienced a decrease in principal 
angle range over time as contraction angles across the recorded region became more consistent. 
An F50 factor was also calculated to quantify the consistency of the contractile strains observed 
across the recorded region. All groups had similar distributions with most samples having an F50 
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of ~80% for the maximum contractile strains. For the average contractile strains, an overall trend 
was that the majority of samples had an F50 value of 100% suggesting consistent contractile 
behavior across recorded regions. For A5tC max regions, the majority of samples had an F50 value 
of 80%, unlike the A5tC min and UA5tC groups whose majorities were F50 values of 100%. 
However, the majority of samples for all groups had F50 values >= 80% suggesting similar 
consistencies in contractile behaviors across all groups.  
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Figure 4.8 A grid assessment for evaluation of contractile behavior consistency across a recorded region. Recorded regions were broken up into 20 sub-regions to evaluate 
contractile strains (A) and associated principal angles (B). No significant differences in principal angle ranges were observed suggesting similar behavior across all groups. Evaluation 
of the distance for the highest maximum and highest average contractile strains from the incorporated fibrin microthreads were evaluated (C-D). Similar trends were observed for 
A5tC layer regions, with highest strains being in regions immediately adjacent to microthreads. Additionally, consistency of contractile strain values across ROIs was compared 
using a F50 factor (E-F) with similar behavior across all groups.  
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4.3.6 Composite Layers with Increased Alignment Have Anisotropic Contractile Wave 
Propagation Speeds 
With the large ROI assessment, the smallest range in principal angles was observed for the 
A5tC Max group suggesting that this group had the most synchronous contractions. As such, 
contractile wave propagation assessments focused on this sample group specifically. Contractile 
wave propagation speeds through the A5tC max regions were evaluated at day 14 for directions 
parallel and perpendicular to the incorporated fibrin microthreads. These assessments were 
completed of spontaneously occurring contractions that occurred at a frequency of ~1.6 Hz. The 
fastest velocity evaluated across all samples was 19.1 mm/s. At that velocity, the distance traveled 
was ~0.5mm. The time required to travel this distance at that speed was 0.03 s. With a recording 
framerate of 60fps, 1 frame is recorded every 0.017 s. This implies that at that speed, 2 frames 
would be taken. The recording framerate was sufficient for capturing the fastest velocity observed 
in this work.  
Samples from 3 separate trials (2 samples per trial) were evaluated. Velocities were 
anisotropic for the A5tC- Max group; 11.1 ± 1.5 mm/sec and 4.5 ± 2.0 mm/sec in directions parallel 
to and perpendicular to the fibrin microthreads, respectively (Figure 4.9). There was a significant 
difference between these speeds, as evaluated through a t-test, p<0.05.  
 
 
Figure 4.9. Contractile wave propagation speeds of spontaneous contractions at a frequency of ~1.6 Hz through 
A5tC Max regions. Velocities parallel to the threads were compared to speeds perpendicular to threads through a t-
test. A bar represents significant difference, p<0.05, n=3.  
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4.3.7 A Model Based on Composite Theory Can be Derived to Predict Modulus Values of Fibrin 
Composite Layers Following Compaction  
Following a 14-day culture, A5tC, UA5tC, and A20tC samples were measured to determine the 
new volume of each construct and the amount of compaction that occurred (Table 4.1). The 
greatest amount of compaction was observed in A5tC samples (65%). The UA5tC and A20tC 
samples had similar compaction with values near 50%. 
 
Table 4.1. Summary of compaction occurring over 14 days of culture. 
Group Average Volume Compaction Relative to Acellular Scaffolds 
UA5tC 54% 
A5tC 65% 
A20tC 48% 
 
Stiffness values were determined by taking the slope of load versus extension curves for acellular 
and cultured A5tC and 20tC layers (Table 4.2). The stiffness values were compared to determine 
whether any changes in the mechanical integrity of the microthreads occurred over the 14-day 
culture period. For 5tC layers, no difference was observed across any groups. For the 20tC layers, 
a significant difference between the acellular and cultured layer stiffness values was observed, as 
evaluated through a t-test with p<0.05.  
 
Table 4.2. Stiffness values for acellular and cultured composite layers. * indicates significant difference as 
evaluated through a t-test, p<0.05.  
Group Stiffness (N/m) 
A5tC- Acellular 7 ± 3  
UA5tC- Cultured 7 ± 2 
A5tC- Cultured 7 ± 6 
A20tC - Acellular 26 ± 7* 
A20tC- Cultured 20 ± 8* 
 
 The stiffness values for the 20tC layers were evaluated to determine the respective modulus 
values for microthreads incorporated in acellular and cultured layers (Table 4.3) The modulus was 
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reduced ~7% for the microthreads in the cultured layers relative to the acellular layers, again with 
the assumption that the any stiffness contributed by the matrix component of the composite layer 
was negligible relative to the stiffness of the microthreads.  
 
Table 4.3. Calculated modulus values for microthreads in acellular and cultured composite layers.  
Group K (N/m) L (m) A (m2) E (kPa) 
A20tC - Acellular 26 ± 7 0.012 1.9 x 10-7 1642 
A20tC- Cultured 20 ± 8 0.012 1.6 x 10-7 1528 
Volume fractions of each component were calculated factoring in the compaction 
observed. These values in combination with the calculated fibrin microthread modulus values were 
used to estimate the modulus of acellular and compacted composite layers. When comparing 
measured acellular modulus values for 5tC and 20tC layers14 to model predictions, values were 
very similar. When comparing the measured acellular values to predicted values for cultured 
layers, all moduli values increased (Table 4.4).  
  
Table 4.4. Predicted moduli values for compacted and non-compacted (acellular) constructs.  
Group 
Predicted Acellular 
Modulus (kPa) 
Measured Acellular 
Modulus Value (kPa)14 
Predicted Compacted 
Modulus (kPa) 
UA5tC 24 20.6 ± 8.1 38 
A5tC 24 20.6 ± 8.1 51 
A20tC 94 97.5 ± 49.3 142 
 
 
4.3.8 Composite Layers Compact in Culture Resulting in an Increased Modulus for 5tC Layers. 
Submerged, uniaxial tensile testing was completed to evaluate layers following a 14-day culture. 
Elastic modulus values were calculated as the slope of the engineering stress vs engineering strain 
curves in the first phase of the curves (~0-30% strain). The UA5tC, A5tC and A20tC groups had 
an elastic modulus of 47 ± 21, 40 ± 26 and 97 ± 29 kPa, respectively (Figure 4.10).  
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Figure 4.10. Comparison of modulus values for predicted and measured cultured composite layers and 
acellular controls. UA5tC, A5tC and A20tC layers were cultured for 14 days and then uniaxially tensile tested to 
determine the modulus for each group. Green lines represent the predicted modulus values from the developed 
model. Black bars represent significant difference as evaluated though an ANOVA on ranks with Dunn’s post-hoc 
comparison, p<0.05. 
 
The predicted values for 5tC layers were similar to the measured values, and were within 1 
standard deviation of the measured values. When comparing the modulus values for cultured 5tC 
layers to previously reported acellular 5tC layers,14 UA5tC and A5tC groups had significantly 
increased modulus values as evaluated through an ANOVA on ranks with Dunn’s post-hoc 
comparison, p<0.05. In fact, the UA5tC and A5tC groups were closer to the measured acellular 
10tC layers with no significant differences observed in modulus values (47 ± 21 kPa, 40 ± 26 kPa, 
46 ± 23 kPa, respectively). The A20tC predicted value was greater than the measured value, and 
was slightly more than ~1.5 standard deviations greater than the measured value. The cultured 
20tC layer did not increase relative to the acellular 20tC layers (97 ± 29 kPa and 98 ± 49 kPa, 
respectively). 
 
4.4 DISCUSSION 
The goal of this study was to evaluate how alignment induced by cell-mediated compaction 
of composite layers would impact cell function. We compared GCS and UA5tC controls to A5tC 
layers for functional assessments of principal contractile strains and the associated principal angle, 
contractile areas, and contractile frequencies via HDM analysis. Large region ROIs and grid ROIs 
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were utilized to assess contractile behaviors for a recorded region and to assess variations across 
the recorded region, respectively. All efforts for functional evaluations were completed with rat 
neonatal ventricular myocytes in 5tC layers as the acellular modulus (20.6 ± 8.1 kPa)14 most 
closely mimics the modulus of rat neonatal myocardium (10 – 20 kPa)35. Further, we compared 
the phenotype of incorporated rNVMs in A5tC and UA5tC layers to human heart tissue controls. 
Finally, we evaluated how compaction impacted the mechanical properties of the composite layers. 
For this assessment, we not only evaluated UA5tC and A5tC groups, but also A20tC groups to 
determine whether the impact in compaction was evident across samples with a larger volume 
fraction of microthreads.  
We demonstrated that the culturing method presented increases nuclear alignment relative 
to UA5tC controls. When evaluating human heart tissue as a control, only ~46% of the nuclei had 
an offset of 0-15o. It has been reported that myocardium is a highly aligned tissue where fibers 
within each layer of the tissue are within 0-13o of the mean fiber direction. The orientation of the 
cells within each layer closely follow the fiber orientation.16 The method used to evaluate nuclear 
alignment involved taking a confocal image and isolating the blue (Hoechst) channel. It is possible 
that the confocal image had nuclei that were not entirely within the plane imaged. If a nucleus 
were out of plane but partially imaged, it may appear to have a different orientation than it truly 
does. While this may have reduced the alignment measured, it was done consistently for each 
sample, enabling comparisons.  
When evaluating the orientation of nuclei within the A5tC layers, it was impossible to 
separate out the max and min regions that were analyzed for function. This is because without 
seeing the contractions occurring within each region, we were not able to ensure that we were 
evaluating alignment in those specific areas. Instead, we evaluated the entire A5tC layer and 
reported alignment for the overall group. However, there were visible differences in alignment for 
the A5tC layers regionally, as was observed in the functional analysis. It is possible that 
compaction did not occur uniformly throughout the layer. Inducing alignment through cell-
mediated gel compaction is similar to other published methods where ends of the scaffolding 
material are restricted. In a pioneering work completed by Zimmermann et al, edges of a fibrin 
hydrogel-based scaffold were restricted by pieces of Velcro. The authors observed variations in 
alignment with the greatest concentration of longitudinally oriented cells at the free edges of the 
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construct.17 While we observed spatial variations as well, the variations were not consistently at 
the edges across all samples. In some cases, the greatest functionality and alignment was within 
the center areas of the constructs. The fibrin microthreads may have acted as a barrier for 
compaction, or influenced the areas that most greatly compacted resulting in regional variability.  
A potential alternative in the future is to utilize a smaller fibrin microthread length. While 
these layers used continuous fibers that extended through the entire length of the construct, 
mechanical reinforcement can be achieved as long as the fiber length is greater than the critical 
length needed for the material.29 The critical length is dependent on fiber diameter, the tensile 
strength of the fiber and the fiber-matrix bond strength. In reports of utilizing a silk fiber to 
reinforce silk hydrogels, critical lengths reported were on the order of 500 µm.36 It is likely that 
the critical length for fibrin microthreads in a fibrin hydrogel is reduced from the current length 
used (12 mm). If we used shorter, discrete, aligned fibers it is possible that more uniform 
compaction could be achieved. With more uniform compaction, it is possible that greater 
alignment and more uniform functionality throughout the layer could result.      
HDM evaluations were completed for large ROI regions. In those comparisons, A5tC 
layers had greater contractile strains and larger contractile areas relative to GCS and UA5tC 
controls. This is likely due to the increased alignment of incorporated rNVMs as cardiomyocyte 
alignment may contribute to enhanced functional maturation.18, 37-39 All functional parameters 
increased over the culture period, with the exception of contractile frequency which was 
maintained at a consistent level from 7- 14 days. It has been reported that, for a fibrin hydrogel, 
constructs finished compaction at days 8-13 in culture.19 It is possible that the increase over the 
culture period in contractile strains and areas was due to compaction occurring throughout the 14 
days, resulting in increased alignment throughout the culture period. 
Contractile strains measured in normal myocardium have been reported to be ~19%.40 
Maximum contractile strains observed for the A5tC max areas were near ~18% on day 10 and 
~22% on day 14. While these values are very near the reported value for healthy myocardium, it 
should be noted that different methods were used to assess the contractile strains. With HDM, the 
use of different parameters (averaging windows, subimage size and subimage shift) can greatly 
impact the measured values.26 While we optimized these parameters to improve the signal to noise 
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ratio and believe the results to be near the actual values, the best comparison would be to evaluate 
healthy myocardium using the same method.  
We observed lower contractile frequencies for all groups (1-5- 2.0 Hz) than reported 
frequencies for neonatal cardiomyocytes in a 3D environment (2.5-3Hz17, 41 ). Data collection for 
the functional experiments was completed on days 7, 10 and 14. However, it has been reported 
that contractile frequencies for rNVMs have decreased in culture as early as day 6.41 It is possible 
that the contractile frequencies reduced prior to the data collection timepoints. 
For the large ROI evaluations, one assessment focused on the consistency of principal 
angles for different contraction cycles. If all cells are contracting in sync, one principal angle 
should be observed for the entire ROI. However, if multiple contractions are occurring out of sync, 
then when evaluating different contraction cycles different principal angles may be observed. With 
this evaluation, the 2D GCS controls had reduced ranges relative to UA5tC 3D controls. This is 
likely because in a 2D environment, all cells are within one plane and may more easily make cell-
cell connections than in a 3D environment. The A5tC Max group was the only group to show a 
decreasing trend in the principal angle ranges observed. By day 14, the A5tC Max group had the 
smallest ranges observed of all groups suggesting that this group had the most synchronous 
contractile behavior. Because the A5tC max regions had the lowest ranges shown for the large 
region ROI principal angle assessment, the contractile wave propagation speed was evaluated for 
this sample group at day 14.  
The A5tC layers have anisotropic contractile wave propagation occurring, a sign of highly 
aligned tissue.15 This assessment does not conclusively show that conduction is occurring as we 
did not inhibit spontaneous contractions from occurring. While we did overlay and match strain 
curves, it is possible that spontaneous contractions were occurring at different locations in the 
layer. However, this method enables visualizations of cell shortening and does estimate contractile 
wave propagation speeds. Healthy myocardium has anisotropic propagation speeds with 
conduction velocities in the longitudinal direction and transverse direction being 73 ±4 cm/s and 
11 ± 3 cm/s, respectively33 (anisotropic ratio = ???????????????????????
???????????????????????
= 0.7). The A5tC max 
regions had contractile wave velocities of 11.1 ± 1.5 mm/sec and 4.5 ± 2.0 mm/sec in directions 
parallel to and perpendicular to the fibrin microthreads, respectively (anisotropic ratio = 0.4). The 
magnitude of the velocities and the ratio of them was reduced relative to conduction speeds that 
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occur in healthy myocardium. It is likely due to immature gap junction formation as was confirmed 
with connexin 43 staining and imaging. Polarized gap junctions are characteristic of highly mature, 
functional myocardium.34 We observed circumferential staining of connexin 43, characteristic of 
immature cardiomyocytes. This study utilized rat neonatal ventricular myocytes from 2- and 3-day 
old rats. Connexin-43 has been shown to exhibit dispersed distributions within the first 20 days of 
postnatal life with polarizations of gap junction proteins being more evident between 20-90 days 
of postnatal life.42 With an improvement in gap junction formation, it is likely that the signal 
propagation speed would increase. Additionally, the alignment of cells within the A5tC layers was 
reduced relative to human myocardium. Further increased alignment could also contribute to faster 
propagation speeds.  
A grid assessment was completed for evaluation of regional variations within a recorded 
region. Consistency across samples was similar for all sample groups. The principal angle ranges 
for all groups significantly decreased over time. However, no significant differences in ranges 
were observed among groups. This was unexpected as it was hypothesized that, with increased 
alignment, a reduction in the range of principal angles across the grid ROIs would be observed. 
The high variation was expected for UA5tC samples as contractions were not aligned. For A5tC 
samples, contractions were visibly highly aligned and resulted in a wave-like motion. It is possible 
that this wave motion is what caused such high variability in the observed principal angles. This 
is because if one region contracting caused it to not only contract inward, but pull upward (like a 
wave), it would also pull adjacent regions. In those regions, when contractions would begin, pixels 
may have already been at a different angular offset from one another than when no cells in the 
recorded region were contracting. Another factor with this assessment was that in each trial, 
primary isolations of cells were utilized. Primary isolations can result in variations in the ratios of 
cells isolated.  We have used a pre-plating step following isolation to try to enrich the number of 
cardiomyocytes and minimize this issue.19   
The F50 factor was a method for quantifying the uniformity of contractile strains across 
the entire grid. Overall trends showed that the majority of samples had F50 values of 80% and 
100% for maximum contractile strains and average contractile strains, respectively. The increased 
F50 value for the average strains relative to the maximum strains is not surprising; the maximum 
values were the highest values across the entire sample while the average was closer to the overall 
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mid-line contractile behavior observed. The similar distributions suggest that across all sample 
groups, contractile behavior is similarly consistent. The distributions would change with the factor 
level being set to a different threshold (i.e. 75% instead of 50%). For our purposes, the 50% 
benchmark resulted in non-flat distribution plots to assess patterns in behavior. 
The grid assessment was also utilized to evaluate the distance of the highest maximum and 
highest average contractile strains from incorporated fibrin microthreads. What was observed is 
that overall, the highest values for both categories were in regions immediately adjacent to fibrin 
microthreads. It is possible that the microthreads may increase alignment in the immediately 
adjacent areas,14 resulting in greater contractile function. This pattern was observed for the A5tC 
max and min regions, but was not observed for the UA5tC samples whose highest contractile 
strains were ~200µm from the nearest fibrin microthread. It is possible that this trend may be 
observed because, with the A5tC layers compaction brings more of the total gel phase in closer 
proximity to the incorporated fibrin microthreads. With the UA5tC samples, distances of the gel 
phase from the microthreads are consistently maintained. It is also possible that there are regional 
variations in the mechanical environment that are present for the UA5tC samples that are not 
observed with the A5tC layers. Cells have been shown to have the ability to sense rigid bodies not 
in direct cellular contact.43 In fibrous polymers like fibrin, cell sensing distances of ~150 µm have 
been reported.44 One hypothesis for the observed outcome is that the observed distance was a result 
of the cells no longer sensing the incorporated fibrin microthreads. 
Compaction reduces the volume fraction of the gel phase of the composite layer. We 
developed a model for predicting modulus values of cultured, compacted layers. First, we 
evaluated the stiffness of acellular and cultured layers for 5tC and 20tC layers. Stiffness is a metric 
that can be utilized to compare the mechanical nature of the incorporated fibrin microthreads; 
cross-sectional area is not factored into stiffness. Stiffness was calculated by taking the slope of 
the load versus extension curve. We assumed that the contribution of the gel phase to the stiffness 
of the material was negligible. We found that the 5tC layers all had similar stiffnesses, suggesting 
that the culture did not impact the mechanical integrity of the incorporated fibrin microthreads. 
We did observe a significant difference between the acellular 20tC layer and the cultured 20tC 
layer. When calculating the modulus from the stiffness values for the 20tC samples, the difference 
resulted in a change of ~7%. It is likely that this difference was not observed with the 5tC layers 
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as the standard deviations for each layer when evaluating stiffness was much greater than 7%. 
With fewer threads, the change may have been masked by variations observed in the data. As such, 
for the predictive model we incorporated the reduced modulus value for all cultured groups. The 
change in mechanical properties of 7% was reduced from previous reports of seeded microthread 
bundles cultured with aprotinin supplementation having modulus values reduced by an order of 
magnitude after 3 days in culture.32 This is likely because, in that particular study, the cells were 
seeded directly onto the microthreads while in our system cells were dispersed throughout the gel 
phase.  
Through composite theory, we anticipated that we should see an increase in the measured 
modulus values for each group. While the anticipated trend was evident for the 5tC layers, when 
testing a 20tC layer, no increase was observed. Potentially because the 5tC layers initially began 
with a higher volume fraction of hydrogel relative to the 20tC layers, the effect of compaction on 
the modulus may have been more apparent with the 5tC groups. Another possibility is that the 
volume fractions were not estimated accurately with the method reported. As an example, if the 
diameter of the microthreads was overestimated, this would result in an overestimation of the 
volume fraction of the microthreads and ultimately an overestimation of the modulus of the layer. 
This may explain why the measured A20tC modulus was lower than anticipated. Additionally, the 
assumption of a rectangular geometry of the cross-section of the composite layers may not have 
been an accurate assumption. Compaction may have resulted in narrower hydrogel regions relative 
to regions with fibrin microthreads. This also could impact the calculated volume fractions. A 
potentially better way to estimate the volume fractions would be to measure images of the cross-
sections of the composite layers using imaging software such as ImageJ.  
In the future, we plan to investigate the critical lengths of fibrin microthreads needed for 
mechanical reinforcement. We hypothesize that shorter fibers will enable a more uniform 
compaction, increasing alignment and ultimately cell function. We further plan to laminate 
composite layers to mimic the hierarchical architecture and mechanical properties of ventricular 
myocardium. With lamination, an increase in patch thickness will be observed. To circumvent 
diffusion limitations and ensure cell viability, we plan to incorporate a fibrin gel-based vasculature 
into the cardiac patch. Ultimately, we anticipate that fibrin composite layers can be used to 
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generate a patch that is able to mechanically and functionally integrate into the host myocardium, 
promoting regeneration of functional myocardial tissue in an infarct environment.   
 
4.5 CONCLUSIONS 
In this work, we demonstrated that cell-mediated compaction of composite layers can increase the 
alignment of incorporated cells. With increased alignment, increases in contractile strain and 
contractile area were also observed. A grid assessment showed that consistency of contractile 
behavior of incorporated cardiomyocytes was similar across all sample groups. Additionally, for 
aligned samples, the highest contractile strains are predominantly found in regions immediately 
adjacent to fibrin microthreads. Contractile wave propagation occurring throughout the layer was 
anisotropic and fastest in the direction parallel to the threads for the aligned samples. However, 
signal propagation was slow relative to healthy myocardium and was likely due to the immature 
phenotype of the cells (circumferential distribution of the gap junction protein connexin 43). 
Compaction resulted in significantly increased modulus values for 5tC layers, but not for 20tC 
layers. Regional variations that were observed for alignment and function may have been due to 
non-uniform compaction occurring across the layers. In the future, we plan to investigate the 
critical length of microthread required for mechanical reinforcement to see if with a shorter length, 
more uniform compaction result increasing alignment and cell function.  
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Chapter 5: Fibrin Composite Layers Can Be 
Strategically Laminated to Mimic the Mechanical 
Anisotropy of Ventricular Myocardium 
 
 
5.1 INTRODUCTION 
Approximately 614,000 people died in 2014 from heart disease in the United States alone.1 A 
key event that begins the progression towards heart failure is a heart attack. A heart attack initiates 
a series of events that ultimately culminate in scar tissue formation.2 Scar tissue hinders the heart 
from performing as it should. While treatment options exist, they are palliative in nature and no 
current treatment acts to regenerate the damaged heart tissue. As such, there is a clinical need for 
a regenerative therapy for those with damaged myocardium.   
A cardiac patch is one treatment option available to patients that aims to stop progression 
towards heart failure by limiting ventricular remodeling from occurring. Current patches are 
acellular and do not contribute to the active function of the heart.3 These approaches do not restore 
baseline function, but a cell-populated cardiac patch may be able to do so. For a patch to be able 
to provide functional assistance, it will need to integrate functionally and mechanically into the 
host myocardium. Matching mechanical properties of the laminated composite tissue with the 
surrounding myocardium is critical for efficiently coupling load transfer between the scaffold and 
the native tissue.4 For a material stiffer than myocardium, a tethering effect may be observed that 
hinders the mechanical functioning of the surrounding tissue. For materials less stiff than 
myocardium, the material may fail in the dynamic environment of the heart.5-6  
We recently created fibrin composite layers for use in a cardiac patch.7 To date, we have 
demonstrated that fibrin hydrogels can be mechanically reinforced with fibrin microthreads with 
no impact to incorporated cardiomyocyte contractile strain or frequency. We showed that 
manipulation of the fibrin microthread volume fraction could tune the elastic modulus of the 
composite layers. Further, we observed that orientation of incorporated cells could be improved 
through cell-mediated compaction of the construct, inducing a static tension through the layer. 
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Compaction of the gel phase resulted in a significant increase in the composite modulus for 5-
thread composite (5tC) layers, but did not result in a change for 20-thread composite (20tC) layers.  
The material is an aligned, fiber reinforced anisotropic material. Ventricular myocardium is an 
anisotropic tissue that is comprised of multiple layers that rotate relative to one another from the 
endocardium to the epicardium (Figure 5.1). As such, we hypothesize that through the strategic 
lamination of composite layers, we can mimic the hierarchical and mechanical properties of 
ventricular myocardium.  
 
 
Figure 5.1. Biomimetic patch structure. Ventricular myocardium is comprised of layers that rotate relative to 
one another (A). We plan to mimic this structure with fibrin-based composite layers (B), ultimately producing a cardiac 
patch (C) with mechanical and hierarchical properties similar to ventricular myocardium. 
 
To test our hypothesis, we first defined required material properties of a cardiac patch 
functioning as a wall replacement. We then generated a model using laminar composite theory to 
determine what angular offset of laminated layers would best mimic the anisotropic nature of the 
elastic modulus of ventricular myocardium. A lamination method was generated that utilized a 
fibrin glue to adhere layers together. In order to evaluate the effects of the fibrin glue on the 
mechanical properties, a control of two layers cast in one hydrogel and two layers glued together 
were uniaxially tensile tested. Uniaxial tensile testing was further completed to evaluate the 
mechanical properties of a cardiac patch with layers laminated to mimic the mechanical nature of 
ventricular myocardium. We then compared material properties of individual composite layers, 
laminated cardiac patches and target values of healthy myocardium. Ultimately, we envision this 
patch as a wall replacement that, when coupled with a vasculature system, could functionally and 
mechanically integrate with adjacent healthy myocardial tissue.  
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5.2 MATERIALS and METHODS 
5.2.1 Definition of Material Requirements 
Design criteria for the mechanical properties of a cardiac patch can be created from 
understanding the material properties of the ventricular myocardium. A defect area for an infarct 
is on average approximately 10-50 cm2.8 By assuming a square defect area of 16 cm2, we can 
define the length and width as 4 cm. The thickness of ventricular myocardium is approximately 
1.5 cm.9 and the modulus of the myocardium ranges from 20-500 kPa.10 With this information, we 
can determine a membrane stiffness of ventricular myocardium using Equation 5.1.   
? ? ? = ?      5.1. 
In Equation 5.1, E is the elastic modulus, t is the thickness and k is the membrane stiffness. 
For an axial elastic modulus, the slope of the stress strain curve would be evaluated where stress 
is calculated as the force applied divided by the initial cross-sectional area. For the membrane 
stiffness, the value would equate to the slope of a stress strain curve where the stress was calculated 
as the force applied divided by the initial width. Because loads in native myocardium are applied 
across the width of the sample rather than in a tensile fashion, this parameter is a more relevant 
comparison term. A literature search was conducted to evaluate the wall stress that the ventricular 
myocardium experiences. Information for a patient population with abnormally high ventricular 
pressure was used as this value is towards the upper range of what the patch would experience in 
vivo. To ensure the patch could withstand this stress, the ultimate tensile stress (UTS) of the patch 
will need to exceed this value. For our design criteria, the stress was multiplied by the thickness 
of the ventricular myocardium to determine force per width that would be required for a cardiac 
patch. Additionally, the corresponding strain at that stress value should correspond to what the 
heart typically experiences cyclically. With these values, design criteria for the cardiac patch were 
defined.   
 
5.2.2 Composite Theory Model 
Myocardium is composed of highly aligned layers that rotate relative to one another +/ -60o.9  
To produce a cardiac patch with structural and mechanical properties similar to native tissue, we 
anticipate that lamination of composite sheets will need to occur at an angular offset. To understand 
which layer orientations may best mimic native myocardium, a model developed from the 
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generalized Hooke’s law was used to estimate the contribution of a composite layer to the y and x 
direction moduli at various offset angles with assumed plane stress conditions.11 Offset values 
ranged in 30 degree increments from 0- 120 degrees (the rotation observed of layers through the 
width of the ventricular wall of myocardium)12. To calculate the modulus value of one individual 
layer in the x and y directions at an offset, the following equations were used:11    ?
??
= ?????
??
+ ?????
??
+ ? ?
???
?
????
??
? ? ????? ? ?????   5.4.   ?
??
= ?????
??
+ ?????
??
+ ? ?
???
?
????
??
? ? ????? ? ?????   5.5. 
Where  
??? = ?? ? ???? ? ?? + ?? ? ?? 
?? = ??2(1 + ??) 
?? = ??2(1 + ??) 
??? = ?? ? ?? + ?? ? ?? 
?? = ?? ? ?? + ?? ? ?? 
?? = ?? ? ???? ? ?? + ?? ? ?? 
?? = Elastic modulus of the fibrous component 
??= Elastic modulus of the matrix phase 
??= Shear modulus for the fibrous component 
??= Shear modulus for the matrix phase 
??= Poisson’s ratio for the fibrous component 
??= Poisson’s ratio for the matrix phase 
??= Volume fraction of the fibrous component 
??= Volume fraction of the matrix phase 
 
Because a significant difference was observed for 5tC layers following compaction in a 14-day 
culture period, two models were generated; an acellular model and a compacted model. 
Assumptions for each model are summarized in Table 5.1.  
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Table 5.1. Value assumptions for acellular and compacted composite layer models.  
Parameter Acellular Model Value Compacted Model Value 
Ef  1642 kPa* 1528 kPa* 
Em  0.25 kPa13 0.25 kPa13 
Layer 
Volume 
40 mm3 
14 mm3 for 5tC layers 
20 mm3 for all others 
?f 0.3 14 0.3 14 
?m 0.25 (Assumes perfectly isotropic 
material)13 
0.25 (Assumes perfectly isotropic 
material)13 
*Values calculated in Chapter 4: Alignment of Cardiomyocytes Through Static Tension Increases Contractile 
Strains in Composite Layers 
 
5.2.3 Fibrin Microthread Preparation 
Fibrin microthreads were prepared through the co-extrusion of fibrinogen and thrombin 
solutions as has been previously reported.14-17 Briefly, a 70 mg/mL solution of fibrinogen from 
bovine plasma (Sigma, St. Louis, MO) dissolved in HEPES (N-[2-Hydroxyethyl] piperazine-N’-
[2-ethanesulfonic acid]) buffered saline (HBS, 20 mM HEPES, 0.9% NaCl; pH 7.4) was prepared. 
A 40 U/mL solution of thrombin from bovine plasma (Sigma) dissolved in HBS was also made 
and both solutions were stored at -20oC until use. A working solution of 6 U/mL of thrombin was 
made by diluting the stock thrombin solution with 40 mM solution of CaCl2. Equal volumes of 
fibrinogen and thrombin/CaCl2 solutions were loaded into separate 1 mL syringes and extruded 
through a blending applicator tip (Micromedics Inc., St. Paul, MN). Solutions were extruded at a 
flow rate of 0.225 mL/min through polyethylene tubing (BD, Sparks, MD) into a buffer bath of 10 
mM HEPES (pH 7.4) in a Teflon coated pan. Following a 10-15 minute polymerization time, the 
scaffolds were carefully stretched to ~150% of their original length and hung to dry under the 
tension of their own weight.14 
 
5.2.4 Composite Layer Fabrication 
Composite layer fabrication was completed as was previously reported.7 Briefly, a custom built 
fibrin microthread spacer with ridges was used to align fibrin microthreads. The device couples to 
a house vacuum enabling placement of threads with defined spacing. Layers were organized with 
 Chapter 5 
Strategic Lamination  109 
 
either 5 (5tC), 10 (10tC) or 20 (20tC) fibrin microthreads across a 1 cm length. Once organized, 
threads were transferred to vellum frames and secured with medical grade silicone adhesive. 
Polydimethylsiloxane (PDMS) sheets were coated with 1% Pluronic-F127 in DI water (Sigma, St. 
Louis, MO) solution for 1 hour. A hydrogel solution containing 1.6 U/mL thrombin, and 3.1 
mg/mL fibrinogen was mixed in media on ice, cast over the vellum frames and spread using a 
pipette tip to provide an even layer. Media was used as the source of calcium in the polymerization 
reaction. This was done to closely mimic what is done in tissue culture. The media is composed of 
DMEM (+L-glutamine, VWR, Radnor, PA), 10% defined donor equine serum (Fisher Scientific, 
Waltham, MA), 2% chick embryo extract (US Biological Life Sciences, Salem, MA),1% penicillin 
streptomycin (Thermo Fisher Scientific, Waltham, MA), 1% amphotericin B (Thermo Fisher 
Scientific) and 1% 5 mg/mL aprotinin, (Sigma Aldrich, St. Louis, MO).  For the sample size of 
12 x 12 mm (144 mm2 area), 150 uL of hydrogel solution was utilized. Samples polymerized at 
room temperature for 30 minutes, then were moved into wells with 1X PBS, and stored at -4C 
until use.  
 
5.2.5 Lamination Method  
 When fabricating cardiac patches, two composite layers were glued together using a fibrin-
based glue. The glue is comprised of HBS, 17.5 mg/mL fibrinogen, 5 U/mL thrombin, and media. 
The media is the same composition as described in 4.2.4. Composite Layer Fabrication. 150 µL 
of glue was placed on the top of one of the composite layers. The second layer was then pressed 
down onto the first layer at the desired angular offset. When pressing, excess glue was secreted 
from the sides and removed. This method ensured even coverage of glue across the layer. 
 As a control, patches were also generated that did not utilize glue. These patches were 
fabricated by casting 1 gel over 2 layers of organized fibrin microthreads. The same gel volume 
that would have been utilized for 2 separate layers was cast to create 1 larger hydrogel. To evaluate 
the impact of the glue on the thickness of the patch, thicknesses for glued layers and control patches 
were compared. Additionally, to evaluate whether the glue had an impact on the measured 
mechanical properties, glued layers and control patches were uniaxially tensile tested and the 
stiffness values were compared. For this comparison, we evaluated the maximum slope of the force 
versus displacement curve.  
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5.2.6 Uniaxial Tensile Test 
Submerged uniaxial tensile testing was completed on individual composite layers (5tC, 
10tC and 20tC), glued composite layer patches and control patches (without glue). Each patch 
consisted of a 10tC and 20tC layer orthogonally aligned to one another. For patches, mechanical 
characterization was completed by applying load in the direction of the threads for 2 different 
samples; i.e. when testing a patch with layers perpendicular to one another, applied loads were 
parallel to threads of the 10tC in one sample, and parallel to threads of the 20tC in a second sample. 
This was done to evaluate the anisotropic nature of the patch.  
Prior to testing, the thickness of each sample was determined using a laser displacement 
technique.18 A disk with dimensions of diameter 13 mm, thickness of 1.3mm and weight of 1.3 g 
was used to create a reflective surface for accurate measurements. The disk did not deform the 
layers; no indentations upon removal were evident. Thicknesses in three different areas were 
measured and averaged together to obtain a representative measurement. These were used in 
combination with the width of the sample to calculate the cross-sectional area, assuming a 
rectangular geometry. Samples were gripped into an ElectroPuls E1000 testing system (Instron, 
Norwood, MA) with a 1 N load cell. The initial gauge length of all samples was 15 mm. Samples 
were submerged in a PBS bath before being uniaxially loaded to failure at a strain rate of 10 
mm/min. Throughout the test, force and displacement values were recorded at a frequency of 10 
Hz. Prior to evaluating the parameters of interest, all initial load and deformation values were 
zeroed, baselining the onset value for each test. Engineering stress was determined by dividing the 
recorded force by the initial cross-sectional area. Strain was calculated as the extension in length 
from the initial length of the material. To analyze the modulus, a MATLAB (MathWorks, Natick, 
MA) script was written. Fiber-reinforced composite materials generally have two observable 
phases on stress strain curves.19 Because the heart experiences strain values cyclically up to 
~30%,20 our analysis took the slope of the first phase of the curves (0-30%). To analyze membrane 
stiffness, a curve was generated that plotted the recorded force divided by the initial width, against 
the extension. The slope of the first phase of this curve was used to calculate the membrane 
stiffness. Outliers were identified as any modulus value that was 1.5 times greater than the inner 
 Chapter 5 
Strategic Lamination  111 
 
quartile range (IQR) for each sample set (min: quartile 1 - 1.5*IQR, max: quartile 3 + 1.5*IQR) 
and were subsequently removed from further analysis.14  
 
5.2.7 Statistical Analyses 
All statistical analyses were run using SigmaPlot 12.5 software, with all comparisons using a 
significance level of p<0.05. For patch mechanical properties, loads applied in each of the two 
directions were compared through a t-test (applied load parallel to 10tC layer direction compared 
to applied load in the 20tC layer direction). Comparisons of mechanical properties for individual 
layers were compared through a one-way ANOVA with Holm-Sidak post-hoc pairwise multiple 
comparison tests for all post-hoc analyses. 
 
5.3 RESULTS 
5.3.1 Material Property Criteria Can Be Defined for a Cardiac Patch Acting as a Wall 
Replacement 
The modulus, an inherent material property not dependent on geometry, ranges for the 
myocardium from 20- 500 kPa depending on whether the heart is in systole or diastole.10 
Ventricular myocardium is an anisotropic tissue. Measured values from biaxial mechanical testing 
showed that in the direction along the base/apex axis, cadaveric heart tissue is ~376.3 ± 191.7 kPa 
while in the direction along the septum/free-wall axis the tissue is 581.4 kPa, yielding an 
anisotropic ratio of 0.314 ± 0.196. (??????????? ????? =  ???? ?????? ?
???? ??????? ).21 Membrane stiffness 
is another important consideration. The range of required membrane stiffness for a patch acting as 
a wall replacement was calculated to be 300-7500 N/m, as explained in 5.2.1.  
Ideally, the patch should react to load in a similar manner to adjacent healthy myocardium. A 
patient population with high blood pressure experienced wall stress of 16.1 kPa on average.22 For 
our design criteria, this value was multiplied by the thickness of ventricular myocardium to yield 
a required ultimate stress per width of 242 N/m. Furthermore, when experiencing a stress of 16.1 
kPa, the strain would need to be comparable to the strain that the heart experiences cyclically. The 
average peak shortening in the left ventricle at the midwall has been reported to be ~23%± 4,23 and 
30% ± 6.24 All design criteria are summarized in Table 5.2.  
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Table 5.2. Summary of design criteria for a cardiac patch functioning as a wall replacement.  
Parameter Value 
Modulus 20 – 500 kPa *10 
Anisotropic Ratio of Modulus Values 0.31421 
Membrane Stiffness 300 – 7500 N/m 
Ultimate Tensile Stress 242 N/m 
Strain at 16.1 kPa of Stress ~23- 30%23-24 
*For a wall replacement, a value closer to the upper limit of the modulus would be beneficial.10 
 
5.3.2 Composite Theory Can Be Utilized to Yield a Model That Informs a Strategic Lamination 
of Composite Layers to Produce a Biomimetic Patch 
For individual layers, Chapter 4: Alignment of Cardiomyocytes Through Static Tension 
Increases Contractile Strains in Composite Layers demonstrated that the 5tC, 10tC and 20tC layers 
were predicted to have modulus values of 24 kPa, 47 kPa and 94 kPa, respectively. Actual 
measured modulus values of these composite layers were 20 ± 8 kPa, 46 ± 23 kPa and 98 ± 49 
kPa.7 Additionally, for compacted layers modulus values were predicted to be 51 kPa and 142 kPa 
for aligned 5tC and aligned 20tC layers. Measured values were similar for the 5tC layers (40 ± 26 
kPa), but were reduced for the 20tC layers (97 ± 29 kPa). The compacted 20tC layer had very 
similar mechanical properties to the acellular 20tC layer with average modulus values of 97 and 
98 kPa, respectively. For a wall replacement, modulus values closer to the upper value of the range 
(500 kPa) would be beneficial.10  
One potential method to increase the modulus values of composite layers is to increase the 
volume fraction of fibrin microthreads. Using equations 5.4 and 5.5, 70-thread (70tC), 80-thread 
(80tC) and 90-thread (90tC) composite layers were analyzed with modulus values for offsets 
ranging from 0-120o summarized in Table 5.3.  
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Table 5.3. Summary of theoretical moduli values for 70tC, 80tC and 90tC layers with an offset. Offsets are 
taken from the x-axis. Ey and Ex show the modulus values with loads applied in the direction of the y and x axes, 
respectively 
 
Thread Count Offset (degrees) Ey (kPa) Ex (kPa) 
70 
0 0.3 327.7 
30 0.3 0.6 
60 0.6 0.3 
90 327.7 0.3 
120 0.6 0.3 
80 
0 0.3 374.5 
30 0.3 0.6 
60 0.6 0.3 
90 374.5 0.3 
120 0.6 0.3 
90 
0 0.3 421.3 
30 0.3 0.6 
60 0.6 0.3 
90 421.3 0.3 
120 0.6 0.3 
 
For layers constructed with 70, 80 or 90 fibrin microthreads, the resultant theoretical modulus 
values are much closer to the upper range of the modulus for ventricular myocardium of 500 kPa. 
The average diameter for a fibrin microthread is ~ 110 µm.16 For this average diameter, the spacing 
required for a 70tC layer is 57.5 µm; a distance approximately half of the diameter of one thread. 
For 80tC and 90tC layers this value decreases to 24 µm and 2 µm, respectively. Such precise 
spacing will likely require a 3D printing method for exact placements of microthreads. 
Additionally, an important consideration is that there is likely a trade-off in cell volume and loss 
of contractile function if stiffness were to be increased in this manner. Because of the potential for 
a reduction in function with these increased volume fractions, focus for patch development 
remained on the 10tC and 20tC layers.  Application of laminate composite theory for offsets 
ranging from 0- 120 degrees in 30-degree increments yielded the results summarized in Table 5.4.   
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Table 5.4. Summary of theoretical moduli values for acellular and compacted composite layers with an offset. 
Offsets are taken from the x-axis. Ey and Ex show the modulus values with loads applied in the direction of the y and 
x axes, respectively. 
 
Thread 
Count 
Offset 
(degrees) 
Acellular 
Ey (kPa) 
Acellular 
Ex (kPa) 
Compacted 
Ey (kPa) 
Compacted 
Ex (kPa) 
5 
0 0.3 23.6 0.3 50.6 
30 0.2 0.5 0.3 0.5 
60 0.5 0.2 0.5 0.3 
90 23.6 0.3 50.6 0.3 
120 0.5 0.2 0.5 0.3 
10 
0 0.3 47.0 0.3 70.8 
30 0.2 0.5 0.3 0.5 
60 0.5 0.2 0.5 0.3 
90 47.0 0.3 70.8 0.3 
120 0.5 0.2 0.5 0.3 
20 
0 0.3 93.8 0.3 141.3 
30 0.3 0.5 0.3 0.5 
60 0.5 0.3 0.5 0.3 
90 93.8 0.3 141.3 0.3 
120 0.5 0.3 0.5 0.3 
 
The computational model demonstrated that it is likely that a 90 degree offset of layers 
with different microthread volume fractions will be necessary to mimic the anisotropic moduli 
observed of myocardium. When layers are offset, there is negligible contribution to the x and y 
moduli unless the x and y axes align with the fibrin microthread axes. Otherwise, moduli were 
predicted to be below 1 kPa in these directions. Reinforcement of a 20-thread composite layer with 
a 10-thread composite layer at a 90-degree offset may yield a patch with an anisotropic ratio similar 
to myocardium.  
 
5.3.3 Fibrin Glue Can Be Used to Laminate Composite Layers Together Without Significantly 
Impacting Measured Stiffness or Thickness Values.  
 Fibrin glue was used to laminate layers yielding a composite patch. As a control, two layers of 
organized fibrin microthreads were cast in 1 hydrogel eliminating the glue component entirely. 
This control was used to evaluate how the glue impacted patch thickness and patch stiffness 
(Figure 5.2).  
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Figure 5.2. Assessment of fibrin glue impact on cardiac patch properties. The thicknesses of glued patches and 
control patches (no glue) were not significantly different when compared with a t-test, p<0.05 (n=7 for each group) 
(A). The stiffness values for the patches when loads were applied in the 10tC direction did not significantly vary from 
a single 10tC layer when compared with a one-way ANOVA, p>0.05 (B). The same was true of stiffness values for 
patches when loads were applied in the 20tC direction; these values did not significantly vary from a single 20tC layer 
(B). For stiffness evaluations, n= 3 for both glued and control patches, n=12 for single layer assessments. For patches, 
loads were applied in the direction of the first listed composite layer (i.e., 10tC x 20tC implies load was applied in the 
direction of the 10tC layer).  
 
The use of fibrin glue did not significantly increase patch thickness, as evaluated through a t-test, 
p<0.05. The average thickness for patches laminated together with glue were 569.8 ± 62.6 µm. 
Patches generated without glue were on average 665.1 ± 134.5 µm thick.  
 For comparison of stiffness values, patches were also compared to individual composite layers 
with the load applied in the direction of the threads. Similar to the thickness assessment, no 
significant difference was observed between glued samples and controls without glue. 
Additionally, no differences were observed between the patches and individual layers. The 
stiffness values for the 10tC single layer, glued patch with load in the 10tC direction, and control 
patch without glue and load applied in the 10tC direction were 14.1 ± 3.1 N/m, 15.2 ± 2.0 N/m 
and 13.8 ± 2.7 N/m, respectively. The 20tC single layer, glued patch with load applied in the 20tC 
direction, and control patch without glue and load applied in the 20tC direction were 26.0 ± 7.2 
N/m, 33.9 ± 17.9 N/m and 18.3 ± 2.5 N/m, respectively.   
 
5.3.4 When Laminating Composite Layers, Material Properties Similar to Ventricular 
Myocardium are Achieved 
 For material property evaluations, all patches included in the assessment were laminated 
with fibrin glue. When evaluating individual layers through submerged tensile testing, it was 
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observed that all modulus values were within the range for myocardium (20-500 kPa), but were 
on the low end of the range (20 ± 8, 46 ± 23, and 98 ± 49 kPa for 5tC, 10tC and 20tC layers, 
respectively). Similarly, a cardiac patch comprised of a 10tC and 20tC layers had modulus values 
of 45 ± 9 and 96 ± 42 kPa for loads aligned with the 10tC layer and 20tC layer, respectively (Table 
5.5).  
 The anisotropic ratio, calculated as ??????????? ????? =  ???? ?????? ?
???? ??????? ,  of the 10tC x 
20tC patch was found to be 0.36, very near the target value of ventricular myocardium. Anisotropic 
ratios were not calculated for individual layers as the layers were not tested in the direction 
perpendicular to the alignment of the fibrin microthreads. This was not completed because, without 
threads aligned with the direction of applied force, the only phase contributing to the measured 
mechanical properties would be the gel phase. It was anticipated that these measured modulus 
values would be much lower (<1 kPa) than the modulus values measured when load was applied 
in the direction of the threads, yielding an anisotropic ratio much greater than the desired 0.314.  
 The membrane stiffness values for all individual layers and for the 10tC x 20tC patch were 
below the target stiffness range of 300 – 7500 N/m. This is expected as the modulus values were 
within range, but the geometry of the patches do not match the geometry of the assumed defect 
region. Similarly, the ultimate tensile stress (UTS) values were all lower than the target value of 
241.5 N/m. When comparing to the ventricular myocardium strain of 16.1 kPa experienced by a 
patient population with high ventricular pressure, 10 of 16 samples failed prior to reaching 16.1 
kPa for the 5tC group. For the 10tC layers, 2 of 12 samples failed before reaching this stress level. 
The 20tC layers and the 10tC x 20tC did not have any samples fail prior to reaching 16.1 kPa.Strain 
at 16.1 kPa of stress for all groups except the 5tC layers were near the target value range of 23-
30%. The 5tC layer group had strain that was much higher than this target range (70% ± 36).  
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Table 5.5. Result comparisons for individual composite layers and glued cardiac patches. Values shown are averages ± standard deviations. Significant 
differences are noted. All single layers were compared with a one-way ANOVA and holm-sidak post-hoc analysis, p<0.05. All patch parameters were compared 
using a two-tailed t-test, p<0.05. All values that are near the target values are bolded.  
 
Parameter Target Value 5tC  
(n=16) 
10tC  
(n=12) 
20tC  
(n=12) 
10tC x 20tC  
(n=9 for each, 18 total) # 
Modulus (kPa) 20 – 500 10 
20 ± 8 
(10tC: p=0.048) 
(20tC: p<0.001) 
46 ± 23 
(5tC: p=0.048) 
(20tC: p<0.001) 
98 ± 49 
(5tC: p<0.001) 
(10tC: p<0.001) 
45 ± 9 x 96 ± 42 
p=0.007 
Anisotropic Ratio of 
Modulus Values 0.314
21 NA NA NA 0.36 
Membrane Stiffness (N/m) 300-7500  
6 ± 2 
(10tC: p=0.022  
20tC: p<0.001) 
13 ± 7 
(5tC: p=0.022  
20tC: p=0.002) 
26 ± 13 
(5tC: p<0.001 
10tC:p=0.002) 
25 ± 5 x 54 ±24 
p=0.007 
UTS (N/m) 241.522 
3 ± 2 * 
(10tC: p=0.001) 
(20tC: p<0.001) 
13 ± 8 ** 
(5tC: p=0.001) 
 
17 ± 8 
(5tC: p<0.001) 
 
19 ± 5 x 42 ± 10  
p<0.001 
Strain at 16.1 kPa of Stress ~23- 30%23-24 
70% ± 36 
(10tC and 20tC 
p<0.001) 
26% ± 14 
(5tC: p<0.001) 
14% ± 7 
(5tC: p<0.001) 
28% ± 16 x 14% ± 5 
p=0.036 
 
*10/16 samples failed before reaching minimum value of 16.1 kPa.  
** 2/12 samples failed before reaching minimum value of 16.1 kPa. 
# Values are presented as load in the direction of 10 threads x load in the direction of 20 threads. 
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5.4  DISCUSSION 
The goal of this study was to evaluate whether strategic lamination of fibrin-based 
composite layers could mimic the mechanical properties of ventricular myocardium. We defined 
important mechanical properties of modulus, anisotropic ratio of modulus, membrane stiffness, 
UTS and strain at a specific ventricular wall stress characteristic of patients with high blood 
pressure. The use of a high ventricular stress to calculate the required force per width (UTS) and 
ensuring strain at this value did not exceed normal deformations anticipated of myocardial tissue 
was a method for ensuring that, for the target patient population, the patch would not fail in vivo.  
Through laminar composite theory, a model was used to determine that, theoretically, a 
patch with a 20tC layer arranged orthogonally to a 10tC layer would yield an anisotropic patch 
that would mimic the modulus values of ventricular myocardium. In theory, measured modulus 
values with loads applied in the 10tC layer and 20tC layer directions were 47 kPa and 94 kPa, 
respectively. When measuring the actual values through tensile testing, the modulus values were 
very similar to what the model predicted for the 10tC and 20tC layers (45 ± 9 kPa and 96 ± 42 
kPa, respectively). Because the patch will ultimately use cultured, compacted composite layers, a 
secondary model was generated that incorporated properties for compacted layers. In previous 
work, we found that this model accurately predicted a modulus increase for 5tC layers. However, 
we found that this model also anticipated a modulus increase for 20tC layers. When mechanically 
tested, the compacted 20tC layers had remarkably similar mechanical properties to acellular 20tC 
layers. The compaction model was based on volumes measured for the layer and assumed a 
rectangular geometry for the cross-sectional area of the layers. It is possible that the volumes were 
not estimated accurately enough to better predict the layer modulus for 20tC layers. Because the 
20tC layers behaved similarly when cultured or acellular, it is possible that the better predictive 
model for compacted layers with more than 5 threads is the acellular model.  
One critical factor that influences a composite material’s properties is integration between 
components. To achieve an isostrain state where deformation of all phases of the composite 
material are equivalent requires a strong interfacial bond.25 While we anticipate a strong interfacial 
bond as the microthread and hydrogel components of the composite layer are comprised of the 
same polymer, the strength of the bond has not been assessed. In future work, we plan to perform 
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pull-out tests to better understand the strength of the bond, and how the strength may be increased 
through techniques like crosslinking.26   
When looking at potential angular offsets for the layers, 0-120o offsets were considered as 
ventricular myocardium rotates ± 60o from the endocardium to the epicardium. However, when 
fibers in a layer are at an angle from the applied load, very low modulus values were anticipated 
(<1 kPa). The hydrogel phase would be the primary phase contributing to the modulus values at 
these particular angular offsets. The hydrogel component has a low modulus (assumed to be 
~0.25kPa).13 To ensure that the anisotropic behavior of the patches mimicked ventricular 
myocardium, it was critical to have microthreads aligned with the x and y axes (in line with applied 
loads). It is critical to remember that myocardium is not solely loaded in the x and y directions but 
rather in all directions. As such, future work for the development of this patch will need to include 
mechanical testing with a more physiologically relevant loading such as a burst test.27  
To generate a patch, layers were laminated using a fibrin glue. A control patch with layers 
cast within one gel was also evaluated. While there are benefits to casting one hydrogel and having 
a more uniform cardiac patch material, it is necessary that the layers be glued together to form a 
patch for this system. Each layer is approximately 300 µm thick when initially cast. In the patch 
thickness assessment, patches were 569.8 ± 62.6 µm thick when laminated with fibrin glue. 
Patches without glue were similar in thickness; 665.1 ± 134.5 µm. The oxygen diffusion limit is 
100 -200µm.8, 28-29 As such, it is important that the lamination technique not significantly increase 
the thickness of the patch as diffusion will be problematic, likely resulting in the necrosis of the 
central portion of the patch. Fortunately, the composite layers compact when in culture. Observed 
thicknesses at day 14 of culture for individual layers were 131 ± 48 µm and 193 ± 42 µm for 
5tCand 20tC layers, respectively. While the compacted layers laminated will have a reduced 
thickness, in the future it will still be necessary to incorporate a vasculature system into this patch 
to maintain cell viability.  
Additionally, it was important to evaluate whether the fibrin glue would alter the material 
properties of the scaffold. No significant difference was observed between control patches and 
glued patches demonstrating that the glue did not change anticipated behaviors of the cardiac 
patch. The reported stiffness values had a tighter distribution for loads applied in the 10tC layer 
direction relative to loads applied in the 20tC layer direction. Fibrin microthread diameter can vary 
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with average diameter reported as 110 ± 18 µm.30 A variation of 18 µm in diameter will impact 
the volume fraction of the microthreads, ultimately impacting the mechanical properties of the 
composite material. Because the 20tC layers have more fibrin microthreads relative to the 10tC 
layers, there is the potential for more variation of fibrin microthread diameter.  
The cardiac patches (laminated with glue) and individual composite layers (5tC, 10tC and 
20tC) were further evaluated to see how the material properties compared to ventricular 
myocardium. All modulus values were found to be on the lower end of the range of ventricular 
myocardium. The anisotropic ratio of the modulus values was also evaluated. A value close to zero 
would indicate little or no anisotropy. A value close to 1 would indicate a high degree of 
anisotropy.21 The anisotropic ratio of the patch was very near the anisotropic ratio of the native 
tissue (0.314).21 Evaluating the strain at a stress level of 1601 kPa demonstrated that 5tC composite 
layers are not sufficient. The strain observed was on average 70% ± 36. This deformation is much 
greater than the deformation that would be anticipated of the myocardium. In contrast, the 10tC 
layer, 20tC layer and the patch were near the anticipated strain values of myocardium.  
The patch matched all required values except for UTS and stiffness. This is not surprising; 
the modulus values were within the desired range. If the modulus values match, the stiffness will 
only match if the same geometry is used. The patches tested were ~600 µm thick, but the defect 
area had an assumed thickness of 1.5 cm. This implies that we would need 3 patches laminated to 
have approximately the same thickness, and ultimately the same stiffness. Using equation 1 and 
the measured modulus values for the patch, we can estimate the stiffness with an increase in 
volume of the patch to match the size of the myocardium defect: 
? = ? ? ? = 45 ??? ? 1.5 ?? = 675 ?
?
 
? = ? ? ? = 96 ??? ? 1.5 ?? = 1440 ?
?
 
Theoretically, with a patch that has a volume matching the defect size, the stiffness values 
of the patch are within the range desired to mimic ventricular myocardium (300-7500 N/m). 
Similarly, we can estimate what the UTS would be for a patch with a specific thickness. Looking 
at the engineering stress versus strain curves, and taking the greatest engineering stress value for 
each composite type (5tC, 10tC and 20tC), we can multiply that value by the specified thickness 
to see what the UTS (in terms of force over width) would be.  
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???? ???? ??????? ?? ??? 10?? ?????????: 33 ??? ? 1.5 ?? = 495 ?
?
 
???? ???? ??????? ?? ??? 20?? ?????????: 74 ??? ? 1.5 ?? = 1110 ?
?
 
The design criteria was for the patch to have a UTS of at least 241 N/m. When scaling up 
to the same thickness as ventricular myocardium, in theory all composite compositions satisfy this 
requirement. This suggests that it may be possible to generate thinner patches that satisfy this 
mechanical requirement. For example, for a patch to have a UTS of 241 N/m with load applied in 
the direction of the 20tC layers, a thickness of 0.3 cm would be needed.  
The design parameters were based on a literature search for this work but, in the future, 
could be based on patient data. Because each patient is unique, defect sizes may vary as may 
ventricular wall stresses and associated cyclic strains. This study provides a framework for 
modeling a patch that can function as a wall replacement with a specific defect geometry and 
patient requirements. If access to these parameters were available on a patient-by-patient basis, a 
patch could be designed for each case using this modeling method.  
While the patch is promising with the data presented here, it is important to note that an 
important parameter that was not investigated is fatigue strength. Upon implantation the scaffold 
will be subjected to cyclic loading. It is critical that the integrity of the patch not vary pre- and 
post- loading. In the future, we plan to cyclically load the patches in a manner that will mimic 
physiologic loading. Patches will be subjected to cyclic loading at 1 Hz at a peak strain of 10% for 
1 week.31 Additionally, degradation of the patch will need to be characterized to determine if 
replacement of the matrix with extracellular matrix occurs at the same rate. This important metric 
will also be evaluated in future work. Finally, we also plan to perform suture pullout tests to ensure 
that the patch can be implanted with a suturing technique. Ultimately, we plan to couple our patch 
with a fibrin-based vasculature to enable the generation of a thick, implantable construct that can 
serve as a functional wall replacement for damaged ventricular myocardium.   
 
5.5  CONCLUSIONS 
 In this study, we have shown that strategic lamination of composite layers can yield a cardiac 
patch with material properties comparable to ventricular myocardium. While the stiffness and UTS 
of the patch was not in the desired range, the modulus values were within range. Both parameters 
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will likely be in range when the thickness of the patch is equivalent to that of ventricular 
myocardium (1.5 cm). A necessary component for the thick patch is a vasculature to ensure cell 
viability throughout the construct thickness. Future work will focus on integrating a vasculature 
and performing long-term mechanical evaluations to ensure that the patch can withstand cyclic 
loading without a significant change to the failure strength.  
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6.1 OVERVIEW 
The work in this thesis describes the development of a biomimetic composite scaffold 
that recapitulates the architectural and material properties of ventricular myocardium to enable 
functional and mechanical integration with adjacent host tissue upon implantation. Modulation of 
the volume fractions of the composite phases enabled control over the mechanical properties of 
the material without attenuating cell function. Further, we developed a culturing method for 
increasing alignment of incorporated cells. Increased alignment correlated with increased cell 
function. Finally, we demonstrated that the composite layers can be strategically laminated to 
further mimic the structural and mechanical properties of ventricular myocardium.  
 
6.2 RESULTS AND CONCLUSIONS 
6.2.1 Specific Aim 1: Develop a Fibrin Composite Layer that Enables Customizable Modulus 
Values While Sustaining Cardiomyocyte Contractility 
Based on composite theory,1 we hypothesized that fibrin microthreads could be combined 
with fibrin-based hydrogels forming a composite layer scaffold with tunable mechanical 
properties that supports cell contractility. Further, based on earlier work we hypothesized that the 
incorporated fibrin microthreads would promote cellular orientation.2 We developed a 
methodology for generating evenly-spaced fibrin-based composite layers. To do so, a custom-
built fibrin microthread spacer was developed that yields average thread spacing of 140 ± 21.7 
µm. When comparing the spacing between 4 individual users, a one-way ANOVA demonstrated 
that no significant difference in spacing existed. This analysis showed that the method we 
developed is reproducible.  
We then evaluated 3 different volume fractions of fibrin microthreads in a fibrin hydrogel 
through submerged uniaxial tensile testing. We observed that the modulus for the layer was 
tunable through modulation of the volume fraction of fibrin microthreads. Further, the trend 
observed was predicted by using composite theory to estimate what modulus values were 
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expected for the different layer conformations. It is critical that a scaffold have comparable 
mechanical properties to avoid mechanical mismatch upon implantation,3 and to promote proper 
contractile force, phenotype, and gene expression.4-7 Moduli for all configurations (thread counts 
of 5, 10 and 20 per layer) were within the desired range for human ventricular myocardium of 20 
– 500 kPa.5  
To ensure that increasing the volume fraction of fibrin microthreads did not hinder cell 
function, samples were evaluated using high density mapping (HDM) at days 7, 10 and 14 in 
culture. We observed that at no time point did the contractile strain or frequency differ for any 
composite layer relative to a fibrin hydrogel control. Using Hooke’s Law to predict the 
contractile forces, we found that the contractile forces increased with an increasing layer 
modulus maintaining similar contractile strain values for all groups. This demonstrates that with 
an increasing modulus, we can improve the mechanical properties without compromising 
contractile function. The contractile frequencies for all groups were ~2.5 Hz; comparable to 
reported frequencies for neonatal cardiomyocytes in a 3D environment.8 Additionally, when 
evaluating the phenotype of incorporated cells, sarcomeric α-actinin showed striated appearances 
of cells in all composite layer and control groups. This phenotype is considered a hallmark of 
functional cardiomyocytes,6 further supporting that increasing volume fractions of fibrin 
microthreads without attenuating cell function. 
We anticipated that incorporating fibrin microthreads in a gel would provide an 
instructive cue that would promote cellular alignment, similar to results shown previously.2 
Alignment has been correlated with enhanced functional maturation and it is needed for 
integration upon implantation.9-12 When evaluating the nuclear orientation of cells within the 
layer, we first evaluated all regions. We found that no alignment of cells was observed. 
Following this assessment, we evaluated nuclear orientation of cells within 100 µm of the fibrin 
microthreads. We found a slight improvement with alignment; the greatest percentage of cells 
were oriented between 0-15o of the direction of the fibrin microthreads. In ventricular 
myocardium, alignment of the cells closely follows alignment of the fibrils of the tissue. Within 
each layer, fibrils rotate relative to one another ±13o.13 The majority of nuclei within a 100 µm 
distance of fibrin microthreads had similar alignment. The fibrin microthreads may be providing 
an instructive cue for a limited distance in the fibrin hydrogel. This is similar to cells sensing 
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rigid bodies not in direct contact. It has been reported that cells in a fibrous biopolymer, like 
fibrin, can sense rigid bodies at distances as great as 150 µm.14  
In conclusion of Specific Aim 1: Develop a Fibrin Composite Layer that Enables 
Customizable Modulus Values While Sustaining Cardiomyocyte Contractility of this thesis, we 
determined that fibrin microthreads can be incorporated in a fibrin hydrogel generating a 
composite layer. Through manipulation of volume fractions of the components of the composite, 
tuning of the mechanical properties is possible. An increase in volume fraction of fibrin 
microthreads correlates to an increase in layer modulus. Changes in fibrin microthread volume 
fraction did not impact the functionality of incorporated cells; all contractile strain and 
contractile frequency values were not significantly different for 5, 10 or 20 thread composite 
layers relative to a hydrogel control. When evaluating nuclear orientation, there was no 
alignment observed when evaluating all cells. When limiting the evaluation to 100 µm distances 
from the incorporated microthreads, an increase in alignment was observed, suggesting that the 
impact of microthreads on alignment is limited in distance. The composite material overcomes 
limitations of hydrogel materials with weak mechanical properties, but does not promote the 
necessary alignment for functional integration upon implantation.  
 
6.2.2 Specific Aim 2: Develop an Aligned Composite Layer to Enhance Contractile Function 
In this section of this thesis, we incorporated the findings from Specific Aim 1: Develop a 
Fibrin Composite Layer that Enables Customizable Modulus Values While Sustaining 
Cardiomyocyte Contractility, and aimed to increase the observed alignment of incorporated cells 
in the composite layers. To do so, we developed a new culturing method that directed tension 
patterns created by cell-mediated gel compaction. We restricted the scaffold as compaction 
occurred over a 14 day culture period, similar to other reported methods.9, 15 The method utilized 
a PDMS post system coupled with customized vellum frames. When analyzing the orientation of 
incorporated cells, it was found that samples cultured using this method had nuclear alignment 
more similar to human heart controls than unaligned controls prepared using the method 
developed in Aim 1.   
Functional evaluations were completed on large regions of interest (ROIs) and grid ROIs 
which divided the recorded region into 20 smaller sub-regions. The large ROI evaluation showed 
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that composite layers with improved alignment had greater contractile strains and larger 
contractile areas relative to gelatin-coated coverslip and unaligned controls. This is anticipated as 
alignment of cardiomyocytes may contribute to enhanced functional maturation.9-12 For all 
groups, an increase in functional parameters was observed over the culture period, likely because 
compaction was occurring throughout. Compaction has been shown to equilibrate 8-13 days in 
culture for fibrin hydrogels.16 For healthy myocardium, contractile strains have been reported to 
be ~19%.17  For the samples with increased alignment, the highest functioning regions had 
similar contractile strains with average values of ~18% and 22% after 10 and 14 days in culture, 
respectively.  
A grid assessment was used to evaluate consistency of contractile behavior across the 
entire recorded region. Three assessments were completed that evaluated the consistency of 
contractile strains, the consistency of principal angles of the greatest contractile strains in each 
region, and the distance of the greatest contractile strain from the incorporated fibrin 
microthreads. The contractile strain and principal angle assessments demonstrated that all groups 
had similar consistency levels. Interestingly the distance assessment showed that aligned samples 
had the highest contractile strains typically occurring in areas immediately adjacent to the fibrin 
microthreads while in unaligned layers, the highest contractile strains were ~200 µm from the 
nearest microthread. It is possible that compaction of the aligned composite layers results in a 
greater percentage of the gel phase being in close proximity to the incorporated fibrin 
microthreads. Additionally, it is possible that the unaligned composite layers have regional 
variations in the mechanical environment that are not present for the aligned composite layers.  
Contractile wave propagation through the composite layers was also evaluated for 
samples on day 14. It was observed that aligned 5-thread composite layers demonstrated 
anisotropic propagation; comparable to that observed in  highly aligned tissue.18 The aligned, 5-
thread layer had contractile wave propagation speeds of 11.1 ± 1.5 mm/sec and 4.5 ± 2.0 mm/sec 
in directions parallel to and perpendicular to the fibrin microthreads, respectively. These speeds 
are an order of magnitude slower than signal propagation speeds of healthy myocardium (73 ± 4 
cm/s and 11 ± 3 cm/s for the longitudinal and transverse directions, respectively).19 Phenotypic 
evaluations of incorporated cells demonstrated that relative to human heart controls, the 
experimental (aligned) and unaligned control groups had immature expression of connexin 43. 
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The distribution was circumferential, which is comparable to neonatal rat ventricular myocytes 
within the first 20 days of postnatal life.20 This is in contrast to mature, highly functional 
myocardium which exhibits polarized distribution.21 It is likely that the immature gap junction 
formation is a contributing factor to the reduced signal propagation occurring in the composite 
layers.  
For functional evaluations (large ROI assessment of contractile strains) and nuclear 
alignment measurements, it was observed that in the experimental group that there were regional 
differences. This may be because compaction did not occur uniformly across the composite 
layer. When evaluating compaction and its impact on mechanical properties, no significant 
difference was observed between the acellular and compacted 20-thread composite layers. 
However, a significant modulus increase was observed for 5-thread compacted layers relative to 
acellular 5-thread composite layers. It is possible that because the 5-thread layers began with a 
larger hydrogel volume fraction the effect was more pronounced.  
In conclusion of Specific Aim 2: Develop an Aligned Composite Layer to Enhance 
Contractile Function, we demonstrated that tension resulting from cell-mediated compaction can 
be used to increase alignment of incorporated cells. The samples with increased alignment also 
demonstrated increased contractile strain and contractile areas. Additionally, contractile wave 
propagation in the layer was anisotropic, characteristic of highly aligned native tissue. Relative 
to healthy myocardium, contractile wave propagation speeds were reduced, while contractile 
strains were near native values. This may be because of immature gap junction formations 
throughout the layer. Compaction did not appear to be uniform throughout the composite. When 
evaluating the impact of compaction on the modulus of the layer, a significant increase was 
observed for 5-thread layers, which was anticipated with the predictive model. No significant 
increase was observed for the 20-thread layers. The 20-thread layers had similar values to the 
acellular samples and acellular predictive model.  It is possible that the volume fractions of the 
components may not be accurately calculated for the compacted layer predictive model.  
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6.2.3 Specific Aim 3: Produce a Biomimetic Patch with Material Properties Comparable to 
Native Myocardium 
In the final section of this thesis, we incorporated the findings from Specific Aims 1: 
Develop a Fibrin Composite Layer that Enables Customizable Modulus Values While Sustaining 
Cardiomyocyte Contractility and 2: Develop an Aligned Composite Layer to Enhance 
Contractile Function to determine if strategic lamination of composite layers would yield a patch 
with comparable material properties to ventricular myocardium.  First, material requirements for 
a cardiac patch acting as a wall replacement were defined; including a range of modulus values 
(20-500 kPa)5, anisotropic modulus ratio (~0.3)22, membrane stiffness (300-7500 N/m)5, 23-24, 
ultimate tensile strength (UTS) (242 N/m)25, and strain at 16.1 kPa (23-30%).26-27 These metrics 
provided criteria for evaluating whether a patch configuration would warrant further 
investigation as a wall replacement.  
We modeled the theoretical modulus values for a composite layer when the load was 
applied at an angular offset from the direction of the incorporated microthreads. We utilized a 
model developed from the generalized Hooke’s law with assumed planar stress conditions.28 We 
considered angular offsets ranging from 0- 120o in 30o increments as ventricular myocardium 
layers rotate relative to one another from +60o to -60o through the ventricular wall. Using this 
assessment, we found that lamination of a 20-thread composite layer at a 90o offset from a 10-
thread composite layer would yield a patch with an anisotropic modulus ratio, and modulus 
values comparable to ventricular myocardium.  
Because the layers are initially ~300µm thick, it is necessary to culture the layers 
enabling compaction and reduction in thickness prior to laminating them with a fibrin glue. 
Otherwise, necrosis of the central region of the patch may be observed as oxygen diffusion 
through a confluent cell layer is ~ 100 -200µm.23, 29-30 To evaluate how the fibrin glue may 
impact the thickness of the patch and the resulting stiffness values, glued layers were compared 
to a patch generated by casting 1 gel over 2 layers of organized microthreads (no glue control). 
Uniaxial tensile testing was performed in two directions; with loads applied in the direction of 
the 10-thread layer, and with loads applied in the direction of the 20-thread layer. Because it is a 
destructive test, two separate samples were needed for these evaluations. Importantly, we found 
that the fibrin glue did not increase the thickness of the patch and further, that the glue did not 
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significantly change the stiffness. The stiffness values were comparable to the stiffness values of 
individual layers of 10-thread and 20-thread composite layers as well, demonstrating that the 
patch configuration did not alter this mechanical property significantly.  
For a patch laminated with fibrin glue, the material properties were similar to ventricular 
myocardium. For all data listed, the data are shown as loads applied in the 10-thread direction x 
loads applied in the 20-thread directions, respectively. The modulus values (45 ± 9 x 96 ± 42 
kPa) were comparable to the range of ventricular myocardium values. The anisotropic ratio of 
modulus values was similar to the desired ratio value (0.36 and 0.314, respectively). The strains 
at 16.1 kPa of stress were near the desired values as well (28% ± 16 x 14% ± 5). The only 
parameters not within range of native tissue were the stiffness and UTS. This is not surprising 
because the thickness of myocardium was not the same as the thickness of the cardiac patch. 
When calculating the stiffness values for a cardiac patch with thickness matching that of the 
assumed defect (1.5 cm), the stiffness values were 675 N/m and 1440 N/m for loads in the 10-
thread layer direction and 20-thread layer direction, respectively. For the UTS when considering 
a patch of 1.5 cm thickness, the values were calculated to be 495 and 1110 N/m for a patch with 
loads applied in the 10tC and 20tC directions, respectively. These values are within the desired 
range for stiffness (300-7500 N/m) and above the desired value for UTS (241 N/m). 
In conclusion of Specific Aim 3: Produce a Biomimetic Patch with Material Properties 
Comparable to Native Myocardium, we established material requirements for a cardiac patch 
functioning as a wall replacement. Additionally, we evaluated theoretical angular offsets that 
would enable the development of a patch to mimic the material properties of ventricular 
myocardium. A lamination method was established utilizing fibrin glue that does not increase 
patch thickness, or alter the stiffness of the resultant patch. Further, we evaluated a patch 
composed of a 10-thread layer laminated at a 90o offset to a 20-thread layer. This patch was 
within range for all desired material parameters, except for stiffness and UTS. This is likely 
because the thickness of the patch does not match the thickness of the assumed defect size. 
Calculations show that with an increase in thickness of the patch to match the defect size, the 
stiffness and UTS values should meet the design criteria outlined for a cardiac patch. This work 
demonstrated that patches could be strategically designed to meet specified criteria. We 
hypothesize that similar work could be done to produce patient-specific patches.  
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6.3 FUTURE WORK 
The ultimate goal of this dissertation was to develop a biomimetic cardiac patch that will 
ultimately serve as a functional wall replacement following a myocardial infarction.  In 
accomplishing this goal, we created a composite patch with tunable mechanical properties, layers 
that promote aligned contractions, and a cardiac patch with structural and functional properties 
comparable to native ventricular myocardium. To further develop the patch technology, work 
can be done to extend application of the patch for in vitro drug testing. Additionally, 
modification of the patch configuration can be completed to enable more uniform compaction 
and ultimately cell function. Further, to ensure that the patch can maintain cell viability, 
incorporation of a vasculature in the composite patch is needed. Ultimately, we envision this 
composite material as a platform technology that could be investigated for use in a wide range of 
tissue engineering applications.  
 
6.3.1 Use of Composite Patches for In-Vitro Drug Testing 
While we ultimately envision the cardiac patch as providing a functional therapeutic for 
heart attack patients, there is the potential to apply the composite patch in a different application 
while still benefiting many patients. The cost of bringing a new drug to market is approximately 
$1 billion.31 Unfortunately, with current development techniques and conventional testing 
methods, complications that may result from drug use are not always identified. Approximately 
1/3 of these complications are cardiovascular effects. Without adequate in-vitro testing methods, 
the cost of drug development can be inflated to $11 billion in order to detect adverse effects.32 
Recently, in the Pins lab in collaboration with the Gaudette lab, a universal microscope 
incubator for drug screening of 3D models of engineered myocardium was created.33 In this 
work, a cost-effective device houses a 6-well plate and enables perfusion to individual wells 
while maintaining carbon dioxide, humidity and temperature levels. The system couples with a 
microscope allowing visualization of samples while maintaining the desired culturing 
environment. Through a biomimetic screening platform, assays could potentially have 
significantly improved predictive power in informing which compounds should progress to 
clinical trials.34 As such, a highly biomimetic scaffold is needed.   
 Chapter 6 
Conclusions and Future Work 132 
 
With this thesis work, we found that while contractile strains for aligned composite layers 
were comparable to healthy myocardium, action potential propagation speeds were greatly 
reduced likely due to the immature phenotype of the incorporated cardiomyocytes. This thesis 
utilized rat neonatal ventricular myocytes; a cell type not likely to transfer to the clinic. Isolation 
of primary human cardiomyocytes is difficult, and isolated cells have a short lifespan in culture 
before dedifferentiating.35 Another option is to utilize induced pluripotent stem cell derived 
cardiomyocytes (iPS-CMs).  
In 2006, Yamanaka et al demonstrated the ability to generate embryonic like stem cells 
from dermal fibroblasts via transfection with 4 factors; Oct3/4, Sox2, c-Myc, and Klf4. These 
induced pluripotent stem cells (iPSCs) were able to differentiate into the three different germ 
lineages as demonstrated by tumor formation in a mouse model,36 and exhibited morphology and 
growth properties similar to ESCs. While micro-array research has demonstrated that hundreds 
of genes and DNA methylation patterns are expressed differently for ESCs and iPSCs,37-38 it is 
not conclusive that cardiomyocytes derived from either cell type differ in any meaningful way.35 
Similar to ESC derived CMs, iPSC derived CMs (iPS-CMs) can provide a large cell source and 
have been shown to enhance the ejection fraction in an in vivo model.39 Unlike ESCs, iPS-CMs 
have the potential to be autologous without associated ethical concerns.35 With the potential to 
isolate cells from patients, patient specific disease models such as spinal muscular atrophy,40 
amyotrophic lateral sclerosis (ALS)41 and Huntington’s disease42 are possible. This cell type has 
a great deal of potential for disease modeling, drug screening, and potentially therapeutics in the 
future.35  
Currently, iPS-CMs have slower conduction velocities and shorter action potential 
durations relative to human myocardium. This is likely due to the lack of cell maturity.35 Efforts 
are on-going for increasing the maturity levels of iPS-CMs through methods like long-term 
culture, electrical stimulation and mechanical loading.21 There is the potential for the composite 
patch developed in this thesis to become a better biomimetic scaffold through incorporation of 
iPS-CMs and the maturation of incorporated cells through stimulations mimicking those 
anticipated in vivo. A more biomimetic patch will not only be applicable for drug testing, but will 
also likely have better integration upon implantation if utilized as a patch. It is likely that an in 
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vitro testing system is a more realistic near-term goal, while the cardiac patch application is 
something that will require a lengthier development time.   
 
6.3.2 Modification of Composite Layers for More Uniform Compaction and Cell Function 
In this thesis, continuous aligned fibrin microthreads were used as a reinforcing agent for 
fibrin hydrogels. For composite materials, the lengths of the fibers are critical for determining the 
amount of reinforcement achieved. As a material, fibers are able to withstand a maximum fiber 
load. For the fibers to be able to withstand the same load when in a composite material, a critical 
length of fiber must be utilized. At the critical length, the fiber will be able to withstand the 
maximum fiber load at the center of the fiber. For any fiber lengths lower than the critical length, 
virtually no stress transfer occurs from the matrix to the fibers resulting in little reinforcement. 
For lengths greater than the critical length, the reinforcement becomes more effective; the 
maximum fiber load can be achieved over a greater length. When using a fiber that is much 
greater (~15 times greater) than the critical length, the fiber is considered continuous and 
provides a significant improvement in the strength of the overall material.1 
The critical length needed is dependent on the fiber diameter, tensile strength of the fiber 
and the fiber-matrix bond strength. To design a scaffold material for cartilage regeneration, 
Yodmuong et al developed silk microfiber reinforced silk hydrogel composites.43 The goal of 
this work was to improve the mechanical properties of a silk hydrogel scaffold.44 Large, medium 
and small fibers with lengths of >500 µm, 400-500 µm, and 150-200 µm, respectively were 
added to the scaffolds. The investigators hypothesized that the composite mechanical properties 
would depend on fiber length, which is essential for developing a composite that will ensure 
sufficient energy transfer occurs from the matrix to the dispersed phase under mechanical 
loading.45  Mechanical analyses of the scaffolds showed that microfiber incorporation and length 
affected both the dynamic and equilibrium moduli of composites. Composites with fiber lengths 
of 200 µm appeared to fall below the critical length, and failed to provide adequate stress transfer 
along the fibers. The critical length in this study was determined to be 500 µm. This length 
provided sufficient fiber overlap and resulted in increased stiffness. The highest Young’s 
modulus was observed for silk scaffolds reinforced with 500 µm fibers (34 +/- 3.1 kPa). This test 
group also exhibited the highest dynamic modulus at 1 Hz (357.2 +/- 45.7 kPa).  
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 Given that silk is a naturally occurring biopolymer, it is likely that the critical lengths of 
fibrin microthreads (also a naturally occurring biopolymer) in a fibrin hydrogel are shorter than 
the lengths currently used in the scaffolds. In this thesis, the fiber lengths extended through the 
entire length of the construct (12 mm). However, it is possible that smaller fragments could still 
function as continuous fibers and provide significant mechanical reinforcement. With smaller 
segments, it is possible that the compaction throughout the material may be more uniform than 
what was observed in this work. If the fibrin microthreads were behaving as a barrier in the 
current format, then shorter, aligned microthreads may be able to overcome that issue.  
Aligning shorter fragments of fibrin microthreads will present a challenge. While the 
work in this thesis, fibers were aligned prior to integration with a hydrogel, one potential solution 
may be to cast fibers in a hydrogel and align the fibers as the hydrogel is polymerizing. A simple 
technique for aligning collagen fibrils during hydrogel polymerization requiring no specialized 
equipment was presented by Guo and Kaufman.46 The method involves casting the hydrogel 
solution with magnetic beads. A magnet is placed adjacent to the polymerizing sample. This 
work demonstrated that alignment of the collagen fibrils was achieved, and was attributed to the 
magnetic field and the flow created by the beads. While this work was aligning fibrils of a 
biopolymer, a similar method may assist with aligning small microfibers in a hydrogel matrix. 
Furthermore, the method may align the fibrils of fibrin resulting in increased alignment of the 
composite material.  
 
6.3.3 Incorporation of Vasculature in Composite Patch 
Vascularization of tissues is required for oxygen and nutrient diffusion, as well as 
removal of waste products. Additionally, incorporated endothelial cells provide paracrine 
signaling, which promotes cardiomyocyte function and viability.47 Furthermore, if this cardiac 
patch were to be used for drug testing, a vasculature would provide a route for delivery of 
drugs.47 The diffusion limit for oxygen is 100 -200 µm.23, 29-30 With this thesis work, all samples 
were maintained in vitro with an initial layer thicknesses of ~300 µm. Upon implantation in vivo, 
the patch will not have media on both sides of the construct but will rather need to rely on 
transport through a vascular system. Cells incorporated in a cardiac patch will need to be within 
100-200µm of a vasculature. This need is especially strong for cardiac tissue due to the high 
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metabolic demands of the heart.48 When considering the thickness of a laminated patch, this 
thesis showed that two acellular layers laminated together were ~600 µm thick. Individual 10-
thread and 20-thread composite layers compacted to thicknesses of ~200 µm when cultured for 
14 days. As was determined in Aim 3, Produce a Biomimetic Patch with Material Properties 
Comparable to Native Myocardium, in order to achieve a patch with stiffness values in the range 
of ventricular myocardium, a patch thickness of ~1.5 cm is required. With each layer having a 
thickness at the upper limit for oxygen diffusion, a patch will require a vascular layer laminated 
between each composite layer.  
 Current work in the Pins lab is focused on the development of a fibrin hydrogel vascular 
network. To generate the vascular layer, channels are formed in a fibrin hydrogel using a 
sacrificial gelatin mold. In a pilot study, an unaligned 5-thread composite layer was cultured for 
14 days with rat neonatal ventricular myocytes incorporated. Following culture, the layer was 
placed on top of a fibrin-based vascular layer. The only source of fluid was the fluid flowing 
through the vasculature. A 2 µM calcein AM dye in dPBS solution was flowed through 25 gauge 
needles at the inlet and outlet of the vascular layer for 75 minutes. Calcein AM is non-
fluorescent until converted to a green-fluorescent calcein after hydrolysis by intracellular 
esterases in live cells. Following the incubation period, the combined composite layer and 
vascular layer were detached from the pump set-up and placed on a slide to image. Images were 
acquired at 400X (Figure 6.1) on an upright fluorescent microscope.  
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Figure 6.1. Vascular layer fabrication and combination with composite layer. The vascular layer is a fibrin 
hydrogel with embedded channels and defined inlet and outlet ports. The inlet and outlets can connect to a syringe 
pump (A), and fluid (in image, water with red food coloring) can be flowed through the construct (B). When a 
composite layer is placed on top of the vascular layer and calcein AM solution is flowed through, cells near the 
channels (white arrows, white dotted lines) fluoresce green (C, D). C shows a straight channel and D shows a 
rounded curve. These areas of interest are boxed in B. Yellow arrows in C and D show fibrin microthreads.  
 
In Figure 6.1, cells near the channels of the vascular layer fluoresced green while cells 
further from the channels did not fluoresce. These images demonstrate that diffusion of fluid 
from the vasculature to the composite layer is possible. Additionally, it is visible how it is critical 
that the vascular layer be designed to have channels with spacing that ensures diffusion of 
nutrients uniformly across adjacent composite layers. Work on the vascular layer continues for 
establishing diffusion distances, optimizing the channel spacing, endothelializing the vascular 
channels and ultimately, lamination with a composite patch to maintain cell viability throughout 
the construct.  
 
6.3.4   Fibrin Composite Layers as a Platform Technology 
To promote functional tissue regeneration in a clinical application, an engineered scaffold 
must recapitulate the structural and mechanical properties of the native tissue. This provides cells 
with appropriate signaling cues to direct a sustained regenerative environment.49 Native tissue 
constructs are complex; they are comprised of protein-based fibrillar elements arranged into 
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hierarchically ordered constructs. The structural arrangements are tissue-dependent, and enable 
the tissue functionality.50 Conventional biofabrication strategies for the production of engineered 
scaffold materials lack the multiscale combination of properties to create tissue constructs 
comparable to native tissue.  
Biopolymer microthreads have been explored for tissue engineering applications ranging 
from skeletal muscle2, 51-52 and cardiac tissue,53-55 to tendon and ligament.56-59 Microthreads are 
appealing as a scaffold because they can be engineered to biomimetic, hierarchical structures 
with tissue-specific morphologies. Additionally, microthreads can provide mechanical and 
biochemical cues to promote regeneration. Furthermore, through manipulations such as 
crosslinking, degradation rates and mechanical properties can be finely tuned to mimic material 
properties of native tissues.60 Although these scaffolds are promising, a composite material may 
be able to better recapitulate the material and biochemical environment enabling greater tissue 
regeneration.  
 With the development of the composite material in this thesis work, there is an exciting 
opportunity to utilize the material as a platform technology. By combining different materials 
into one, a range of better, or different, properties can be achieved. One potential application 
may be the incorporation of therapeutic proteins to promote endogenous regeneration of 
tissues.60 With a composite material, there is the opportunity to incorporate proteins in multiple 
places potentially yielding different release profiles that could ultimately better mimic the 
various stages of tissue regeneration. Considering most tissues in the body are composites, we 
hypothesize that the fibrin-based composite material developed will be applicable across a wide 
variety of engineered tissues. 
 
6.4 FINAL CONCLUSIONS 
In this thesis, we developed a composite material for use as cardiac patch. We evaluated 
how volume fraction manipulation of the fibrin microthreads impacted the modulus of the 
composite material. An increasing volume fraction correlated with an increasing modulus; the 
same trend as was predicted using composite theory. With the increasing volume fractions, we 
evaluated the impact on incorporated cardiomyocyte function. Through high density mapping 
(HDM) analysis, we found that all composite layers had contractile strains and contractile 
 Chapter 6 
Conclusions and Future Work 138 
 
frequencies comparable to fibrin hydrogel controls. This demonstrated that the increase in 
volume fraction of microthreads did not attenuate cell function. Additionally, cells in regions 
within 100 µm of a fibrin microthread showed increased nuclear alignment. This showed that the 
fibrin microthreads influenced regional cell orientation.  
Without cellular alignment across the entire layer, functional integration with host tissue 
will not be efficient. We developed a culturing method that capitalized on the tension produced 
through the composite material by cell-mediated gel compaction. By constraining two ends of 
the scaffold, we utilized the tension to increase alignment of incorporated cells. Nuclear 
alignment of constrained samples showed distributions qualitatively similar to human heart 
tissue and greater than unaligned controls. When evaluating cell function through HDM, 
composites with improved alignment also had increased contractile strains and contractile areas 
relative to unaligned composite layers and gelatin-coated coverslip controls.  
Contractile wave propagation through the layers was evaluated and showed that aligned 
regions had anisotropic signal propagation although the speeds shown were still well below those 
observed in healthy heart tissue. This was likely due to immature gap junction formation. This 
hypothesis was further supported by the immature connexin 43 expression observed in all 
composite layers. To improve function, a shift from rat neonatal ventricular myocytes to induced 
pluripotent stem cell derived cardiomyocytes may be beneficial. Additionally, to improve 
maturity, mechanical and electrical stimulation mimicking in vivo stimulations should be 
explored.  
Finally, we showed that strategic lamination of composite layers could be achieved to 
produce a patch with material properties comparable to ventricular myocardium.  Using a model 
based on generalized Hooke’s law and assuming a plane stress state, we evaluated the impact 
angular offsets of microthreads from the direction of applied load would have on the material 
modulus. We found that microthreads need to be in the direction of applied load to ensure 
material properties comparable to ventricular myocardium. We laminated layers together at a 90o 
offset using fibrin glue and found that the configuration met all of the required material 
properties except stiffness. This is likely because the geometry of the patch did not match the 
geometry of the assumed defect size. In order to match the needed stiffness values, a patch with a 
thickness of 1.5 cm will be needed. For a cell-populated patch to remain viable with this 
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thickness, a vasculature system is needed. Future efforts will need to focus on continuing the 
development of vascular system for the composite cardiac patch.  
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Appendix 1: Summary of Functional Behavior 
 
 
 
Table A.1. Summary table of functional behavior. Values shown are averages +/- standard error.  
 
* Denotes significant difference from GCS at respective time point.  
Ϯ Denotes significant difference from 5tC at Day 10 
‡ Denotes significant difference from FGC at day 7. 
ƍ Denotes significant difference from 10tC at day 7.  
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Appendix 2: Comparison of Media Formulations on 
2D and 3D Cultures with Rat Neonatal Ventricular 
Myocytes 
 
 
A.2.1  INTRODUCTION 
Media components can cause changes in cell behavior. In a study completed by Franke et al, 
media supplemented with fetal bovine serum (FBS) or horse serum (HS) was used to culture 
primary equine bronchial fibroblasts. Data from this study demonstrated that media supplemented 
with FBS promoted enhanced proliferation and had faster doubling times relative to HS.1 With rat 
neonatal ventricular myocytes (rNVMs), a similar trend has been reported; horse serum can limit 
fibroblast proliferation.2 This is desirable as fibroblasts can overtake a primary isolation culture,3 
hindering contractile function of incorporated myocytes. This is especially problematic in 2D 
cultures as a 3D environment can help to limit fibroblast proliferation, possibly due to contact 
inhibition.3 
 Additionally, chick embryo extract (CEE) is a supplement that has been used in rNVM 
cultures.4 It has been demonstrated that following the development of a contractile rNVM 
engineered tissue scaffold, when HS and CEE were withdrawn from the media, contractile activity 
rapidly ceased.5 An additional study showed that the force development of cells incorporated in a 
3D scaffold was greatly reduced or entirely absent when CEE or HS was not included in the media, 
respectively.6  
For Aim 1 of this thesis work, the media formulation had a combination of FBS and HS, and 
no CEE supplementation. In this study, we were interested in comparing this media formulation 
to a published media formulation containing CEE and HS.7 We compared 2-dimensional (2D) and 
3-dimensional (3D) samples seeded with rNVMs and cultured with either media. We evaluated 
the contractile strains, contractile frequencies, and contractile areas. Additionally, we performed 
LIVE/DEAD staining to evaluate the relative number and viability of incorporated cells 
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throughout the culture period. The goal of this study was to determine what media formulation 
should be used with future experimentation.  
 
A.2.2 MATERIALS and METHODS  
For more detailed methods on scaffold preparation, please refer to Chapter 4: Alignment of 
Cardiomyocytes in a Fibrin Microthread-Based Composite Layer Enhances Contractile 
Function.   
A.2.2.1  Microthread Extrusion 
Fibrin microthreads were generated by co-extruding two solutions; a 70 mg/mL solution 
of fibrinogen (from bovine plasma, Sigma, St. Louis, MO) in HEPES (N-[2-Hydroxyethyl] 
piperazine-N’-[2-ethanesulfonic acid]) buffered saline (HBS, 20 mM HEPES, 0.9% NaCl; pH 7.4) 
and a 6 U/mL solution of thrombin isolated from bovine plasma (Sigma) in HBS and CaCl2 
solutions.8-11 The solutions were extruded through polyethylene tubing (BD, Sparks, MD) and 
threads were hand-drawn into a 10 mM HEPES buffer bath (pH 7.4) in a Teflon coated pan at a 
flow rate of 0.225 mL/min. Following a polymerization time of 10-15-minutes, the scaffolds were 
stretched to ~150% of their original length and hung to dry.11 
 
A.2.2.2  Fibrin Microthread Organization 
Dried fibrin microthreads were organized as previously reported,12 using a purpose-built 
fibrin microthread spacer. For this work, evaluations were completed utilizing composite layers 
with 5 fibrin microthreads (5tC) evenly spaced across a 12 mm width. Once organized, threads 
were secured using medical grade silicone adhesive (Vendor, City, State) to precut vellum frames.  
 
A.2.2.3  Rat Neonatal Ventricular Myocyte (rNVM) Isolation 
All work involving animals was submitted to and approved by the Institutional Animal 
Care and Use Committee at Worcester Polytechnic Institute. rNVMs were isolated following a 
previously described protocol.13 Ventricles of excised hearts of 2 and 3 day old neonatal Sprague 
Dawley rats (Charles River, Wilmington, MA) were separated from atria, and minced. Serial 
digestion using type II collagenase (Thermo Fisher Scientific, Waltham, MA) was completed. 
Cells were pre-plated for 45 minutes, then immediately used for experimentation.7  
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A.2.2.4  Fabrication of Composite Layers  
 Organized fibrin microthreads on vellum frames were rehydrated in phosphate buffered saline 
(PBS) for 1 hour, then placed on either polydimethylsiloxane (PDMS) sheets (for unaligned 
composite layers – UAC) or custom PDMS casting devices (for aligned layers- AC) coated with 
1% Pluronic-F127 (Sigma, St. Louis, MO) in DI water. 150 µL of hydrogel solution consisting of 
4 x106 cells/mL, 4% (v/v) 40 U/mL thrombin, and 28% (v/v) 11 mg/mL fibrinogen was mixed on 
ice, cast over the vellum frames and spread using a pipette tip to provide an even layer. The paper 
outlining the media formulation containing CEE and HS also included a methodology for creating 
aligned fibrin-based hydrogels.7 The hydrogel formulation was similar to the hydrogel formulation 
described here, but included Matrigel. To evaluate if Matrigel in combination with HS and CEE 
supplemented media provided the best combination for promoting cardiomyocyte contractile 
function, an additional sample group (UACMAT M2) was included with a hydrogel formulation 
of 4 x106 cells/mL, 2% (v/v) 40 U/mL thrombin, 20% (v/v) 11mg/mL fibrinogen, 10% (v/v) 
Matrigel and 20% (v/v) 2X DMEM. The 2X DMEM solution was made by rehydrating powdered 
DMEM (Gibco, cat. no. 31600034) with half of the recommended volume of distilled water 
yielding a DMEM solution that was twice the concentration of regular DMEM. Following a 30-
minute incubation time, samples were transferred to wells. UAC layers were free-floating, while 
aligned samples were transferred to culturing devices and secured to the PDMS posts of the device 
with silicone o-rings (McMaster-Carr, Princeton, NJ).  
 
A.2.2.5  Seeding of Gelatin-Coated Glass Coverslip Controls (GCS)  
Gelatin coated coverslips (GCS) were used to assess 2D cultures. Glass coverslips (VWR) 
were coated with sterile 0.7% gelatin (Sigma Aldrich) in DI water for 4 hours, then secured to the 
bottom of wells in a 12 well plate using vacuum grease. 100 µL of cell suspension (2 x 106 
cells/mL) was seeded on each coverslip and incubated at 37oC for 18 hours. Samples were then 
rinsed and covered with medium for extended culture.  
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A.2.2.6  Media Preparation and Extended Culture 
Two media formulations (M1 and M2) were evaluated for this assessment and are summarized 
in Table A.2.1. For all samples, culture was maintained for 14 days with medium changes every 
other day.  
 
Table A.2.1. Media formulations evaluated for experiment. Media formulation 1 (M1) is what had been utilized 
in Aim 1. Media formulation 2 (M2) is based on a published formulation.7 
 
Media Component Media Formulation 1 Media Formulation 2 
Iscove’s Modified DMEM ~82.5% ---- 
DMEM +L-glutamine ---- 85% 
FBS 10% ---- 
HS 2% 10% 
pen strep 1% 1% 
Amphotericin B  1% 1% 
Aprotinin (5mg/mL) 1% 1% 
Chick Embryo Extract ---- 2% 
Gentamicin 0.5% ---- 
Glutamax 1% ---- 
B-mercaptoethanol 0.007% ---- 
1.2mM CaCl2 and 0.8 mM 
MgCl2 in DiH20 
1% ---- 
 
To thoroughly compare the conditions, the following schema was utilized (Table A.2.2):  
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Table A.2.2. Outline of sample nomenclatures and study design to compare media formulations in 2D and 
3D cultures.  
 Base 
Nomenclature 
Media 1,  
Name/ n# 
Media 2,  
Name/ n# 
Gelatin-Coated 
Coverslips (2D) GCS GCS M1/ n=3 GCS M2/ n=3 
Aligned Composites 
(3D) AC AC M1/ n=3 AC M2/ n=3 
Unaligned Composites 
(3D) UAC UAC M1/ n=5* UAC M2/ n=3 
Unaligned Composites 
+Matrigel (3D) UACMAT ----- UACMAT M2/ n=5* 
*: Extra samples were prepared for LIVE/DEAD analysis at days 7 and 14.  
 
A.2.2.7 Cardiomyocyte Functional Analysis Through High Density Mapping (HDM) 
Spontaneous contractions were recorded at days 7, 10 and 14 for ~1300 frames at 100X 
magnification and 60 frames per second with a high speed camera (HiSpec 4, Fastec Imaging Corp, 
San Diego, CA) attached to an inverted microscope (DMIL, Leica Microsystems, Buffalo Grove, 
IL). There were visible differences regionally for AC samples. Because of this, two regions per 
sample were recorded per time point: one at a region of larger global movements (as identified by 
thread movement) and one at a region of low global movements (as identified by little if any thread 
movement). High density mapping (HDM), was used to evaluate regional mechanical function.14 
Regions of interest (ROI) selected for each sample (size: 1200 x 986 pixels) were divided into 16 
x 16 pixel subwindows. An 8 pixel shift and 5 averaging windows were used to track pixel 
displacements of sequential frames.15-16 The resulting displacement fields were then used to 
determine the maximum principal contractile strain, the average principal contractile strain, 
frequency of contractions and total contractile area.  
 
A.2.2.8 LIVE/DEAD Staining 
 LIVE/DEAD staining was completed after 7 and 14 days in culture on UAC M1 and UACMAT 
M2 samples (1/ time point). It is important to note that samples from each group could not be 
stained due to the limited number of cells (and therefore, limited number of samples) from the 
isolation. These groups were chosen for staining as there were extra samples in each. Following 
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the manufacturer’s protocol (Molecular Probes, Waltham, MA), a 2 µM calcein AM and 4 µM 
ethidium homodimer-1 (Ethd-1) solution was prepared in Dulbecco’s phosphate-buffered saline 
(D-PBS). Samples were rinsed with D-PBS, then incubated with the prepared staining solution for 
30-45 minutes at 37oC. Following incubation, samples were imaged at 100X using a fluorescent 
Zeiss inverted microscope (Zeiss, Thornwood, NY). Because of the difference in cell densities at 
day 7 and 14, samples could not be imaged at the same exposure times and were adjusted for each 
sample group (Figure A.2.1). Because of this, qualitative comparisons between images were made 
but were not quantified as different exposure times can change potential outcomes.  
 
 
Figure A.2.1. Exposure times for fluorescently labeled samples. When imaging UACMAT M2 and UAC M1 
samples, each sample group required different exposure times to clearly visualize the LIVE/DEAD stain. Exposure 
times shown for the left and right images are the times used for all samples within those groups, respectively. The 
center sample is an example of why the same exposure times could not be used as the settings for UACMAT M2 
resulted in over-exposure of cells in the UAC M1 samples. 
 
A.2.2.9  Statistical Analyses 
Statistical analyses were run using SigmaPlot 13 software. For all comparisons, a 
significance level of p<0.05 was utilized. For contractile strains, areas and frequencies, 
comparisons were made at each time point using a One-way ANOVA with Holm-Sidak post hoc 
analysis. For all data presented, data are reported as means ± standard deviation. 
 
A.2.3 RESULTS 
A.2.3.1 M2 Media Promotes Increased Functional Behavior in a 14-Day Culture   
 Appendix 2 
Impacts of Media Supplements on Cell Function  149 
 
 There were striking differences in the functional parameters evaluated for samples cultured in 
M1 relative to M2. When evaluating the maximum contractile strains, samples cultured in M2 had 
an increasing trend in strains over time (Figure A.2.2) while samples cultured in M1 had a 
decreasing trend in strains over time. At day 10, AC M2 Max samples had significantly higher 
maximum contractile strains than all other samples cultured in M1 media (12.6% ± 5.2, 0% ± 0, 
2.7% ± 0.7, 3.3% ± 0.1%, 2.9% ± 0.4 for AC M2 Max, GCS M1, UAC M1, AC M1 Max and AC 
M1 Min, respectively).  By day 14, a similar pattern to day 10 was observed where all samples 
cultured in M2 media trended higher than all samples cultured in M1 media. Average principal 
contractile strains followed very similar trends to maximum principal strains. At day 10, both AC 
M2 Max and AC M2 Min groups were significantly greater than all samples cultured in M1 media 
(1.8% ± 0.1, 1.9% ± 0.1, 0% ± 0, 1.1% ± 0.1, 1.2% ± 0.1, 1.1% ± 0 for AC M2 Max, AC M2 Min, 
GCS M1, UAC M1, AC M1 Max and AC M1 Min, respectively).  At day 14, all M2 samples had 
higher average contractile strain values than all M1 samples.  
 At day 7, UAC samples cultured in M1 had comparable contractile areas to all M2 samples 
(79.0% ± 7.6, 82.4% ± 3.5, 86.1% ± 7.3, 79%, 73%, 79.4% ± 11.2 for UAC M1, GCS M2, UAC 
M2, AC M2 Max, AC M2 Min and UACMAT M2, respectively). By day 14 of culture, all M2 
samples apart from GCS M2 had significantly higher contractile areas than all M1 samples. At this 
point, measurable contractions were no longer observed for any M1 sample except for UAC M1. 
While all M1 samples appeared to decrease in strain and area values, the M2 samples appeared to 
increase in these parameters over the culture period.  
 There were no significant differences in contractile frequencies among samples that had 
measurable contractions. When groups began having contractions that we could no longer evaluate 
using the imaging and HDM parameters outlined in this study, we began seeing significant 
differences. Again, with the exception of the GCS M2 samples, all samples cultured in M2 had 
measurable contractions over the 14 day culture period. Only the UAC M1 samples continued to 
have measurable contractions by day 14 out of all samples cultured in M1 media.  
 The UACMAT M2 group had a slightly different hydrogel formulation relative to the UAC 
M2 group. Matrigel was incorporated in the UACMAT M2 samples but not the UAC M2 samples. 
Both sample groups were cultured in M2 media. At no time point for any functional parameter did 
these two groups have significant differences.  
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Figure A.2.2.  Summary of functional data for 2D and 3D samples in M1 and M2 cultures. M1 samples showed decreasing patterns for functional parameters 
over a 14 day culture (blue bars) while samples cultured in M2 media (Orange and gray bars) had increasing trends in functional parameters. All significant 
differences were determined through a One-Way ANOVA with holm-sidak post hoc analysis, p<0.05. All data are shown as averages ± standard deviations. *: 
Significant difference from GCS M1. **: Significant difference from GCS M1 and GCS M2. $:Significant difference from all M1 samples. Bar: Significant 
difference between two groups. 
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A.2.3.2 M1 Media May Promote Proliferation of Fibroblasts 
 Qualitative comparisons were made for LIVE/DEAD staining of UACMAT M2 and UAC M1 
samples. The comparisons demonstrated that although samples were initially seeded with the same 
number of cells, there was evidence of an increased number of cells in the UAC M1 samples at 
days 7 and 14 (Figure A.2.3). At both time points, the UACMAT M2 samples have less green 
(Calcien-AM positive) and less red (Ethd-1 positive) stained cells, suggesting there are less cells 
in those constructs at both time points. In the images, there appear to be at least two cell types; an 
elongated cell and a smaller, more compact cell. The smaller, more compact cells appear to 
increase in number for both sample groups from day 7 to day 14 and are potentially fibroblasts. 
Taken together, the observations listed here suggest that the M2 formulation may limit fibroblast 
proliferation relative to M1 medium. 
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Figure A.2.3 LIVE/DEAD staining of composite samples. Samples cultured in M1 and M2 were compared using LIVE/DEAD 
staining. The green channel shows live cells (calcein -AM positive) while the red channel shows dead cells (Ethd-1 positive). In the 
UACMAT M2 samples, less cells appear to be present (larger black spaces visible) at day 7 (A) and day 14 (B), even though samples 
were seeded with the same number of cells. Direct quantitative comparisons were not made as exposure times had to be adjusted on a 
group basis to ensure clear visibility of the stains.
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A.2.4 DISCUSSION 
The cellular composition of tissue engineered cardiac scaffolds is heavily influential on the 
resultant functional behavior. While cardiomyocytes are functional cells that generate contractile 
force and propagate an electrical signal, other cells play critical roles. Fibroblasts, stromal and 
endothelial cells influence matrix deposition, paracrine signaling and vascularization.17 While 
action potential speeds increase with an increasing purity of cardiomyocytes, contractile forces 
have been reported to be optimized with cardiomyocytes comprising 60-80% of the total cell 
population.18 While it is generally agreed that non-myocytes like fibroblasts are beneficial to 
cardiomyocyte maturation and function, when present in too great amounts function can be 
compromised.17 Therefore, it is critical that the media utilized not promote fibroblast proliferation 
as this cell type can overtake cardiomyocytes in culture. This study demonstrated that CEE and 
HS had large impacts on the resultant cell function. It is likely that this was due to limited fibroblast 
proliferation. This hypothesis is further supported by the LIVE/DEAD staining showing a 
potentially increasing cell population over time for samples not cultured with CEE or 10% HS. As 
such, subsequent work for this thesis utilized M2 media formulation for all cell culture.  
UACMAT M2 and UAC M2 samples enabled comparison of hydrogel formulations that 
contained or did not contain Matrigel, respectively. In this study, these sample groups never 
significantly differed from one another for any functional evaluations at any time point. As such, 
Matrigel addition does not appear to impact resulting cell function. The lack of increase in cell 
function with Matrigel was justification for excluding Matrigel from all hydrogel formulations in 
subsequent thesis work. 
A.2.4.1 Study Limitations 
The goal of this study was to evaluate the impact of two media formulations on rat neonatal 
ventricular myocytes cultured in 2D and 3D formats. More specifically, the goal of this work was 
to determine which media formulation should be utilized for work following Aim 1 of this thesis. 
The comparisons of interest required 9 sample groups with the study design described. A limiting 
factor influencing the study design was the number of cells obtained from the cell isolation. A 
more thorough study would separate the media components of interest (CEE and HS) to determine 
how each impacted the resulting function of incorporated cells, as well as the combination of 
supplements. Additionally, another limitation of this study was that the base media components 
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were slightly different between the two formulations. A more robust study would remove those 
variables to ensure all impacts to function were caused by the CEE or HS supplements. The data 
presented does show clear differences in cell function, but does not fully elucidate the causality of 
those changes. For our goal, this study was sufficient for determining which media promoted 
greater cell function, and which media was used for subsequent work of this thesis. 
Because of the limited number of cells and therefore samples, LIVE/DEAD staining could 
not be completed for all sample groups, and was not completed at all time points. Only UAC M1 
and UACMAT M2 groups were compared. The UACMAT M2 group not only was cultured in M2 
media, but also had Matrigel incorporated in the hydrogel formulation. The qualitative differences 
observed therefore, are only suggestive but not indicative of how the media formulations impact 
the incorporated cells. With more resources available, it would have been preferable to evaluate 
UAC M2 samples that did not include Matrigel. This would have more clearly shown the 
differences resulting from the media formulations. Matrigel addition did not impact cell function 
relative to UAC M2 samples. As such, it is possible that the Matrigel addition did not change the 
phenotype of incorporated cells or proliferation rates. This is speculative, and would need to be 
confirmed. 
We had no measurable contractions for GCS M1 samples throughout the culture period 
which seems contradictory to the results of Aim 1 where GCS samples in the same media had 
measurable contractions at all time points. The reason for this difference is the change in recording 
and HDM analysis parameters. Because of the high function observed with samples cultured in 
M2, the HDM parameters used in Aim 1 were not sufficient for evaluating cell function. In Aim 
1, we recorded samples at a magnification of 400X. With global movements occurring in M2 
samples, quantitative evaluations became difficult at this magnification. For this assessment, a 
magnification of 100X enabled quantification of all 3D samples regardless of global movements. 
While contractions were likely occurring for GCS M1 samples, they were not above the noise 
threshold when imaged at 100X. In all subsequent thesis work, recordings were taken at 100X.  
We only had measurable contractions at D7 for GCS M2 samples. We did however, have 
measurable contractions at all time points for these same samples in subsequent work summarized 
in Aim 2. In this particular study, we had limited number of samples and the data pulled for the 
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GCS M2 samples was unfortunately very noisy. While contractions were observed, we had 
difficulty quantifying the functional behavior.  
 
A.2.5 CONCLUSIONS 
 In this work, we demonstrated that samples cultured in M2 media formulation had increased 
cell function relative to samples cultured in M1. As fibroblast proliferation has been shown to 
hinder cardiomyocyte function, a possible explanation is that the 10% HS and CEE supplements 
in M2 helped limit proliferation relative to M1. This hypothesis is further supported with the 
LIVE/DEAD data obtained where samples cultured in M1 appeared to have more cells present 
within the constructs than samples cultured in M2 at days 7 and 14. Further, when comparing 
samples cultured in M2 media that did or did not contain Matrigel, no significant difference in 
function was observed at any time point for any functional parameter. Following this study, we 
chose to continue all subsequent work for this thesis with M2 media and to not include Matrigel 
in the hydrogel formulation used with our composite layers.   
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